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ABSTRACT
The aim of this study was to establish further knowledge of the endometrial cyclical immune
response and its controls and to relate this to previous pregnancy and in particular
unexplained subfertility. In addition the possibility of examining the direct effect of early
embryo products on individual endometrial leucocyte populations in vitro was explored.
The clinical aspects of this work were performed in the Centre for Reproductive Medicine,
Royal Victoria Infirmary, Newcastle-upon-Tyne and laboratory work was performed in the
Departments ofPathology and Immunology.
For the majority of the study subjects were recruited into one of four groups; parous fertile,
parous infertile, nulliparous, presumed fertile and nulliparous infertile. Timed endometrial
biopsies were obtained at 7 and 13 days following the urinary luteinising hormone surge in
separate cycles from these subjects. Further studies were performed using endometrial
biopsies obtained from hysterectomy specimens and decidua from first trimester
terminations ofpregnancy.
Endometrial leucocyte populations, their distributions and characteristics and their
endometrial milieu were examined primarily using double and single labelling
immunohistochemical techniques.
This work has shown that there are significant differences in the leucocyte populations of
infertile compared with fertile endometrium. In particular CD56-positive endometrial
granulated lymphocytes are present in greater numbers in the early secretory phase in
infertile endometrium and undergo a smaller increase in numbers as the cycle proceeds. In
addition a different balance of T-helper and cytotoxic T cells in both subfertile and fertile
endometrium at LH+7 compared with LH+13 has been seen. A significant difference in
endometrial leucocyte populations resulting from parity alone has been excluded such that
the need to examine parous and nulliparous endometrium separately when investigating
endometrial leucocyte populations appears to be negated, thus validating the results of some
previous authors.
It has also been shown in this study, that there can be no direct ovarian steroid effect on
endometrial leucocytes as they fail to express either oestrogen or progesterone receptors. It
has been shown however, that endometrial steroid hormone receptor expression is altered by
parity and fertility status, in particular surface epithelial progesterone receptor expression.
Previously reported differences in some adhesion molecule distributions between fertile and
subfertile endometrium have also been confirmed.
Further studies have shown that it is possible to isolate T cells from Pipelle samples of
endometrium in great enough numbers and purity to examine their functions in vitro without
prior cloning. In addition modified lymphocyte proliferation assays have been used to
examine embryo product influences on leucocyte responses. It would be possible therefore to
study the effects of individual embryo culture supernatants on isolated endometrial leucocyte
populations. This opens the way to further explore the gene product functions of an
individual blastocyst.
Thus these studies have contributed to the understanding of endometrial function in relation


















Embryo Influences on Endometrial Immunology
Endometrial Biopsy
Timing ofendometrial samples
Clearplan — One Step




Timed Endometrial Pipelle Biopsies (frozen)
Recruitment
1. Nulliparous infertile (unexplained) and 2.
Parous fertile (unexplained).
3. Nulliparousfertile (presumedfertile).
4. Parous fertile (proven fertile).
Endometrial sampling
Tissue processing





























































CONTROL OF THE ENDOMETRIAL ENVIRONMENT













Serum oestrogen and progesterone concentrations
The effect ofprevious parity andfertility status















THE CONTROL OF ENDOMETRIAL LEUCOCYTE
POPULATIONS
Introduction









































A. single labelling 89
B. double labelling 89
Evaluation 90
Results 90





















Total stromal cell counts 112
General distributionof leucocytes 112
Cyclical changes 113
Nulliparous versus parous 119
Infertile versus fertile 119
Nulliparous subfertile versus parous fertile 121
T cell sub-populations 122


















CD49a (VLA-1, Cdfa) 145
CD49d (VLA-4, a4Pi) 149
CD61 (13s subunit of avfa) 152
ICAM and VCAM 155





THE EFFECTS OF EMBRYO DERIVED FACTORS ON
ENDOMETRIAL LEUCOCYTES 164
Introduction 165
1. Evaluation of a Low Volume Leucocyte
Proliferation Assay. 171
Materials and Methods
Preparation ofperipheral blood lymphocytes 173





Experiment 1 - 96-well plates compared with
Terasaki plates. 175
Experiment 2 - Optimisation ofPHA
concentration 175
Experiment 3 - Optimisation ofcell concentration 175








2. Assessment of theEffect of Individual Embryo
supernatants on PHA induced peripheral blood
Leucocyte Proliferation. 180
Materials and Methods
Embryo and blastocyst supernatants. 181







Blastocyst versus non-blastocyst. 185
The effect ofPHA. 187
Conclusion 187
























Figure 1.1 Primary causes of infertility. 2
Figure 1.2 Cumulative conception rates in normal fertile couples
and couples with unexplained subfertility of greater
than 5 years duration. 3
Figure 1.3 The endometrial cycle. 8
Figure 1.4 Proliferative and late secretory phase endometrium.
H&E 9
Figure 1.5 Transvaginal ultrasound scans of uterus 11
Figure 1.6 Integrin subunit associations. 18
Figure 1.7 Endometrial leucocyte distribution throughout the
menstrual cycle and early pregnancy. 21
Figure 1.8 Pipelle endometrial sampler 31
Figure 1.9 Clearplan - One Step 33
Figure 2.1 Pipelle and frozen sections. H&E 43
Figure 3.1 Frozen sections of Pipelle endometrial samples single
labelled for ER-LH2 58
Figure 3.2 Frozen sections of Pipelle endometrial samples single
labelled for PGR. 59
Figure 3.3 The change in endometrial surface epithelial oestrogen
receptor expression. LH+7 to LH+13. 62
Figure 3.4 The change in endometrial surface epithelial progesterone
receptor expression. LH+7 to LH+13. 64
Figure 3.5 Serum oestradiol concentrations. LH+7 to LH+13. 65
Figure 3.6 Serum progesterone concentrations. LH+7 to LH+13. 65
Figure 3.7 Oestrogen and progesterone receptor expression in
endometrial stroma, glandular epithelium and surface
epithelium and taking into account fertility and parity. 67
Figure 3.8 Frozen sections of Pipelle endometrial samples labelled
for Bcl2. 74
vi
Figure 3.9 Endometrial expression of bcl-2 and Ki67. 75
Figure 3.10 Frozen sections of Pipelle endometrial samples single
labelled for Ki67 77
Figure 4.1 Paraffin wax sections of secretory endometrium double
labelled forCD45 and ER-6F11 91
Figure 4.2 Paraffin wax sections of early pregnancy decidua double
labelled for PGR and CD45 and for PGR and MT-1 92
Figure 4.3 Paraffin wax sections of endometrium double labelled for
MT-1 and ER-6F11 93
Figure 4.4 Paraffin wax sections of decidua labelled for oestrogen
receptor 94
Figure 4.5 Double labelling in secretory phase endometrium for PGR
and CD45 and forPGR and CD56 95
Figure 4.6 Double labelling in secretory phase endometrium for PGR
and MT-1 and for PGR and CD45 96
Figure 4.7 Frozen sections of Pipelle endometrial samples double
labelled for CD56 and bcl-2 101
Figure 5.1 Frozen sections of Pipelle endometrial samples labelled for
CD45 114
Figure 5.2 Frozen sections of Pipelle endometrial samples labelled for
CD56. 115
Figure 5.3 Frozen sections of Pipelle endometrial samples labelled for
CD3, CD14 and CD19 116
Figure 5.4 95% confidence intervals for the numbers of CD45 and
CD56 cells 118
Figure 5.5 CD45 changes from LH+7 to LH+13 120
Figure 5.6 CD56 changes from LH+7 to LH+13 120
Figure 5.7 Endometrial stromal leucocyte populations. Nulliparous
subfertile versus parous fertile. 121
Figure 5.8 Frozen sections of Pipelle endometrial samples labelled for
CD 8 and CD4 124
vii
Figure 5.9 Endometrial stromal T cell sub-populations. Stromal
labelling at LH+7 and LH+13. 125
Figure 5.10 Endometrial T cell sub-populations. CD8:CD4 ratio. 126
Figure 5.11 Frozen sections of Pipelle endometrial samples labelled for
TCRcc|3 and TCRyS 127
Figure 5.12 Frozen sections of Pipelle endometrial samples labelled for
CD57 128
Figure 5.13 Frozen sections of Pipelle endometrial samples labelled for
HLA-DR,CD69 and CD25 130
Figure 5.14 Endometrial expression of leucocyte activation markers 131
Figure 6.1 Frozen sections of Pipelle endometrial samples labelled for
CD49a (VLA-1, cciP.O 147
Figure 6.2 Endometrial CD49a expression at LH+7 and LH+13. 148
Figure 6.3 Frozen sections of Pipelle endometrial samples labelled for
CD49d (VLA-4 , a4|3,). 150
Figure 6.4 Endometrial expression of VLA-4 at LH+7 and LH+13. 151
Figure 6.5 Frozen sections of Pipelle endometrial samples labelled for
CD61 153
Figure 6.6 Endometrial expression of CD61 at LH+7 and LH+13. 154
Figure 6.7 Frozen sections of Pipelle endometrial samples labelled for
ICAM and VCAM 156
Figure 6.8 Frozen sections of Pipelle endometrial samples labelled for
P-selectin and E-selectin 159
Figure 7.1 8-cell human embryo and human blastocyst 170
Figure 7.2 Standard 96-well plate and Terisake plate 172
Figure 7.3 Scatter of inhibition and stimulation of peripheral blood
lymphocyte proliferation without PHA 186
Figure 7.4 Diagram ofMini MACS process 191
Figure 7.5 Data from FACS analysis 193
viii
TABLE OF TABLES
Table 2.1 Recruits to fertility/unexplained subfertility studies. 39
Table 2.2 Details of recruits to fertility/unexplained subfertility
studies 40
Table 3.1 Oestrogen receptor staining scores for fertile and subfertile
endometrium. LH+7 versus LH+13. 61
Table 3.2 Progesterone receptor staining scores for fertile and
subfertile endometrium. LH+7 versus LH+13. 63
Table 3.3 Oestrogen and progesterone receptor distributions.
Significances when comparing fertile versus subfertile and
parous versus nulliparous endometrium. 68
Table 3.4 Monoclonal antibodies 71
Table 3.5 Endometrial bcl-2 expression. LH+7 and LH+13. 73
Table 3.6 Endometrial epithelial expression of bcl-2. LH+7 versus
LH+13. 76
Table 3.7 Endometrial Ki67 expression. LH+7 and LH+13. 78
Table 3.8 Endometrial stromal expression of Ki67. LH+7 versus
LH+13. 78
Table 3.9 Endometrial epithelial expression of Ki67. LH+7 versus
LH+13. 79
Table 4.1 Monoclonal antibodies. 88
Table 4.2 Double labelling combinations 89
Table 5.1 Monoclonal antibodies 111
Table 5.2 Cyclical changes in endometrial leucocyte populations 117
Table 5.3 Endometrial leucocyte populations. Changes from LH+7
to LH+13 in paired samples. 119
Table 5.4 Cyclical changes in endometrial T cell sub-populations. 123
Table 5.5 Cyclical changes in endometrial leucocyte activation
markers. 129
ix
Table 6.1 Monoclonal antibodies 142
Table 6.2 Endometrial CD49a expression. LH+7 and LH+13. 146
Table 6.3 CD49a expression in endometrium. LH+7 versus LH+13. 146
Table 6.4 Endometrial VLA-4 expression. LH+7 and LH+13. 149
Table 6.5 Endometrial VLA-4 expression. LH+7 versus LH+13. 152
Table 6.6 Endometrial CD61 expression. LH+7 and LH+13. 152
Table 6.7 CD61 expression in endometrium. LH+7 versus LH+13. 155
Table 6.8 Endometrial ICAM expression. LH+7 and LH+13. 157
Table 6.9 Endometrial VCAM expression. LH+7 and LH+13. 157
Table 6.10 Endometrial P-selectin expression. LH+7 and LH+13. 158
Table 6.11 Endometrial E-selectin expression. LH+7 and LH+13. 160
Table 7.1 Comparison of 96-well plates versus Terasaki plates. 177
Table 7.2 Comparison of PHA concentrations in Terasaki plate. 178
Table 7.3 Comparison of cell concentrations in Terasaki plate. 179
Table 7.4 Effect of EBSS medium on cell proliferation. 180
Table 7.5 The effects of individual embryo culture supernatants on
PHA induced peripheral blood lymphocyte proliferation. 184
Table 7.6 The effects of individual embryo culture supernatants on
peripheral blood lymphocyte proliferation without PHA. 185
Table 7.7 Percentage inhibition of peripheral blood lymphocyte
proliferation by embryos. 187
Table 7.8 Percentage inhibition of peripheral blood lymphocyte






A couple is considered to be subfertile if they have failed to conceive after at least
two years of regular sexual intercourse. It is a problem affecting around 1 in 7
couples. In the UK it has been estimated (Fig. 1.1) that about 20% of subfertility is
primarily tubal in origin (blocked or damaged Fallopian tubes), 30% related to
ovulation failure (both female causes) and about 25% of fertility problems are mainly
male factor in origin. It is of interest that in around 38% of couples more than one
disorder is detectable, often a combination of male and female problems, whilst in
approximately 25% of cases, routine examination and investigation of a couple fails
to diagnose a cause (Hull 1992).
Fertility Investigation
Standard fertility investigations include a thorough history from and examination of
both partners and, depending on specific features of these, a battery of endocrine
tests. In addition laparoscopy and dye insufflation or other tubal patency tests are
performed and ovulation is confirmed in the female partner, usually by estimation of
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secretory phase serum progesterone concentration. Semen analysis is performed for
the male partner (RCOG 1992, 1998).
Unexplained Subfertility
Unexplained subfertility is generally defined as a failure to conceive over 2 years
with regular sexual intercourse in the face of normal fertility investigations. It is
unlikely however, that these couples are all identically affected; for example, in some
normal couples chance alone may have been responsible for their failure to conceive,
although 95% of "normal" couples will have conceived within two years of regular



















Figure. 1.2. Cumulative conception rates in normal fertile couples and couples with unexplained
subfertility ofgreater than 5 years duration (Hull et al. 1985).
Subtle combinations of sperm abnormalities or cervical mucus interactions may play
a role, whilst lifestyle, psychological and emotional factors may all play a part to
some degree in the aetiology of subfertility. Specific areas which are not amenable
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to standard investigations but which would be important candidates for the site of
abnormality in some cases of unexplained subfertility include; egg and sperm
function; tubal function as opposed to anatomy; the tubal environment acting as the
milieu for fertilisation; early embryo development and, most importantly, the
endometrium and its interactions with that embryo.
The endometrium must be implicated in at least some cases of otherwise unexplained
subfertility because of its relations to the embryo and its ability to support
implantation and trophoblast invasion.
Fertility Treatment
The main strategies for the management of fertility problems are correction or
bypassing of the problem. Tubal surgery and ovulation induction correct some of the
underlying problems, whilst abnormalities of sperm structure or function may be by¬
passed by means of specialised in vitro fertilisation (IVF) techniques such as
intracytoplasmic sperm injection (ICSI). By definition, as no specific pathology is
identifiable in couples with unexplained subfertility, directed corrective measures are
impossible. The treatment of choice therefore is to again by-pass any potential
problems and, whilst some units will perform intrauterine insemination with or
without ovulation induction, the "bottom-line" for management of this condition is
often assisted reproductive techniques (ART), namely in vitro fertilisation (IVF) or
gamete intra-fallopian transfer (GIFT). These can give a pregnancy success rate of
approximately 15-40% per cycle undertaken (Hull 1992) but as such, treatment is
relatively unsuccessful, with many couples failing to conceive each cycle.
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Although it is to be hoped that no pregnancy is undertaken lightly, the decision to
proceed to ART is a major one, which if successful may be amply rewarded. There
is a significant cost however, not only in financial terms but also emotionally and
socially to the couple undergoing ART particularly when unsuccessful. There is also
a not insignificant physical risk to otherwise healthy individuals. Major
complications include ovarian hyper-stimulation syndrome (OHSS),
thromboembolism and multiple pregnancy with its associated risks. It would thus be
of benefit to all, providers and patients alike if simpler, more straightforward
measures could be taken to correct at least some of problems currently labelled as
unexplained. Potential endometrial problems are not necessarily addressed by these
treatment strategies, although they may be modified by hormone regimes. Attention
needs to be paid to this aspect because endometrial factors causing subfertility may
well also have a bearing on the success of any of the above interventions.
There are as yet no clear diagnostic features relating to the endometrium in
unexplained subfertility and no proven therapeutic remedies in relation to
endometrial dysfunction. Thus although some investigators will perform luteal phase
endometrial biopsy, it is difficult at present to justify this procedure as anything other
than a research tool (Balasch et al. 1992, RCOG 1998).
The Endometrium
The endometrium lining the uterine cavity is a dynamic tissue throughout the
reproductive years. In the human, monthly menstrual cycles involve the shedding
and rebuilding of most of the endometrial thickness. The endometrium comprises
stromal, vascular and epithelial elements, all of which undergo cyclical changes
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influenced by the ovarian hormone cycles of oestrogen and progesterone secretion,
related to the process of ovulation. As ovulation occurs approximately mid-cycle
and implantation a few days later, it is likely that the characteristics of the
endometrium around this time must be at an appropriate "stage" for the successful
reception of a fertilised ovum. It would seem reasonable to presume that the
endometrium of fertile women share common characteristics which may be
identified and which may be absent or deranged in the endometrium of some women
in whom pregnancy appears unobtainable.
As has been suggested above, although not as yet amenable to diagnosis, the
endometrium remains a prime site for abnormalities in relation to subfertility. Two
studies up to now have suggested differences specifically in the endometrium of
women with unexplained subfertility (Klentzeris et al. 1993; Lessey et al. 1995). It
should be noted however, that unexplained subfertility can be primary or secondary,
whilst in general study controls have been parous fertile women. The possibility that
the endometrium of parous women may differ from that of nulliparous women has
not previously been taken into account. Studies involving malarial parasitisation of
the placenta in unigravid and multigravid women suggest that there is a permanent
effect on utero-placental immunology exerted by previous pregnancy and thus the
ability to withstand placental malaria resulting in a higher incidence of the disease in
primiparous women (Rasheed et al. 1993). The factor of parity may affect other
areas of endometrial function and therefore needs to be considered prior to further
studies.
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The Normal Endometrial Cycle (Fig. 1.3)
Immediately following menstruation only the basal layer of the endometrial stroma
containing the bases of glands and shut down spiral vessels remains. The surface
epithelium is absent. Although the basal layer of the endometrium undergoes some
necrosis and leucocyte infiltration prior to menstruation, it is mostly protected from
breakdown, presumably by supply from basal arterioles. Following menstruation
and under the influence of rising oestrogen concentrations, the residual glands, the
epithelium of which is initially low columnar, grows, producing pseudostratification.
The epithelium grows out of the glands, reaching that of neighbouring ones and
forming a continuous epithelial layer over the endometrial luminal surface. In
addition the stroma enlarges and unbranched spiral vessels begin to extend into it.
Under the influence of oestrogen, in the so-called proliferative phase of endometrial
development (Fig. 1.4a), the glands continue to grow having a straight, narrow
appearance. Mitotic figures are seen in the glandular epithelium, which becomes tall.
The stroma appears compact and cellular in this phase and again mitotic figures can
be seen. The incorporation of water into the stroma leads to the increase in its
thickness from 0.5mm to almost ten times that. Blood vessels grow freely through
the stroma leading to a highly vascular appearance.
Oestrogen promotes the synthesis of progesterone receptors in the endometrium such
that following ovulation, as ovarian progesterone production increases there is a
change in the character of the endometrium during what is termed the secretory
phase of the cycle (Fig. 1.4b). These changes are characterised by changes in the
7














Figure 1.4. a) Proliferative phase endometrium. H&E. (x20). b)
proliferative phase endometrium. H&E (x40). c) Late secretoryphase
endometrium. H&E (xlO)
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stromal, glandular and vascular elements of the tissue. The first observable change
denoting ovulation and occurring 36-48 hours later is the development of subnuclear
vacuolation in the glandular epithelial cells. These vacuoli disappear as the secretory
phase progresses, nuclei returning to their basal position, and the glands become
increasingly tortuous and dilated. Glycogen rich secretions appear in the lumen of
the glands, which are maximal in amount by 10-11 days after ovulation. The stroma
in the secretory phase of the cycle becomes increasingly oedematous. Oedema is the
result of oestrogen dependent effects on the intracapillary hydrostatic pressure. The
stromal cells themselves increase in size. At this stage the endometrial arterioles
growing towards the endometrial cavity from the basal vessels appear to take an
increasingly spiral course as they continue to grow without further increase in the
endometrial thickness. At this stage there is a three layer appearance of the
endometrium - the unchanged basal layer, the oedematous middle layer representing
about 50% of the endometrial thickness (sometimes known as the stratum
spongiosum) and the relatively dense superficial layer (stratum compactum).
Together the luminal two layers form the functional endometrium. This three-layer
appearance is reflected in the ultrasound appearance of endometrium in early
secretory phase (Fig. 1.5a).
In a non-conception cycle, the corpus luteum regresses leading to falls in both
progesterone and oestrogen concentrations. This results in a resolution of the stromal
oedema and reduction of endometrial thickness giving the more compact appearance
seen and the mid to late secretory phase appearance of dense endometrium on
ultrasound scanning (Fig. 1.5b). This physical shrinkage results in the buckling of
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Figure 1.5. Transvaginal ultrasound scans ofuterus demonstrating a) early secretory
phase endometrium and b) late secretoryphase endometrium.
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the spiral vessels which with accompanying vasoconstriction and relaxation results in
ischaemia of the functional layer of the endometrium. Leucocyte infiltration occurs
and overt necrosis follows. There is a natural break line between the relatively
protected and compact basal layer and the "spongiose" portion of the functional layer
of the endometrium and this subsequently sloughs off as part of the menstrual flow.
Haemorrhage occurs from the exposed vessels but their vasoconstriction and
formation of terminal clots, enhanced by oestrogen rising to commence the next
cycle results in haemostasis and cessation of menstruation. Regeneration, originating
from the basal layer, then proceeds.
If the oocyte derived from that ovarian cycle is fertilised, then implantation of the
developing embryo occurs in the mid-secretory phase when the progesterone
concentration and its influence are at their peaks. Successful conception and early
embryo attachment results in continued progesterone secretion and endometrial
decidualisation - notably persistence of stromal oedema and changes in stromal cell
morphology. The stromal cells enlarge further giving a plump, polygonal
appearance. Endometrial glands continue to increase in size with increased glandular
secretion and there is continued capillary growth. These changes spread through the
endometrium over the following days during implantation as secondary decidual
changes.
Progesterone support of the endometrium continues well into the succeeding
pregnancy as a result of the influence of human chorionic gonadotrophin (hCG) on
the ovarian corpus luteum. Failure of fertilisation or implantation leads to atresia of
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this structure, reduction in serum progesterone concentration, loss of hormonal
support to the endometrium and its subsequent breakdown culminating in
menstruation. Abnormalities of the implantation process would finally have a
similar effect, with the possibility of an observable delay in menses. Early
pregnancy failure results in miscarriage.
Endometrial Dating
The average human menstrual cycle is approximately 28 days and the endometrial
changes occurring each day have been characterised: 1. In order to date an
endometrial sample accurately; and 2. In order to identify any unexpected delay or
acceleration in progression of the cycle, which could account for fertility problems.
Noyes et al. (1950) in a much cited paper described the changes in endometrial
histology based on dating from the next menstrual period - considered to be a more
reliable landmark than the last menstrual period. Much debate has occurred over the
subject of dating of the endometrium. It is generally agreed that this is most accurate
and of most benefit when related to the time of ovulation rather than menses (either
last or next). The rationale for this is that ovulation is a significant, fixed point in the
hormone cycle upon which endometrial changes depend (Li et al. 1987; Shoupe et al.
1989). The problem with using ovulation as an anchor point for dating the
endometrium is that there are no reliable overt signs for its identification compared
with the onset of menstruation. Detecting the time of ovulation for the purposes of
this thesis is discussed below (Clearplan- one step).
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Previously much effort has been put into the assessment and treatment of "luteal
phase" or "progesterone deficiency" (LPD) (Li and Cooke 1991). This diagnosis
was based on the finding that endometrial biopsies, when dated histologically, were
on occasion found to be "out-of-phase" with the actual time of the cycle at which the
biopsy was taken. There is much contradictory evidence but as most of the
histological dating in this work was based on Noyes' criteria (Noyes et al. 1950), and
in most cases biopsies were timed from menses, much of the persuasiveness of the
arguments is lost. Luteal phase progesterone secretory abnormalities have not been
clearly demonstrated in relation to so-called LPD (Li et al. 1989b, 1990) and
importantly the potential therapeutic effect of exogenous progesterone has not been
confirmed in this situation. Finally a tendency to sample the endometrium as near to
menses as possible developed, the rationale being that this would show the maximal
cumulative effect of the "deficient" luteal phase.
Implantation
As ovulation occurs at approximately mid-cycle (day 14 of a 28 day cycle) and
implantation of a developing embryo about seven days later it follows that during the
secretory phase of the cycle the endometrium must be receptive to that embryo. In
humans the embryo must attach to and invade the endometrium in order to establish
the pregnancy.
The very earliest embryo to endometrial signalling was considered to be hCG
secretion by the embryo on the first post-implantation day (Bergh and Navot 1992).
Rudimentary evidence, however, for a pre-implantation embryonic influence on the
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endometrium is available in mice (Das et al. 1994), a blastocyst dependent induction
of heparin binding epidermal growth factor (HB-EGF) occurring in mouse
endometrium prior to blastocyst adhesion.
Blastocyst adhesion involves major co-operation between embryo and endometrial
epithelium and must provide the basis for many other interactions. Subsequent
invasion of the endometrium by the blastocyst involves the break down of epithelial
intercellular binding allowing trophoblast penetration to occur (Tabibzadeh and
Babaknia 1995).
Window of implantation
The cyclical changes in endometrial histology have been discussed. It is known that
human implantation occurs about seven days post ovulation at which time the
endometrium must be considered to be receptive. There has been described, a
window of opportunity for the embryo, during which time if it is appropriately
developed it may adhere to and implant in the endometrial tissue (Bergh and Navot
1992). Outwith this time implantation is either not favoured or possibly directly
inhibited leading to embryonic loss. The implantation window may involve many
features of the endometrial cycle but adhesion is a major factor and has most
precisely been described by Lessey et al. (1994) in terms of the changes in adhesion
molecules expressed by endometrial stroma (Chapter 6).
Other features of the endometrium that relate to the implantation window are the
appearance and disappearance of pinopodes and changes in the thickness of the
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epithelial glycocalyx - increasing in thickness in humans. These aspects are
reviewed by Giudice (1999).
Adhesion Molecules
Adhesion molecule is a general term used for a group of "families" of inter-cellular
and some cell-substratum receptors (Abelda and Buck 1990; Fleming 1990; Garrod
1993). There are several families of adhesion molecules:
i) Cadherins - these are the major adhesion molecules of adhesive cell junctions.
They are calcium dependent transmembrane glycoproteins and include neural (N-),
epithelial (E-) and placental (P-) cadherin. N-cadherin is found in adult neuronal and
muscle tissue and may have a developmental role in neuronal migration. E-cadherin
plays an important role in early embryogenesis at the compaction stage, whilst P-
cadherins are expressed in placental and epithelial cells and may be necessary for
implantation. The glycoproteins making up the classical desmosomal plaque for
cell-cell interactions are cadherins.
ii) Integrins - these are transmembrane glycoproteins made up of a and (3 subunits
which determine their cytoskeleton linkage ([3 subunit) and ligand binding specificity
(a subunit). a subunits, of which there are at least eight, may be associated by
covalent linkage to different (3 subunits to produce integrins with specific binding
qualities and functions (Fig. 1.6). They perform cell-cell and cell-matrix binding
functions. An integrin may bind several different ligands and a single cell type may
express multiple integrins.
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iii) Immunoglobulin super-family members - this group exhibits calcium
independent binding that may be hetero- or homophilic. They are of particular
importance in embryogenesis - neural cell adhesion molecule (N-CAM) for example;
and immune cell antigen recognition and adhesion. Immune cell adhesion molecule-
1 (ICAM-1, CD54) present on immune accessory cells has as its ligand the integrin
receptor lymphocyte functional antigen-1 (LFA-1, 0ClP2, CDlla) present on T cells,
whilst vascular cell adhesion molecule-1 (V-CAM-1) is expressed by endothelial
cells and binds very late antigen-4 (VLA-4, the integrin OC4P1).
iv) Selectins - this is a small family of adhesion molecules which unusually bind
carbohydrates. They are intimately involved in the inflammatory response: for
example, L-selectin which affects neutrophil adhesion to endothelium at sites of
inflammation.
Thus adhesion molecules include a vast array of compounds which perform a variety
of roles with regard to cell-cell and cell-extracellular matrix adhesion, but which, by
virtue of these specific links also have the potential to provide important signalling
functions.
The medical importance of adhesion molecules is becoming apparent as more is
being discovered about them. For example, in pemphigus vulgaris, autoimmunity to
desmosome cadherins develops, causing a breakdown of cell-cell junctions in
keratinocytes of the skin and giving rise to blistering. Autoantibodies of a different
specificity cause the disease of bullous pemphigoid as a result of failure of
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epidermis-basement membrane adhesion. A variety of rare immunodeficiency
diseases are known to be due to adhesion molecule abnormalities, for example,
leucocyte adhesion deficiency (LAD) is due to lack of specific integrin subunits
(Garrod 1993).
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It seems reasonable to presume that amongst their vast array of functions and
ubiquitous distribution, adhesion molecules would play a fundamental role in the
function of the endometrium; its cyclical response, its immunology and importantly,
its ability to attach, and maintain attachment to the developing embryo. Aberrant
expression of such molecules in endometrial sites could lead to failure of these
functions.
Endometrial Immunology
As foreign material, acceptance of an embryo must involve not only tolerance to that
foreign phenotype but also control of its growth in order to prevent excessive
invasion. This type of give and take suggests special modifications to the immune
response of maternal endometrium in order to cope with the establishment of early
pregnancy. Protection for the fetus against the maternal immune response is
conferred by the absence of classical major histocompatability (MHC) antigens on
trophoblast surfaces thus avoiding MHC dependent T cell activity (Johnson and
Christmas 1996). The invasive extravillous cytotrophoblast, expresses a class of
antigen (HLA-G) not seen in adult tissues (Kovats et al. 1990, Ellis et al. 1990)
which although remaining inert to T cell detection, conveys enough identity to
protect against the "absent self' responses of natural killer (NK) cells (Ljunggrens
and Karre 1990). Trophoblast also expresses cluster of differentiation (CD) 46,
CD55 and CD59, complement regulatory proteins which protect against antibody-
mediated attack (Johnson and Christmas 1996). Fetal immune cells, once developed,
are separated from maternal tissues by the trophoblast barrier thus avoiding any fetal
to maternal immune reaction.
19
The immune changes occurring in the endometrium throughout the menstrual cycle
have been described in detail (Starkey et al. 1991, Bulmer et al. 1991b, Klentzeris et
al. 1992). The stromal leucocyte populations in human endometrium vary as the
cycle progresses and it is because of these marked changes in leucocyte populations
and the need to invoke immunological factors in the process of implantation that the
importance of endometrial leucocytes and fertility has become an issue.
Endometrial granulated lymphocytes
Endometrial granulated lymphocytes (eGLs) or large granular lymphocytes (LGLs),
more recently termed "uterine NK cells" are a specific group of cells found in the
endometrium and decidua. Originally considered to be derived from stromal cells
and known as Kornchenzellen or "K" cells (Hamperl 1955, Hamperl and Hellweg
1958, Dallenbach-Hellweg 1981), eGLs were later identified by Bulmer et al. in
1983 and using immunohistochemistry, shown to express the leucocyte common
antigen (CD45) confirming their bone-marrow origin.
These cells possess small oval or indented hyperchromatic nuclei and contain
phloxinophilic cytoplasmic granules (Pace et al. 1989). They are found throughout
the endometrial stroma and in decidual tissue either scattered singly or in small
aggregates associated with endometrial glands or spiral arteries (Klentzeris et al.
1992, Bulmer et al. 1991a).
In the non-pregnant endometrium there is a cycle stage dependent increase in the
numbers of eGLs, occurring between LH+7 and LH+13 (denoting 7 and 13 days
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respectively, from the luteinising hormone surge), such that although at LH+4 eGLs
make up 45% of endometrial leucocytes, the proportion of leucocytes which are
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Fig. 1.7. Endometrial leucocyte distribution throughout the menstrual cycle and early pregnancy
(Bulmer et al. 1991b).
Large numbers are "shed" at menstruation although it has been suggested as a result
of their changing appearance at this stage that they may be undergoing apoptosis
premenstrually (King et al. 1989).
In first trimester decidua around 75% of endometrial leucocytes are eGLs (Bulmer et
al. 1991b) but there is a general decline in numbers as pregnancy progresses. Bulmer
and Sunderland (1984) and Bulmer et al. (1987) characterised these cells to be of
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early T cell lineage expressing CD2 (E-rosette receptor). They fail however, to
express other major mature T cell markers; CD3, CD4, CD5 and CD8. They react
with OKT 10, a B and T cell marker which is not present on mature lymphocytes and
CD7 the T cell differentiation antigen. Further characterisation of their phenotype by
Ritson and Bulmer (1987), Pace et al. (1989) and King et al. (1991) [Appendix 1] has
led to the finding that they are similar to a small subset of peripheral blood NK cells.
It is of interest that the murine equivalent cells - granulated metrial gland cells -
have in gene-ablated mice been assigned NK cell lineage (Croy et al. 1997), and that
their absence results in implantation abnormalities (Guimond et al. 1997). There is
no known human deleted equivalent.
The origins of the increased population of eGLs are considered to be mainly by local
proliferation. The evidence for this comes from the fact that emigration from
peripheral blood, the logical alternative, would be presumed to give cells with a
similar phenotype. The eGL phenotype is virtually exclusive to endometrium and
comparable cells are rare in peripheral blood. In addition, examination of
endometrial tissue has shown that although there are few mitotic figures seen in the
population, the co-expression of Ki67 (a product of cell replication found in any cells
not in G0 phase) increases as the cycle progresses (Pace et al. 1989, Tabibzadeh
1990a, King et al. 1991). This is in keeping with the observed increase in population
numbers. Klentzeris et al. (1992) suggest that this is supported by their findings that
CD2 expression in eGLs decreases as the cycle progresses, perhaps as a lag in its
manufacture in a rapidly expanding population, resulting in a larger proportion of
less well differentiated eGLs in the later stages of the cycle. The control of this
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proliferative activity has yet to be elucidated. Loke and King (1995) suggest that
both oestrogen and progesterone are essential for their presence in the endometrium
of ovariectomised women. It is likely that there are local secondary factors which
may be under overall hormonal control, although Klentzeris et al. (1992) argue that
the biggest rate of proliferation of eGLs occurs when secretory phase steroid
hormone concentrations are waning premenstrually. Critchley et al. (1996) however,
found no significant change in the numbers of CD56 positive cells in decidua
following the administration of the antigestogen RU486 in vivo.
It is possible that circulating eGL-like peripheral blood NK-cells represent a transfer
of bone marrow-derived cells to the endometrium as a topping-up process or as a
source of precursor for subsequent population expansion (King et al. 1991). Evidence
for the recruitment of leucocytes from the endometrial vascular system comes from
the findings that there are larger numbers of eGL-like peripheral blood NK cells in
females than males (King et al. 1991) and that specific chemoattractant agents
(interleukin-8 [IL-8], monocyte chemoattractant protein-1 [MCP-1] and cyclo-
oxygenase-2 [COX-2]) have been located at perivascular sites at crucial times of the
cycle (Jones et al. 1997b).
The functions of eGLs are poorly understood but have been mostly studied in cells
derived from early pregnancy decidua rather than non-pregnant endometrium. They
are known to exhibit a degree of activation; 40% express CD69 and 20% are HML-1
positive (King et al. 1991). These are known leucocyte activation markers. In
addition eGLs can be made, in vitro, to exhibit NK-type functions and are
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interleukin-2 (IL-2) responsive, probably via the IL-2R(3 sub-unit which they express
(Starkey et al. 1991). They are cytotoxic to the NK cell target, K562 cell line, a
function enhanced by IL-2 stimulation. They can be made, by prior incubation with
IL-2 to become cytotoxic to BeWo and JEG-3 choriocarcinoma cell lines, fetal
fibroblasts and normal human trophoblast (King and Loke 1990a, Ferry et al. 1991).
This is a phenotype dependent observation; Christmas et al. (1990), found that CD16
positive cells had high cytotoxicity whilst that of CD16 negative clones was low.
Cytotoxic clones were almost all CD2 positive. Non-cytotoxic clones were CD2
negative.
NK cell activity is HLA independent. NK cells detect cells that do not possess MHC
molecules that is cells that are "non-self' (the "missing self' hypothesis) (Ljunggren
and Karre 1990). They are relatively indiscriminate therefore with respect to foreign
cells. In their similarity to NK cells it can be seen that eGLs may or may not play a
role in the control of trophoblast invasion of the endometrium. Deniz et al. (1994)
also found that CD 16 negative eGLs had lower cytotoxic activity than their
peripheral blood equivalents against Molt 4 and BSM cell lines, suggesting a role for
the CD 16 antigen but in addition they found that the presence of HLA-G appeared to
significantly protect cells from eGL cytotoxicity, protection which is not afforded
against peripheral blood cells. Furthermore, Bulmer et al. (1984) reported that eGLs
are abundant in decidua where trophoblast invasion is least prominent and they are
not seen in large numbers at the site of tubal ectopic implantations unless there is
decidualisation of tubal mucosa, whilst they are present in the uterus in this
condition. Thus the direct effect of eGLs on trophoblast control seems less likely.
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Deniz et al. (1994) also reported that eGLs could exert an effect on an in vitro mixed
lymphocyte response (reported to be inhibitory using freshly prepared clones) whilst
Christmas et al. (1990) have shown the production of interferon y (IFNy), tumour
necrosis factor a (TNFa) and transforming growth factor (3 (TGF(3) in varying
amounts by eGL clones. This supports the idea that these cells may act in a
regulatory fashion within the endometrium rather than through a direct action on
trophoblast. Clarke et al. (1994) have confirmed eGL production of TGF(3 in vitro,
and Saito et al. (1993) detected mRNAs coding for granulocyte colony stimulating
factor (G-CSF), granulocyte and macrophage colony stimulating factor (GM-CSF),
macrophage colony stimulating factor (M-CSF), TNFa, IFNy and leukaemia
inhibiting factor (LEF) in eGLs isolated by cell-sorting from first trimester decidual
tissue. Cultures of these cells produced the respective proteins, detected by enzyme-
linked immunosorbent assay (ELISA) and bioassays, thus lending further weight to
the idea of a regulatory role.
Thus eGLs are endometrial stromal cells of bone marrow origin with NK cell-like
features, and which proliferate in the secretory phase of the menstrual cycle and
persist into early pregnancy at decidual sites both at and distant from the site of
implantation. The control of their numbers and their functions in this situation are
not fully elucidated. Whilst direct cytotoxic effects on trophoblast may appear less
likely, a regulatory function could be most important.
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Endometrial T cells
Endometrial T cell numbers are believed to be relatively constant throughout the
menstrual cycle (Starkey et al. 1991, Klentzeris et al. 1992) (Fig. 1.7). The majority
of endometrial T cells are cytotoxic / suppressor type (CD8 positive) with a
CD8/CD4 ratio of 2.8, again believed to remain fairly constant throughout the cycle
(Klentzeris et al. 1992). Most T cells in the endometrium express T cell receptor ap
(TCRaf)) subtype with only a small minority expressing the y8 antigen (Vassiliadou
and Bulmer 1996). aP positive T cells are scattered throughout endometrial stroma
and form small aggregates towards the basal layer of the endometrium (Klentzeris et
al. 1992). Their specific functions are unclear; however, as unlike eGLs their
phenotypes are common to T cells at other sites and in the blood and not peculiar to
the endometrium then normal T cell functions might be expected. Whether or not T
cells contribute directly to the control of implantation is debatable. T cells by virtue
of a wide range of soluble products, which act locally, are capable of co-ordinating
and modulating the local immune response. Typically they recognise antigens
presented in relation to class II MHC molecules on a cell's surface and respond
appropriately according to their sub-type.
Trophoblast in contact with decidual tissue does not, as discussed earlier, express
classical class I or class II MHC antigens and consequently cannot be directly
responsible for eliciting an aggressive aP positive T cell response. Thus a direct
effect of aP positive T cells on implantation is unlikely.
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Wegmann et al. (1993) discussed the likely effects of the balance of T cell functions
in the uterus of the mouse. They suggested that the production of the correct balance
of T cell derived cytokines is crucial to embryo survival. So-called TH1 cytokines
(IL-2, rFNy and TNF) produced by some helper T cells are considered to be
generally harmful to pregnancy maintenance. They hypothesised that IL-4, 5, 6 and
10, coined TH2 cytokines, protect a conceptus which produces them by down-
regulating the production of ThI cytokines. In mice these cytokines have been
detected in supematants of decidual cell cultures, implying production at the feto-
matemal interface (Lin et al. 1993). Th2 cytokines are involved in B cell
development, favoring the humoral immune response: ThI cytokines favour the
cytotoxic immune response. This may be reflected in altered immunology generally
in pregnancy resulting in exacerbation of humoral dependent auto-immune
conditions e.g. systemic lupus erythematosis (SLE) and improvement of conditions
dependent primarily on the cell mediated response e.g. rheumatoid arthritis. It is
postulated that any local stimulus resulting in an imbalance of these two groups of
cytokines, for example infection favoring a cell-mediated response might affect
implantation and early pregnancy survival.
Further to these discussions, it is clear that local cytokines may affect NK cell
activity, for example via IL-2 production. There is some evidence that peripheral
blood NK cells are effectors in the induction of cytotoxic T cells from precursor to
effector cells - a function of the CD56 antigen which is blocked by anti CD56
monoclonal antibodies (Kos et al. 1995). It is possible that a similar influence by
CD56 positive eGLs may prevail in the endometrium also.
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The function of y5 positive T cells in the endometrium is unknown. They are
capable of non-MHC restricted killing and in mice, whilst present in greater numbers
than in human endometrium, are capable of trophoblast recognition (Heybourne et
al. 1994). A role in trophoblast / endometrial interaction has not been determined in
humans but in this situation abnormal function could potentially result in altered
fertility.
Endometrial macrophages
Macrophages comprise 10-30% of endometrial leucocytes (King et al. 1991,
Klentzeris et al. 1992) (Fig. 1.7). Various opinions have been given with regard to
their numbers throughout the menstrual cycle. Starkey et al. (1991) found them to
remain fairly stable in number until menstruation when their numbers increased,
whilst Klentzeris et al. (1992) found their numbers to increase in the late secretory
phase. There is no evidence to suggest any endometrial sub-specialisation and
although highly activated in pregnancy, their functions would be expected to be
similar to those of macrophages at other sites providing a non-specific defence
against infection (Johnson and Christmas 1996). The perimenstrual increase in
numbers may be related to the structural endometrial remodelling required during
and following menstruation. Many will be lost during menses reducing the numbers
for the start of the next cycle.
Endometrial B cells
There are very small numbers of scattered B lymphocytes in the endometrium.
There appears to be no real fluctuation in their numbers. Any specific endometrial
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functions have not been evaluated and any increase in their numbers is likely to be
related to infection.
Embryo Influences on Endometrial Immunology
As has been suggested above even pre-implantation embryos may have specific
effects on the endometrium. In addition once adhesion has occurred there is set in
train one of the most complex systems of co-operation between what are essentially
two separate organisms. It is well known that the developing embryo and fetus
initially promotes its own survival by the secretion of hCG which results in
maintenance of the ovarian corpus luteum and its secretory function - mainly
progesterone production. What is much less well understood are the local
interactions between embryo and endometrium. The physical attachment and
invasion of the embryo have been considered but adhesion molecules have
messenger functions as well as structural and this attachment process may give rise
to a cascade of downstream events. In addition the embryo is a source of cytokines -
local messenger molecules which may well have a modulatory function on the
endometrium. Previous attempts have been made to identify proteins secreted by
pre-implantation embryos. The effects of these proteins in vivo on endometrial
function, in particular immunological function, are unknown. This aspect of fertility




When required endometrial biopsy, although an invasive procedure, is relatively
simple and safe to perform as an outpatient (Li and Cooke 1990). Outpatient
endometrial sampling is most usually used in younger women with dysfunctional
uterine bleeding where hysteroscopy is not mandatory, or in older women with
postmenopausal bleeding in conjunction with vaginal ultrasound scanning. There is
as yet insufficient evidence to support the routine use of endometrial sampling as part
of the work-up for fertility assessment (RCOG 1998).
A variety of disposable samplers are available, but the sampler favoured for the
following studies was the Pipelle endometrial sampler (Euro Surgical Ltd.,
Guildford, UK) (Fig. 1.8), which can be inserted through the cervical canal without
analgesia with a minimum of dysmenorrhoeic type discomfort for most women. The
endometrial biopsy is obtained by withdrawing the central core of the sampler
producing a degree of suction adequate to aspirate endometrium through the side port
near the tip whilst moving it around the uterine cavity [Appendix 2]. About 1ml of
sample can be obtained, although smaller samples would be produced if an attempt
was made to direct the biopsy to a particular site in the uterus. Good volume samples
can be obtained and processed immediately (Chapter 2 - Materials and Methods).
Vaginal spotting may succeed sampling and subsequent menstruation is usually
normal. Complications, which potentially include uterine perforation and infection,
are rare (Li and Cooke 1990).
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In order to correctly sample the uterus and make sense of the histological findings
when the biopsy is examined, its timing needs to be related to ovulation. Various
markers for this have been used previously - basal body temperature (BBT) changes,
ultrasound scan follicular tracking, last menstrual period or luteinising hormone (LH)
surge, either urinary or serum. For the purposes of the present studies urinary LH
surge identified by Clearplan (Unipath, Bedford, UK) kits was used (see below).
Ultrasound and identification of the serum LH surge are the best markers of
ovulation but would have required an unacceptable number of hospital visits for
subjects.
Clearplan - One Step
This urine test kit is marketed to the public as an ovulation predictor kit, designed to
enhance a couple's chance of conceiving by making them aware of the "fertile
period" (Fig. 1.9a). It is designed to detect the onset of the LH surge occurring 32 to
38 hours before ovulation and which is approximately coincident in serum and urine
(Corsan et al. 1990). LH is a di-peptide glycoprotein sharing an a sub-unit structure
with those of follicle stimulating hormone (FSH), human chorionic gonadotrophin
(hCG) and thyroid stimulating hormone (TSH). The (3 sub-unit determines the
biological activity and is structurally and functionally distinct from the other
glycoprotein hormones, although hCG and LH 3 subunits share 85% sequence
homology and potentially therefore cross-react.
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b)
Lli surge = line in the large window is as dark as or darker than the line in small window.
No LH surge — no line in large window, or tine pater than line in small window.
Figure 1.9. Clearplan - One Step, a) test device, b) interpretation ofresult.
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Clearplan One-Step is basically an immunoassay using chromatography to separate
bound and free coloured label. Urine moving along the device first comes into
contact with mouse monoclonal antibody to the (3 subunit of LH, which binds to the
hormone if present and is mobilised into the urine. This antibody is labelled with
blue latex. The second antibody is fixed below the test window and binds the a
subunit of LH, thus immobilising the hormone and its blue latex labelled primary
antibody, producing a blue line. The test incorporates a control window to ensure
proper use of the kit. This contains fixed anti-mouse antibody which will pick up
excess and unbound anti-LH antibody drawn along the device in the urine and which,
bearing the blue latex will again produce a blue line. This line will only develop
therefore if urine has passed along the whole device ensuring that there is adequate
coverage of the test window. It can be seen that this window will contain a blue line
even in the absence of LH in the urine sample and thus acts as a control (Fig. 1.9b).
A kit where a blue line does not develop in the control window cannot be considered
valid as a false negative test may result.
Schmultzer et al. (1994) described the use of Clearplan kits in stimulated and
spontaneous ovarian cycles and suggested a specificity of 100% and sensitivity of
97.5% (100% and 100% respectively in spontaneous cycles) for its detection of the
LH surge. It has however, been shown to be less efficient than laboratory urine LH
testing by Anderson et al. (1996) in a program for donor insemination treatment. It is
likely that personal motivation is important in the appropriate use of the kits and this
may differ in different situations.
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Aim of This Thesis
The aim of this thesis is to establish more information about the significant problem
of unexplained subfertility. It can be seen from the above discussion that the
endometrium is a highly complex and dynamic structure. It is unlikely therefore, that
it serves purely as a passive recipient of an embryo for implantation. There is
growing evidence that specific endometrial features are required to be present around
the time of implantation and there is therefore the possibility that abnormalities in the
cyclical events of the endometrium may affect fertility.
To this end the hypotheses which have been tested are;
• endometrial immunological changes are directly controlled by ovarian sex
steroids;
• endometrial cell proliferation and demise are altered in unexplained subfertility;
• endometrial leucocyte populations are altered in unexplained subfertility;
• endometrial adhesion molecule distribution is altered in unexplained subfertility;
• previous parity affects endometrial immunology and adhesion molecule
distribution; and






This chapter describes the processing of specimens for the subsequent studies and
includes a discussion of subject recruitment. The methods used to examine
specimens are described as are the techniques used for the statistical analysis of the
results. The methodologies for specific studies are described in the appropriate
chapters' experimental design.
1. SampleAcquisition
Timed Endometrial Pipelle Biopsies (frozen) (Chapters 3.5 and 6)
Recruitment
In this chapter Pipelle samples were obtained from volunteers in each of four groups:
1. Nulliparous infertile (unexplained) and 2. Parous infertile (unexplained).
These women were recruited by written invitation sent to all those with unexplained
subfertility on the National Health Service (NHS) waiting list for assisted
reproductive treatment at the Centre for Reproductive Medicine, Royal Victoria
Infirmary, Newcastle-upon-Tyne. One hundred and eighty one women with
unexplained infertility of at least two years standing were approached by letter: fifty-
five replied, thirty-two positively. Six other subjects were recruited from clinics and
by word of mouth. Recruiting from clinic was not very fruitful because many
women, particularly nulliparous women, were seen with less than two years'
subfertility and were therefore excluded. Of those who had had at least two years'
problems, parous women were excluded from NHS treatment and were therefore
either undertaking private treatment at the first opportunity or would not be
undergoing treatment and having no wish to return to the unit could not be recruited.
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All women recruited to groups 1 and 2 had had basic fertility investigations
performed including confirmation of ovulation and confirmation of tubal patency and
exclusion of endometriosis. Their partners had submitted normal sperm samples.
3. Nulliparousfertile (presumedfertile)
These women were recruited mainly by word of mouth. A few volunteered
following application to pre-clinical medical students. Three were recruited from the
donor insemination programme having had ovulation and tubal patency confirmed
but as there was no waiting list for donor insemination, recruiting from this source
was limited as participation would entail at least a two to three month delay in
commencing the treatment program. These women as a group have clearly not
proceeded as far along their reproductive path as those of the other groups, a factor
reflected in their average ages (Table 2.2).
4. Parous fertile (proven fertility).
These women came from family planning clinics and sterilisation waiting lists, again
by written invitation and also by word of mouth from subfertile subjects, associates
etc. Women from the "fertile" groups were excluded if any form of hormonal
treatment including the oral contraceptive pill or an intra-uterine contraceptive
device (IUCD) were used as forms of contraception.
Nulliparous women had had no pregnancies (including miscarriages and terminations
- nulligravid). Parous women had had at least one pregnancy delivering after 24
completed weeks.
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In total sixty-four women were consented into the subject groups (Tables 2.1 and
2.2).
Twenty-three women defaulted from the study, fifteen prior to any sampling and
eight following a single sample. Only one woman formally withdrew prior to the
study. One subject was withdrawn because of poor tolerance of the first sample, one
withdrew because of insurmountable problems interpreting Clearplan kits, and three
withdrew to commence fertility treatment. Five nulliparous women were withdrawn
because of difficulties passing the Pipelle sampler. Although their notes were
annotated as such, of the four subfertile women in whom sampling was impossible
two have subsequently undergone IVF and embryo transfer (ET) without difficulty.
ET catheters are narrower gauge, more flexible and the need to insert them despite
discomfort is clearly greater, hence the discrepancy.
Table 2.1. Recruits to fertility/unexplained subfertility studies.
Total Number of samples submitted
Recruited 2 1 0
Nulliparous fertile
(NF)
12 5 2 5
Nulliparous infertile
(NI)
27 8 6 13
Parous fertile 11 8 2 1
(PF)
Parous infertile 14 5 5 4
(PI)
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Table 2.2. Details of recruits to fertility/unexplained subfertility studies.
Mean age- Mean cycle Mean parity No. of LH+7 No. of
years length-days samples LH+13
(range) (range) samples
Nulliparous 24.6 29.1 0+0 7 5
fertile (NF) (19-30) (24 - 35)
Nulliparous 32.3 28.9 0+0 12 10
infertile (NI) (28 - 37) (26 -35)
Parous 33.8 29.1 2+0 9 9
fertile (PF) (27 - 40) (26 - 35)
Parous 34.9 28.2 1+0 10 5
infertile (PI) (29 -39) (25 - 32)
Endometrial sampling
Pipelle samples (Appendix 2) from these subjects were obtained on days LH+7 and
LH+13 in separate cycles where LH+0 is the day of onset of the LH surge detected
by Clearplan urinary test kits (Introduction). Four women failed to provide an LH+13
sample because of "early" menses commencing on day LH+13 on one or more
occasion. All subjects providing endometrial Pipelle samples received an
information leaflet and gave their informed consent [Appendix 3]. Unless previously
sterilised, all were advised to use condoms during the test cycles in order to avoid
sampling a conception cycle. There were no complications of sampling other than
vaginal spotting in any of the subjects.
Tissue processing
Once obtained, endometrial samples were each extruded from the Pipelle sampler
into a foil formed cup then immediately snap frozen in liquid nitrogen cooled
isopentane (methyl-2-butane, BDH Chemical Company Ltd., Poole, UK) to form a
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frozen tissue block. Samples were stored in cryotubes (Bibby Sterilin, Stone, UK) at
- 70°C.
6pm cryostat (Reichert Jung) sections of endometrium from each sample were cut
onto poly-L-lysine (Sigma Chemical Co., Poole, UK) coated slides and air-dried
overnight at room temperature. They were fixed in acetone (BDH) for ten minutes,
again at room temperature and stored, foil wrapped, at - 20°C until used.
Haematoxylin and eosin (H&E) staining was performed on sections of all tissues to
ensure that an adequate amount of endometrium, with well-preserved morphology
was present (Fig. 2.1).
Tissues Derived From Pathology Specimens (Chapter 4)
Frozen blocks
In Chapter 4 reference is made to samples of endometrium derived from
hysterectomy specimens and from first trimester terminations of pregnancy. Blocks,
5-10mm cubes of endometrium with attached myometrium to allow good orientation,
were snap-frozen in liquid nitrogen cooled isopentane. Decidual tissue, identified
macroscopically by its opaque grey-white, solid appearance, was obtained from early
gestation suction terminations of pregnancy with fully informed consent. Decidual
tissue was irrigated in normal saline to remove excess blood and snap-frozen in a
similar way in 5-10mm cubes. All blocks were stored at -70°C. Storage and
preparation of slides was similar to that already described.
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H&E staining was performed to check orientation at cutting to ensure that an
adequate amount of tissue with normal well preserved morphology was included in
sections (Fig. 2.1).
Paraffin-embedded blocks
Paraffin sections were prepared from archival blocks of endometrium and decidua.
They were cut onto 3-aminopropyltriethoxysilane (APES) (Sigma) coated slides at a
thickness of 3pm.
Embryo supernatants (Chapter 7)
The acquisition of embryo supernatants and subject selection for this is discussed in




Frozen sections were unwrapped, allowed to warm to room temperature and
rehydrated prior to immunohistochemical processing.
Paraffin-embedded tissue
After the sections were deparaffinised in xylene (BDH) and rehydrated in graded
alcohols, antigen unmasking was achieved by microwaving (800W, Panasonic) for 2
x 5 minutes either in 0.01M sodium citrate buffer (pH 6.0) (BDH) (Norton 1993,
Cattoretti et al. 1993) or, for ER-6F11 (see Table 4.1), in ImM ethylenediaminetetra-
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Figure 2.1. a) Pipelle sample ofendometrium H&E. (x20). b) Frozen section
endometrial block. H&E. (xlO).
43
acetic acid (EDTA) buffer (pH 8.0) (BDH). After cooling, immunohistochemical
staining was performed as outlined below.
Single Immunohistochemical Labelling (Chapters 3, 4, 5 and 6)
Single immunohistochemical labelling of frozen sections was performed using the
Vectastain Elite ABC kit (Vector Laboratories, Peterborough, UK) and secondary
and tertiary reagents were prepared according to the kit instructions given. This kit is
based on the avidin-biotin-peroxidase complex (ABC) immunohistochemical
technique described by Hsu et al. (1981). The procedure was carried out at room
temperature except where otherwise stated. After initial rehydration for 10 minutes
in 0.05M Tris buffered 0.15M saline pH 7.6 (TBS) (Sigma), sections were overlain
for 30 minutes with non-immune serum (provided as a reagent in the kit) from the
same species as that in which the secondary antibody was raised. Its purpose is to
block non-specific binding by excess antibody. Normal serum was then drained off
and the slides incubated with primary monoclonal antibodies (mAb) at the
appropriate dilution in TBS for 60 minutes. After washing in TBS, biotinylated
secondary antibody was applied for 30 minutes followed by further washing and
incubation with ABC reagent (an avidin and biotinylated peroxidase preparation) for
30 minutes. The detection of labelling with primary monoclonal antibody in this
assay is dependent on the ability of avidin, an egg white protein to bind multiple
biotin molecules (there are four binding sites per avidin molecule). As multiple
biotin molecules can be bound to a single peroxidase molecule a complex structure
of avidin, biotin and peroxidase can result based on a single antibody molecule. This
leads to a major amplification of apparent labelling that can then be visualised by
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conversion of a peroxidase substrate to a coloured product. Thus a third wash in
TBS was followed by incubation with the peroxidase substrate, 3-3' di-
aminobenzidine (0.1%, DAB, Sigma) prepared in TBS with 0.01% hydrogen
peroxide (H2C>2, BDH) giving a brown reaction product (Chapters 3, 4, 5 and 6). In
Chapter 4 amino-ethyl carbazole (AEC) (Vector), supplied as a kit reagent was also
used as a peroxidase reagent, producing a red reaction product. The reaction was
monitored microscopically to avoid excessive colour development that would
obscure the tissue morphology, and stopped after approximately 5-10 minutes for
DAB, and approximately 15 minutes for AEC, by washing in excess water. The
sections were lightly counterstained with Mayer's haematoxylin producing purple-
blue nuclear staining for morphology.
Controls
Negative controls, excluding primary antibody were included in all
immunohistochemistry runs to assess background staining and non-specific labelling.
Positive controls included frozen sections of human tonsil for leucocyte antigens and
adhesion molecules whilst breast tumour tissue provided the positive control for
steroid hormone receptors.
Double Immunohistochemical Labelling (Chapter 3)
Double immunohistochemical labelling was performed in order to detect co-
expression of steroid receptors by endometrial leucocyte populations. Sections were
initially labelled for leucocyte antigens with the ABC method described above using
AEC. After development of the AEC red reaction product, sections were washed in
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TBS for 10 minutes, overlain with blocking serum for a further 30 minutes and
incubated with the second primary monoclonal antibody directed against oestrogen
receptor (ER) or progesterone receptor (PR) for 60 minutes. After further washing in
TBS, sections were incubated for 30 minutes with biotinylated secondary antibody,
washed in TBS and incubated with ABC alkaline phosphatase (Vectastain alkaline
phosphatase kit) for 30 minutes. The reaction was developed using alkaline
phosphatase substrate kit III (Vecta Blue)(Vector). Sections were incubated at room
temperature and the reaction was monitored microscopically until the appropriate
blue colour developed after approximately 10 minutes. The reaction was stopped by
excess water. Double-labelled slides were not counterstained.
Controls
Positive controls were as for single immunohistochemical labelling (above).
Negative controls were performed for each tissue by replacement of both primary
antibodies with normal serum. In addition for each double labelled section the
primary antibody was omitted from each stage of the technique separately to produce
the appropriate single immunolabelling. The different antibody-enzyme-substrate
combinations were also reversed in the double labelled runs to confirm consistency
of the reaction patterns with the different enzyme labels. The single labelled and
double labelled slides were compared to confirm consistent distribution of labelling
in each tissue and to check that no spurious double labelling had occurred.
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Blocking Endogenous Peroxidase Activity
Endogenous peroxidase can cause non-specific staining with the peroxidase
substrates DAB and AEC in immunohistochemistry. Routinely endogenous
peroxidase activity is reduced by incubation with H2O2 in methanol at the start of the
procedure. This technique was used for double labelled and paraffin sections.
Blocking of endogenous peroxidase with phenylhydrazine was evaluated for use in
frozen endometrial biopsies in this study because of the finding in some negative
controls of staining due to endogenous peroxidase, despite routine treatment with
H2O2. This method has routinely been used in the Department of Pathology during
the preparation for immunostaining of cytospin preparations of pleural and peritoneal
fluid. The technique has been shown to be non-deleterious with respect to
lymphocyte surface antigens (Andrew and Jasani 1987).
Blocking of endometrial endogenous peroxidase with phenylhydrazine was initially
evaluated in frozen sections of tissue obtained from hysterectomy specimens from
pre-menopausal women removed for non-endometrial pathology. It was tested at
various stages in the immunohistochemical process and was considered to be most
effective after the use of secondary antibody. There was no apparent effect on
antibody binding due to cell surface damage or loss of surface antigens. Thus,
following the application of biotinylated secondary antibody sections were washed in
warm TBS for 10 minutes and then washed in a solution of 0.1% phenylhydrazine
(Sigma Chemical Co.) at 37°C for 45 minutes. The blocking step was followed by




Sections labelled with DAB were dehydrated in increasing alcohol concentrations
followed by clearing in xylene. They were overlain with DPX (Raymond A. Lamb
Ltd., London, UK) a synthetic resin mountant, and mounted with coverslips.
Sections labelled with alcohol soluble products (AEC, Vecta Blue) were overlain
with Supermount (Biogenex, San Ramon, USA), dried overnight in air and then
permanently mounted with DPX and coverslips.
3. Evaluation
All labelled sections were examined by eye under the microscope, either
qualitatively for distribution of labelling or quantitatively using a 10x10mm graticule
for individual cell counts.
Quantitative assessment
For quantitative assessment of immunohistochemical labelling (Chapter 5), sections
were examined microscopically under high power (x40 objective and xlO eye-piece)
and labelled cells counted directly using a 10x10mm graticule. The counts were
expressed as a proportion of the total cell numbers in a given area.
Semi-quantitative assessment
For some antibody labelling a counting technique was not suitable either because of
the overlapping of staining, its extracellular nature or a non-uniformity of labelling
throughout a tissue. In these situations tissue areas under examination were given a
score to indicate the proportion of cells or area labelled.
48
Staining Scores
0 = no labelling
1 = up to 20% labelling
2 = 20-40% labelling
3 = 40-60% labelling
4 = 60-80% labelling
5 = 80-100% labelling
Qualitative assessment
Double immunohistochemical labelling of sections was inspected for evidence of
dual expression of the antigens examined as well as single labelling red or blue.
Statistical Analysis
The analysis of data presented in Chapters 3, 5 and 6, is complicated by the use of
four subject groups sampled at two different times in the menstrual cycle. Multiple
individual tests of significance would be likely to give a relatively high return of
falsely significant results. In order to overcome this, analysis of variance (ANOVA)
has been performed using Scheff's correction. The result of using such a technique
is that it errs on the side of non-significance. The value of this however, is that any
significant results are sound.
Since endometrial samples taken at LH+7 and LH+13 can be considered to be
functionally distinct, in all evaluations apart from LH+7 versus LH+13, the data are
examined as two separate sets of four subject groups. Comparison of samples at
49
LH+7 versus LH+13 employed the Mann-Whitney non-parametric test of
significance. Mann-Whitney test was also used in Chapter 3 to compare serum
oestrogen or progesterone concentrations from LH+7 and LH+13.
The paired endometrial samples examined in Chapter 5 were tested using 2-tailed,
paired t-test.
In all cases p<0.05 denotes significance. Trends were inferred when p<0.25 or
where changes in means or medians were all in the same direction in comparable
groups.
Summary
The samples, materials and methods employed for the purposes of this thesis are
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CONTROL OF THE ENDOMETRIAL ENVIRONMENT
1. Steroid hormone receptor distribution in relation to fertility
Introduction
The complex relationships of the hypothalamo-pituitary-ovarian-endometrial axis
have at their hub the steroid hormones oestrogen and progesterone, secreted in a
cyclical fashion by the ovary in normally ovulating women. The pattern of secretion
of these hormones is crucial to the overall cyclical performance of the endometrium
and derangement of ovarian hormone secretion such as at the menopause or in
anovulatory cycles has a profound effect on the pattern of menses; amenorrhoea or
oligomenorrhoea. This relationship has allowed numerous endocrine manipulations
to be used for a variety of purposes; including contraception and the control of
menorrhagia amongst others.
The hormone/endometrium relationship has been well studied and is well
documented in standard texts. Research has also focused on the possibility that
fertility problems may be related to, for example, abnormal luteal function - so-called
luteal phase deficiency (LPD). Evidence for the existence of this condition however,
is variable. LPD was first described in 1949 by Georgianna Jones (Jones 1949) who
considered urinary pregnanediol excretion and endometrial biopsies timed from and
correlated with basal body temperature (BBT) changes. Although flawed from the
point of view of timing and the accuracy of histological assessments, this study
stimulated a vast area of research. Lenton et al. (1984) and Smith et al. (1984)
focussing purely on cycle length, have shown that a short luteal phase is as likely to
occur in fertile as in subfertile populations implying that if LPD plays a significant
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role in fertility then it is not related to short cycles. Jordan et al. (1994) attempted to
evaluate all the possible modes of assessment of the luteal phase, including BBT,
follicular development, endometrial biopsy and progesterone production. They
concluded that an assessment of serum progesterone concentrations (the sum of three
measurements from LH+5 to LH+9) would establish a defective luteal phase if lower
than 30ng/ml. This, however, implies a primary hormonal aetiology which should be
correctable by the administration of progesterone. Rosenberg et al. (1980) and Soules
et al. (1977) diagnosed LPD on the basis of late luteal phase endometrial biopsies
from two cycles and treated with progesterone claiming conception rates of 71% and
50% respectively. Daly et al. (1983) used a variety of treatment regimes
(progesterone, clomiphene citrate and gonadotrophins) for women when the
endometrial maturity of biopsies taken on the 12th post-ovulatory day were
considered to be histologically delayed on two occasions. This group stressed the
importance of "normalisation" of the endometrial biopsy and claimed an 81%
conception rate in compliant patients where this had occurred. None of these studies
provided non-treatment controls. Davidson et al. (1987), Wentz et al. (1990) and
Balasch et al. (1986), however, in studies of endometrial biopsies showed that not
only did treatment with progesterone or clomiphene citrate not improve the
pregnancy outcome, but also that the incidence of biopsy diagnosed LPD was as
common in the fertile as the subfertile population. It was concluded therefore, that
the diagnosis of LPD was without clinical significance. There have been no
randomised controlled trials of the treatment of LPD with progesterone to finally
settle this argument.
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It can be seen that a disorder of the luteal phase may have a variety of effects on the
"window of implantation" alluded to previously (Chapter 1). A steroid hormone
production problem has not been generally supported in the face of normal luteal
phase progesterone concentrations in most ovulatory cycles, but there remains the
possibility that the endometrial response to normal steroid hormone levels may be
abnormal. This may result in an environment hostile to the process of implantation,
leading to the inability to achieve or support a pregnancy which may then contribute
to otherwise unexplained subfertility (Li and Cooke, 1991). The possibility of an
abnormal endometrial response to endocrine stimuli has not previously been
investigated and it could occur at a number of levels.
The expression of sex steroid receptors in human endometrium during the normal
menstrual cycle has been well documented. Early studies using hormone-receptor
binding techniques showed peaks of oestrogen and progesterone receptors in late
proliferative and peri-ovulatory phases respectively, with a subsequent reduction in
each through the secretory phase (Levy et al. 1980). This approach does not allow
the study of individual cell types afforded by more recent immunohistochemical
techniques (Press et al. 1986 andl988, Garcia et al. 1988, Lessey et al. 1988, Snijders
et al. 1992, Coppens et al. 1993, Critchley et al. 1993, Amso et al. 1994). More
specifically oestrogen receptors (ER) have been shown to be expressed in both
epithelium and stroma in proliferative and secretory phase endometrium, peaking
around ovulation. Immunostaining for ER in the mid and late secretory phase is
reduced. Progesterone receptor (PR) expression similarly increases in glands and
stroma through the proliferative phase, peaking around ovulation and in the early
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secretory phase. Although stromal PR expression is relatively constant in both
phases of the cycle, glandular expression generally falls to negative by the late luteal
phase.
Although the general cyclical distribution of oestrogen and progesterone receptors
has been described, there has been no previous examination of the receptor
distributions in fertile compared with subfertile endometrium. The following study
therefore was designed to examine the potential for normal and subfertile
endometrium to respond to oestrogen and progesterone by assessment of their
respective receptors in the endometrium of women with unexplained subfertility
compared with normal controls.
Experimental Design
Endometrial samples
Pipelle endometrial samples obtained as previously described, from both fertile
women and women with unexplained subfertility were studied from the subject
groups described above (Chapter 2).
Monoclonal antibodies
Novocastra (Newcastle-upon-Tyne, UK) monoclonal antibodies (mAbs) to oestrogen
receptors (ER-LH2) and progesterone receptors (PGR) were used at concentrations
1:20 and 1:100, respectively.
ER-LH2 and PGR are IgG class mouse antibodies raised for research purposes and
producing nuclear staining patterns with immunohistochemistry. ER-LH2 is raised
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against a recombinant oestrogen receptor fusion protein and PGR against a synthetic
peptide corresponding to a site on the human progesterone receptor.
Single immunohistochemical labelling
Standard single immunohistochemical labelling with DAB was performed as
described previously (Chapter 2) on frozen sections from both LH+7 and LH+13
samples obtained from the four subject groups.
Positive control was as described in Chapter 2. In addition, since the antibodies
described had previously been fully evaluated for use in frozen sections of
endometrium and decidua in this laboratory, endometrium provided an "in-built"
positive confirmation. Negative controls, where no primary antibody was added
contrasted with positive labelling in test sections and excluded significant non¬
specific staining.
Evaluation
All sections in this study were examined semi-quantitatively for oestrogen and
progesterone receptor distribution. A score of 0 to 5 was used according to the
proportion of cells positively labelled as described above (Chapter 2). The
assessment was blind to the group and timing of the original sample.
Surface epithelium (when present), glandular epithelium and stroma were each
scored separately in each section.
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Statistical analysis
Statistical analysis of these data has been discussed in Chapter 2.
Results
The results reflect the general heterogeneity in expression of oestrogen and
progesterone receptors in the secretory phase. There was a variation in staining
between different sections as would be expected, but also in extent and intensity
between areas of, for example, stroma in the same section, or from one gland to
another or in different areas of the same surface epithelium.
LH+7 versus LH+13.
Expression of both receptor types was in general low at mid (LH+7) and late
(LH+13) secretory phase (median scores < 2 for expression of ER or PR in all
groups), although no proliferative or early secretory phase endometrium was
available from these subjects for direct comparison. The labelling of surface
epithelium, identified in around 60% of sections examined, was patchy when present
(Figs. 3.1a and 3.2a-b). Similarly glandular epithelial cells could all be labelled
clearly in some glands whereas in other glands in the same specimen all the epithelial
cells were negative (Figs. 3.1b-c and 3.2b-c). Stromal labelling was also generally
variable in intensity (Figs. 3.1 and 3.2). Thus even the semi-quantitative scoring
assessment had pitfalls, as it was difficult to represent an overall impression for each
individual tissue.
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Figure 3.1. Frozen sections ofPipelle endometrial samples. Single
labelling, ER-LH2. a) LH+13 (x20); b) LH+7 (xlO); c) LH+13
(xlO).
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Figure 3.2. Frozen sections ofPipelle endometrial samples. Single
labelling, PGR a) LH+7 (x20); b) LH+13 (xlO); c) LH+7 (xlO).
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Oestrogen receptor labelling
Stromal labelling of ER, although showing a degree of variability within tissues, was
in general similar in all tissues of each group and at both stages of the cycle
examined. Most tissues scored 2 and all showed a degree of positive labelling.
Glandular and surface epithelial staining was more heterogeneous both within tissues
and between groups; occasional sections exhibited either no glandular epithelial or
no surface epithelial labelling but with definite stromal labelling. Surface
epithelium, because of the nature of Pipelle sampling and the subsequent tissue
processing, was not identified in 38% of the sections examined.
There was no significant difference in ER expression between LH+7 and LH+13
(Table 3.1). When mean scores were considered there was a trend towards lower
expression of oestrogen receptors in fertile glandular and particularly surface
epithelial sites at LH+13 compared with LH+7. Of note however, is that this trend
was apparently reversed in the endometrial epithelium of subfertile individuals (Fig.
3.3). In other words, in contrast with previous studies of normal endometrium, there
was an increase in expression of epithelial oestrogen receptor from LH+7 to LH+13
in subfertile endometrium. It should be noted however, that for surface epithelium,
sample numbers were low and the range of staining score wide, such that any such
trend may be considered serendipitous.
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Table 3.1. Oestrogen receptor staining scores for fertile and subfertile endometrium. LH+7 versus
LH+13.
Oestrogen LH+7 LH+13 P
Receptors staining score staining score
Nulliparous
Fertile
n median mean range n median mean range
Stroma 7 2 2.07 1-3 5 2 2.10 2-2.5 1.000
Glands 7 2 1.79 0-3.5 5 1 1.50 1-2.5 0.755




Stroma 10 2 2.05 2-2.5 7 2 2.29 2-4 0.887
Glands 10 1 1.45 1-3.5 6 1 1.71 0-5 0.887




Stroma 8 2 2.50 2-4 9 2 2.06 2-2.5 0.321
Glands 8 2 2.38 1-5 9 2 1.56 0-2.5 0.370




Stroma 9 2 2.00 2-2 4 2 2.00 2-2 1.000
Glands 9 1 1.39 1-2.5 4 1 1.25 1-2 0.825
Surface 7 2 1.71 0-3 1 2.5 2.50 2.5 0.500
Epithelium

































The change in endometrial surface epithelial oestrogen receptor expression. LH+7 to
Progesterone receptor labelling
Stromal expression of PR was, like that for ER, fairly similar between samples and
between groups (Table 3.2). Occasional tissues exhibited more marked labelling
(scoring 3-5), but most again scored 2. PR labelling was mostly negative in both
glandular and in surface epithelium. Where labelling was present it was more likely
to be in glandular than surface epithelium. Occasionally more marked labelling
occurred corresponding to high levels of labelling throughout the tissue. Again
around 36% of sections examined did not contain identifiable surface epithelium.
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Table 3.2. Progesterone receptor staining scores for fertile and subfertile endometrium. LH+7 versus
LH+13.
Progesterone LH+7 LH+13 P
Receptors staining score staining score
Nulliparous n median mean range n median mean range
Fertile
Stroma 7 2 1.79 0-2.5 5 2 1.90 1-2.5 1.000
Glands 7 0 0.43 0-1 5 1 0.80 0-2 0.530




Stroma 10 2 1.90 1-2.5 7 2 1.92 1-2.5 1.000
Glands 10 0 0.10 0-1 7 0 0.29 0-1 0.536
Surface 8 0 0 0 6 0 0 0 1.000
Epithelium
Parous Fertile
Stroma 8 2 2.44 1-5 9 2 2.44 2-5 0.815
Glands 8 1 1.63 0-4.5 9 0 0.83 0-4.5 0.139




Stroma 9 2 1.89 1-3 4 2 2.00 2 0.825
Glands 9 0 0.33 0-1 4 0.5 0.50 0-1 0.710
Surface 6 0 0.50 0-2 2 0 0 0 0.643
Epithelium
Mann-Whitney. Reaches significance at P < 0.05.
It is of interest that there was only a very low level of expression of progesterone
receptors in the surface epithelium in subfertile endometrium at both luteal phase
stages assessed, whilst endometrium from fertile individuals exhibited a reduction in
surface epithelial progesterone receptor expression from LH+7 to LH+13 (Fig.3.4).
This reached significance in the parous fertile group (p = 0.022). The lack of this
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reduction in subfertile endometrium may be explained by the reduced expression of






















Figure 3.4. The change in endometrial surface epithelial progesterone receptor expression. LH+7 to
LH+13.
Serum Oestrogen and Progesterone Concentrations
These women had carefully timed samples from the LH surge and in addition there
were no significant differences between the four patient subgroups in serum













Figure 3.6. Serum progesterone concentrations. LH7 to LH13.
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The Effect ofPrevious Parity and Fertility Status.
When endometrium from the four subject groups was compared at LH+7 and at
LH+13 there were few clear differences in oestrogen receptor distribution between
fertile and subfertile and between parous and nulliparous individuals (Fig. 3.7).
Interestingly however, there were significant differences in the progesterone receptor
distribution at LH+7; there was less epithelial progesterone receptor expression in
subfertile compared with fertile endometrium whether nulliparous or parous,
reaching significance in the parous group at LH+7 (Table 3.3). These findings are in
keeping with the idea of an earlier loss of epithelial progesterone receptor expression
in subfertile compared with fertile endometrium. In addition it was found that
expression was greater in parous as compared to nulliparous endometrium, again
approaching significance at LH+7.
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LII+7 LH+13 LH+7 LH+13
Oestrogen receptor labelling of surface
epithelium
Progesterone receptor labelling of stroma
LII+7 LH+13 LH+7 LH+13
Progesterone receptor labelling of glandular
epithelium










LH+7 LH+13 LII+7 LH+13
Figure 3.7. Oestrogen and progesterone receptor expression in endometrial stroma, glandular
epithelium and surface epithelium and taking into account fertility and parity.
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Table 3.3. Oestrogen and progesterone receptor distributions. Significances when comparing fertile
versus subfertile and pa rous versus nulliparous endometrium.
Nulliparous Parous Fertile Subfertile
Fertile vs. Fertile vs. Parous vs. Parous vs.




Stroma 1.000 0.200 0.379 0.997
Glands 0.853 0.282 0.848 0.999
Surface Epithelium 0.838 0.967 0.986 1.000
Progesterone
Receptors
Stroma 0.995 0.640 0.555 1.000
Glands 0.887 0.031 0.075 0.946




Stroma 0.907 0.997 0.998 0.770
Glands 1.00 0.948 1.000 0.925
Surface Epithelium 0.532 0.695 0.440 0.788
Progesterone
Receptors
Stroma 1.00 0.770 0.587 0.999
Glands 0.865 0.961 1.000 0.990
Surface Epithelium 0.945 0.920 0.995 1.000
n, medians, means and ranges for each group have been recorded in Tables 3.1 and 3.2.
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2. Bcl-2 and Ki67 Expression in Endometrium inRelation to Fertility.
Introduction
Bcl-2 is an oncoprotein encoded by the bcl-2 (B cell lymphoma/leukaemia-2)
oncogene. It is known to protect cells against apoptosis, although the exact
mechanism of action has not been elucidated (Reed 1994, Brown 1996). Several
studies have examined bcl-2 expression in human endometrium and it appears to be
generally agreed that major expression of bcl-2 is in glandular epithelium, peaking at
the end of the proliferative phase. Expression of bcl-2 in endometrial epithelial cells
has been reported to decrease (Otsuki et al. 1994; Tabibzadeh et al. 1995) or be
absent (Gompel et al. 1994) in the secretory phase of the cycle, although Koh et al.
(1995) reported an increase in bcl-2 expression in the late secretory phase at these
sites. Stromal bcl-2 expression also displays a degree of cyclical variation increasing
during the secretory phase (Gompel et al. 1994, Koh et al. 1995, Tabibzadeh et al.
1995).
The increase in stromal bcl-2 expression in the late secretory phase of the menstrual
cycle has been attributed by some to the large numbers of eGLs present (Chapter 4),
but expression of bcl-2 on stromal cells (and on other leucocyte groups) remains a
possibility. Although the function of bcl-2 in endometrium is not clear, it has been
suggested (Koh et al. 1995) that glandular and stromal expression have separate roles
in the maintenance of endometrial surface integrity and in the control of onset of
menstruation, respectively. However, bcl-2 protects cells from apoptosis and the
findings by Koh et al. (1995) of increased bcl-2 expression in the late secretory phase
are not consistent with the reports of increased apoptosis in glandular epithelium at
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this time (Tabibzadeh 1994). It is possible that the protection against apoptosis
afforded by expression of bcl-2 antigen is incomplete. This could be inferred from
the work of Tabibzadeh et al. (1995) who suggested that secretion of TNFcc,
increased throughout the menstrual cycle in relation to a reduction in bcl-2
endometrial epithelial expression. It should be noted that bcl-2 is only one of a
family of proteins involved in cell longevity and in addition is probably dependent on
bound ligands; for example, the bax protein for normal function (Brown 1996). Thus
until the mechanism of action of bcl-2 and its related proteins are established its
significance in any situation must be somewhat speculative.
Ki67, a cell proliferation marker, is known to be expressed in endometrial stroma to
different degrees throughout the menstrual cycle. Expression of Ki67 is high in
endometrial stroma in the proliferative and early secretory phases, decreasing in the
mid-secretory phase but increasing again premenstrually (Jones et al. 1998a). This
final increase corresponds to the proliferation of eGLs in the secretory phase of the
cycle and Ki67 has been shown by single and double immunohistochemical
techniques to be expressed by these cells (Pace et al. 1989, King et al. 1991, Jones et
al. 1998a). Endometrial glandular epithelial cells have been shown, as expected, to
be strongly labelled for Ki67 in the proliferative phase (Pace et al. 1989, Tabibzadeh
1990a). Ki67 labelled cells have been reported to remain numerous in the epithelium
in the secretory phase also, especially in the early secretory phase (Pace et al. 1989),
although Tabibzadeh (1990a) found markedly diminished glandular epithelial
proliferation in early secretory phase endometrium and none in mid and late
secretory phases.
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The expression of bcl-2 and Ki67 have not previously been investigated in subfertile
endometrium. However, as the turnover of cells in the endometrium is likely to be of
great importance to the maintenance of its normal structure and consequently its
function, altered expression of either of these antigens may indicate a problem
relating to subfertility. The second study in this section therefore, was designed to
examine the expression of bcl-2 and Ki67 in the endometrium during the secretory




For this study sections of frozen Pipelle endometrial samples from subjects recruited
and sampled as discussed previously (Chapter 2) were used.
Antibodies
(See Table 3.4)
Table 3.4. Monoclonal Antibodies
Antibody Specificity Source Concentration
Bcl-2 Proto-oncogene Novocastra 1:100
product
Ki67 Proliferation Novocastra 1:10
Marker
Bcl-2 antibody, raised against a synthetic peptide sequence, was first evaluated on
similarly processed control tissues and a working concentration of 1:100 established




Single immunohistochemical staining was performed in all sections as described in
Chapter 2. DAB was used as the peroxidase substrate giving a brown reaction
product. Since expression of both bcl-2 and Ki67 in endometrium has been
previously described in detail, endometrium acted as its own in-built positive control.
Negative controls where no primary antibody was used were included in all
experiments to exclude non-specific labelling.
Evaluation
Stromal Ki67 and bcl-2 labelling was examined quantitatively. The proportion of
stromal cells expressing bcl-2 or Ki67 was assessed by direct counting from 2 high-
power fields of each section using a 10x10mm graticule. Around 1000 stromal cells
per section were counted. The number of labelled cells was expressed as a
percentage of the total number of stromal cells. The general distribution of Ki67 and
bcl-2 expression in glandular and surface epithelial cells was also examined
qualitatively in each section. The extent of labelling in these epithelial cells was
given a score (0 to 5) relating to the proportion of cells stained as described above
(Chapter 2).
Statistical analysis




Stromal bcl-2 expression in both subfertile and fertile endometrium appeared to
increase from LH+7 to LH+13 (Table 3.5) (Figs.3.8 and 3.9), but this increase only
approached significance in the nulliparous fertile group (P = 0.073).
There were no significant differences between the expression in fertile and subfertile
or nulliparous and parous endometrium at either stage of the cycle examined.












NF N 7 7 7 5 5 5
Mean 2.18 1.14 1.71 4.70 1.5 3.4






NI N 12 12 12 8 8 8
Mean 2.25 0.75 1.88 3.66 1.56 2.88






PF N 9 9 9 9 9 9
Mean 2.21 0.89 2.22 3.93 2.11 3.44






PI N 10 10 10 5 5 5
Mean 2.52 0.95 1.95 2.68 1.4 3
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Figure 3. 9. Endometrial expression ofbcl-2 and Ki67.
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Semi-quantitative evaluation of glandular and surface epithelial expression of bcl-2
showed an overall increased expression of bcl-2 at LH+13 compared with LH+7.
This was generally significant in some fertile groups (glandular epithelium; PF;
p=0.019,surface epithelium; NF; p=0.048), and excluding NF glandular epithelium
(p=0.53) approached significance in all other cases (Table 3.6).
When the effect of parity was considered or fertile and subfertile groups were
compared there were no clear differences in expression of bcl-2 in endometrial
glandular or surface epithelium.
Table 3.6. Endometrial epithelial expression ofbcl-2. LH+7 versus LH+13.











Mann-Whitney. Reaches significance when P < 0.05.
Ki67
Stromal Ki67 expression was significantly greater at LH+13 than LH+7 in all groups




Figure 4.1. Paraffin wax sections ofsecretory endometrium. Double
labelled;CD45 (red), ER-6F11 (blue), a) (x20); b) (x20).
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NF n 6 6 6 4 4 1
Mean 7.92 0.5 1 21.77 0 0






NI n 12 11 10 7 7 6
Mean 6.98 0.64 1.7 15.12 0.86 0.83






PF n 9 9 7 9 9 6
Mean 6.42 1.11 2 14.07 0.22 0.83






PI n 8 8 5 5 5 4
Mean 6.24 0.5 1.4 19.90 0 0.5






% total stromal cells labelled with bcl-2 antibody, staining score.
Table 3.8. Endometrial stromal expression ofKi67. LH+7 versus LH+13.





Mann-Whitney. Reaches significance when P < 0.05.
In contrast there was a trend to reduced expression of Ki67 in endometrial epithelial
sites at LH+13 compared with LH+7 (Figs.3.9 and 3.10). This was particularly of
note in surface epithelium where lower expression approached significance in most
groups (Table 3.9). There was no significant difference in Ki67 expression between
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fertile and subfertile endometrium in the stroma or in surface or glandular
epithelium. Similarly parity in either fertile or subfertile groups at LH+7 or LH+13
did not appear to affect Ki67 expression in stroma or epithelium.
Table 3.9. Endometrial epithelial expression ofKi67. LH+7 versus LH+13.











Mann-Whitney. Reaches significance when P < 0.05.
Discussion
The steroid hormones oestrogen and progesterone, play a central role in the cyclical
changes occurring throughout the menstrual cycle in the endometrium. These
hormones act via receptors which have previously been examined quantitatively
from using receptor binding techniques in preparations of cytoplasm and nuclei from
endometrial biopsies (Levy et al. 1980). The development of monoclonal antibodies
and their continual improvement now allows receptor distribution to be examined in
detail using an immunohistochemical approach.
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The distribution of oestrogen and progesterone receptors in normal endometrium is
well documented (Press et al. 1986, 1988; Garcia et al. 1988; Lessey et al. 1988;
Snijders et al. 1992; Coppens et al. 1993; Critchley et al. 1993; Amso et al. 1994)
and this study has confirmed results of previous studies in normal endometrium.
However, a potential difference in the pattern of distribution of oestrogen and
progesterone receptors in women with unexplained subfertility compared with the
fertile population has been observed. Whilst stromal expression remained relatively
constant, there was a tendency not to lose epithelial oestrogen receptor expression at
LH+13 as was shown to occur in normal endometrium, despite similar serum
concentrations of the hormone. This was reflected in the finding that there was
generally lower expression of both oestrogen and progesterone receptor in the
subfertile endometrium, both parous and nulliparous, except for epithelial oestrogen
receptors at LH+13 which appeared to be relatively increased. This may simply be an
example of the heterogeneity displayed by endometrial tissues at these stages in the
menstrual cycle. However, these observations could be of significance with respect
to the endometrial response to hormones and their secondary functions either as a
consequence of, or resulting in an aberrant tissue response to steroid hormone
stimuli. This would clearly be of importance with regard to fertility. In addition,
subfertile endometrial epithelial tissue appeared to exhibit an earlier loss of
progesterone receptor expression compared with fertile endometrium. This, in the
face of similar serum hormone concentrations, may represent a functional difference
between the groups and be associated with infertility.
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Endometrial bcl-2 expression assessed in this study was generally in keeping with
the distribution reported by Koh et al. (1995). In the secretory phase there was
variable stromal expression (although there are no related proliferative Pipelle
samples with which to compare) and no significant change between LH+7 and
LH+13. There was however, an increase in epithelial and glandular bcl-2 expression
at LH+13 compared with LH+7 in both fertile and subfertile samples.
The assessment of stromal Ki67 expression in endometrium was in keeping with
previous studies (Jones et al. 1998a). Although the mid-secretory reduction in
expression was not demonstrated, this study importantly confirms a high level of
expression of this proliferation antigen pre-menstrually. The reduction in epithelial
expression of Ki67 as the cycle progresses may be expected as menstruation is
approached. This is in keeping with the findings of Pace et al. (1989) where
maximal epithelial Ki67 expression was found in early secretory phase endometrium.
Cessation or reduction of active proliferation would suggest reduced activity of the
glandular and surface epithelial cells moving into the mid-secretory phase. Perhaps
the increase in bcl-2 expression helps to maintain the viability of these otherwise
aging cells which are not being so regularly replaced until such time as the onset of
menstruation.
Conclusion
This study has supported the finding that Ki67 expression increases significantly
premenstrually and since this has been previously shown to co-localise to leucocytes
probably confirms that this activation is consistent irrespective of fertility status or
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previous parity. There was a similar pattern of epithelial and stromal bcl-2
expression in all groups also suggesting that the cell dynamics of the secretory phase
may not be fundamental to the problem of unexplained subfertility. However, there
appeared to be important differences in oestrogen and progesterone receptor
distribution in the luteal phase endometrium of women with unexplained subfertility
which could have a fundamental effect on the tissue responses to those hormones.
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CHAPTER 4
THE CONTROL OF ENDOMETRIAL
LEUCOCYTE POPULATIONS
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THE CONTROL OF ENDOMETRIAL LEUCOCYTE POPULATIONS
Introduction
As discussed previously (Chapter 3) the endometrium is a steroid sensitive organ,
which responds to oestrogen and progesterone in a cyclical fashion. The
morphological response during the different cycle phases has been well documented
(Noyes et al. 1950, Good and Moyer 1968, Li et al. 1988, March 1991). The stromal
leucocyte populations in human endometrium have also been reported to change
during the menstrual cycle (King et al. 1989, Bulmer et al. 1991b, Starkey et al.
1991). In particular endometrial granulated lymphocytes (eGLs) increase in number
dramatically in the late secretory phase of the menstrual cycle; if conception and
implantation occur eGLs continue to increase in number and comprise around 70%
of the stromal leucocytes in first trimester decidua (Bulmer et al. 1991b, Klentzeris et
al. 1992) (see Chapter 1).
The control of the alterations in eGL numbers during the menstrual cycle remains
poorly understood. The increase in numbers of CD56 positive eGLs has been
postulated to be either the result of margination of peripheral blood NK cells or to be
due to proliferation of cells in situ within the endometrium. Evidence for eGL
proliferation comes from studies by Klentzeris et al. (1992) examining their
morphometry. They concluded that increasing eGL numbers from LH+4 to LH+13
without change in the total fraction of endometrium occupied by eGL nuclei was
indicative of local proliferation rather than recruitment. Further evidence comes
from the work of Pace et al. (1989) and Tabibzadeh (1990) who investigated, using
immunohistochemical techniques, the expression of proliferation associated antigens,
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namely Ki67, on these cells as previously discussed (Chapterl). Although there is
evidence allowing the possibility of recruitment of cells into the endometrium from
the vasculature (Jones et al. 1997), proliferation of eGLs has been the generally
accepted mechanism for the majority of their increase in numbers.
The reduction of CD56 positive eGLs after menstruation could be the result purely of
menstrual flow, requiring regeneration of numbers in the subsequent menstrual cycle.
The presence of eGLs in the stratum basalis of the endometrium supports this
possibility providing reserve cells to allow for regeneration. It has been postulated
by others, however, that eGL numbers may decrease in a non-pregnancy menstrual
cycle as the result of apoptosis, presumably in a hormone dependent way. The
unusual morphology of the cells in the premenstrual endometrium has lent weight to
this theory (Loke and King 1985, King et al. 1989) (see below). The overall control
of eGL numbers remains to be discovered but it seems likely that the primary factors
will be steroid hormones which have such major roles in other glandular and stromal
structural changes in endometrium throughout the menstrual cycle.
It appears likely that eGLs respond to the sex steroid hormones which influence the
menstrual cycle, namely oestrogen and progesterone. This could be a direct effect on
the leucocytes, which must in consequence express the appropriate receptors, or an
indirect effect mediated by products of other endometrial cells which themselves
express steroid hormone receptors. Direct stimulation of leucocytes by sex steroids
has been suggested by reports that in pregnancy peripheral blood CD8 positive T
lymphocytes express progesterone receptors (Szekeres-Bartho et al. 1990). Earlier
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binding studies, however, excluded the expression of androgen, oestrogen and
progesterone receptors on peripheral blood lymphocytes (PBL), including those
activated by phytohaemagglutinin (PHA) (Neifeld et al. 1977). Progesterone has
been reported to inhibit lymphocyte proliferation. This action, however, was not
blocked by RU486, a progesterone (and glucocorticoid) antagonist, suggesting a
mechanism not related to direct stimulation of progesterone receptors (Monterroso et
al. 1993). Immunohistochemical studies of leucocytes in non-pregnant human
endometrium have detected oestrogen receptor but not progesterone receptor
expression by T cells in aggregates adjacent to endometrial glands in the basal
endometrium (Tabibzadeh and Satyaswaroop 1989). However, King et al. (1996)
reported conflicting results, having shown no evidence of any sex steroid hormone
receptor expression by endometrial leucocytes. The latter study was confined to the
general leucocyte population (CD45 positive), without examination of the specific
leucocyte subgroups. Inoue et al. (1996) cultured endometrial leucocytes in the
presence of progesterone, reporting a significant increase in the CD56 positive
population after 6 days. They concluded that progesterone was important for in eGL
proliferation or differentiation. Their cultures were leucocyte rich co-cultures with
endometrial stromal cells however; and thus an indirect effect of progesterone via
stromal cells and secondary messengers was not excluded.
This study was designed to assess any direct influence of steroid hormones on
endometrial leucocyte populations, in particular on the proliferation of CD56-
positive eGLs. In addition the role of apoptosis in cell demise at menstruation was
considered.
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1. Steroid Hormone Receptor Expression By Endometrial Leucocytes.
Materials and Methods
Frozen tissue
Fresh endometrial tissue was obtained from 15 hysterectomy specimens (5
proliferative, 5 early secretory, 5 late secretory) where the operation was performed
for non-endometrial pathology such as fibroids not involving the uterine cavity,
benign ovarian cysts or persistent cervical intraepithelial neoplasia (CIN). All the
specimens had normal endometrial histology in keeping with the menstrual dates.
Tissues were frozen and sections prepared as described above (Chapter 2). Decidual
samples from 5 first trimester suction terminations of pregnancy were obtained with
informed consent of the subjects. Again cryostat sections were prepared as described
in Chapter 2.
Paraffin embedded sections
Sections (3pm) of late secretory phase endometrium (n=5) and normal first trimester
decidua (n=5) from similar patient groups to those described above, were cut from
archival paraffin blocks. Late secretory phase endometrium and decidua were used
since maximal changes in endometrial leucocyte numbers occur at these stages
(Chapter 1).
Monoclonal antibodies
Antibody specificities, dilutions and sources are given in Table 4.1. ER-LH2 and
PGR were used to identify the distribution of oestrogen and progesterone receptors
by immunohistochemical labelling in both frozen and paraffin sections. ER-LH2
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was less satisfactory when used on paraffin-embedded tissues and therefore was
substituted by ER-6F11 which gave good quality staining in paraffin-embedded
sections after high temperature antigen retrieval (Chapter 2).
Leucocyte populations were identified by single and double immunohistochemical
staining procedures in both frozen and paraffin sections using antibodies to CD45
(leucocyte common antigen), CD3 (T cells) and CD 14 (macrophages). Endometrial
granulated lymphocytes were identified using an antibody to CD56 (Novocastra),
which has been well established in this laboratory for use on frozen sections. In
paraffin-embedded sections eGL distribution was confirmed using MT-1 antibody
(Bulmer et al. 1987) and an anti-CD56 antibody from Vector, Peterborough, UK
(Table 4.1).






ER-LH2 Oestrogen receptor Novocastra, Newcastle-
upon-Tyne, UK.
1/30 1/10
ER-6F11 Oestrogen receptor Novocastra 1/10
PR Progesterone receptor Novocastra 1/100 1/100
CD3 T lymphocytes Dako, High Wycombe,
UK.
1/200
CD3 T lymphocytes Novocastra 1/100




CD56 NK cells Novocastra 1/200
CD56 NK cells Vector, Peterborough,
UK
1/100




Single immunohistochemical labelling was performed as described previously
(Chapter 2) using the Vectastain Elite ABC kit and AEC peroxidase substrate. AEC
was used for the single immunohistochemical labelling in this study to maintain
consistency with the double-labelled sections described below. For double labelling
the red of AEC is more readily distinguished from the blue second label than DAB.
B. DOUBLE LABELLING.
Double immunohistochemical labelling was performed in order to detect co-
expression of steroid receptors by endometrial leucocyte populations. The technique
is described in Chapter 2. Double-labelled slides were not counterstained. Table 4.2
shows the double labelling combinations prepared.
Table 4.2. Double labelling combinations.
Frozen Sections Paraffin Sections
ER-LH2 PGR ER-LH2 ER-6F11 PGR
CD45 Yes yes yes yes yes
CD3 Yes yes no yes yes
CD56 Yes yes no yes yes
CD14 Yes yes no no no
MT-1 No no yes yes yes
All slides were initially mounted in Supermount and, after overnight drying, with
DPX mountant and coverslips.
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Evaluation
All sections were analysed qualitatively for double and single labelling.
Results
As described previously (Chapter 3), large numbers of CD45 positive cells were
identified throughout the endometrium (Figs. 4.1 and 4.2) and decidua with
aggregates adjacent to glands and vessels. CD3 positive cells were present in all the
frozen tissues, with aggregates in the stratum basalis, particularly adjacent to glands.
There was a marked increase in CD56 positive cells in late secretory phase and
decidual tissues in comparison with proliferative endometrium, findings
complimented by the increased number of MT-1 positive cells in formalin-fixed
paraffin-embedded tissues. MT-1 also reacted with T cells in endometrium. Only
small numbers of CD14 positive cells were identified in all frozen tissues studied.
In frozen and formalin-fixed tissues oestrogen receptor was expressed in both
epithelium and stroma in proliferative and secretory phase endometrium as
previously described (Chapter 3) (Fig. 4.3). Oestrogen receptor staining was present
throughout the decidual stroma and oestrogen receptors were expressed by glandular
epithelial cells of decidualised endometrium (Fig. 4.4).
Progesterone receptor was variably expressed in some glands in proliferative
endometrium, but glands generally showed little expression in the luteal phase as
previously described (Chapter 3). Progesterone receptors were expressed throughout
the stroma in both phases of the cycle (Figs.4.5 and 4.6) in non-pregnant
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Figure 4.1. Paraffin wax sections ofsecretory endometrium. Double
labelled;CD45 (red), ER-6F11 (blue), a) (x20); b) (x20).
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Figure 4.2. Paraffin wax sections ofearlypregnancy decidua. Double
labelled a) PGR (blue), CD45 (red), (x40); b) PGR (blue), MT-1 (red), (x40).
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Figure 4.3. Paraffin wax sections ofendometrium. Double labelled; MT-1
(red); ER-6F11 (blue), a) (x40); b) (x10).
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Figure 4A.Paraffin wax sections ofdecidua. Oestrogen receptor labelled
brown, a) (x40); b) (x20).
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Figure 4.5. Double labelling in secretoryphase endometrium, a) Paraffin wax
section, PGR (blue), CD45 (red) (x20); b)frozen section, PGR (blue), CD56
(red) (x20).
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Figure 4.6. Double labelling in secretoryphase endometrium, a) Paraffin
wax section, PGR (blue), MT-1 (red), (x40); b)frozen section, PGR (blue),
CD45 (red), (x40).
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endometrium and throughout the decidual stroma (Fig. 4.2). These results are in
keeping with those described in Chapter 3 in Pipelle endometrial samples.
The results of single labelling of frozen and paraffin-embedded sections for both
leucocyte subpopulations and steroid hormone receptors were in keeping with these
observations and those documented previously (Bulmer et al. 1991b, Coppens et al.
1993, Wu et al. 1993).
There was no evidence of double labelling for ER or PR by any of the leucocyte
populations in any of the sections examined (Figs. 4.1, 4.3, 4.5 and 4.6). In
particular, the T cell aggregates in the stratum basalis (CD3 positive and MT-1
positive) did not show steroid receptor binding (Fig. 4.3). CD56 positive cells (and
MT-1 positive in paraffin sections) did not express oestrogen or progesterone
receptors at any stage of the cycle (Figs. 4.3, 4.5 and 4.6) or in early pregnancy
decidua (Fig. 4.2).
2. Bcl-2 Expression in Endometrial Leucocytes
Introduction
CD56 positive eGLs have been said to be undergoing apoptosis in the late secretory
phase because of their unusual morphological appearance at that time, the nuclei
exhibiting changes compatible with apoptosis - becoming shrunken, dark and
pyknotic (King et al. 1989, Loke and King 1995). This would parallel, for example,
the apoptosis occurring in lymph nodes to remove excess T and B lymphocytes
following cessation of a specific immune response (Ekert and Vaux 1997). This
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suggestion, however, contradicts evidence that eGLs continue to proliferate up to
LH+13 (Klentzeris et al. 1992, Pace et al. 1989) and continue to function
premenstrually (Jones et al. 1997c).
Gompel et al. (1994) demonstrated endometrial stromal and epithelial cell expression
of bcl-2 in particular noting maximal stromal expression in the secretory phase. Koh
et al. (1995) attributed the rise in endometrial stromal bcl-2 expression to the
proliferation of endometrial CD56 positive leucocytes, demonstrating co-localisation
of bcl-2 and CD56 in secretory phase endometrial stroma by double
immunohistochemical labelling. Bcl-2 is known to play a role in normal immune
cell function (Reed et al. 1994, Ekert and Vaux 1997).
This study was designed to assess dual expression of CD56 and bcl-2 in endometrial
stromal tissue and to clarify the argument that proliferating eGLs may also be
undergoing apoptosis in the late secretory phase of the menstrual cycle. T cells and
macrophages have not been examined in this study because their populations do not
display the large fluctuations of numbers seen in eGLs through the menstrual cycle,




Frozen endometrial tissues were derived from subjects recruited into fertile groups
who had been sampled as described in Chapter 2 at either LH+7 or LH+13.
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Monoclonal Antibodies
Antibodies to CD56 (Novocastra, Newcastle upon Tyne, UK) (1:200) and bcl-2
(Novocastra) were used.
Double immunohistochemical labelling
This was performed as described in Chapter 2.
Sections were initially labelled for bcl-2 using the ABC method developed with AEC
to produce a red reaction product. Following washing in TBS for 10 minutes and
incubation with blocking serum for a further 30 minutes, the slides were incubated
with the second primary antibody, namely anti-CD56. In this case the ABC alkaline
phosphatase kit was used, the alkaline phosphatase substrate kit III (Vecta Blue)
producing a blue reaction product. The sections were mounted with Supermount,
dried and subsequently mounted with DPX and coverslips. Double labelling
negative controls were performed as described in the previous section of this chapter.
Tonsil sections were used as positive controls for bcl-2 labelling.
Evaluation
Sections were examined qualitatively for double labelling.
Results
Although a small proportion of CD56 positive cells also expressed the bcl-2 antigen,
the majority did not at either LH+7 or LH+13. In addition there was an excess of
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bcl-2 labelled cells in stroma (around 60% of the total) which were not CD56
positive (Fig.4.7). This was the case at both LH+7 and LH+13.
Discussion
The cyclical effects of the sex steroids oestrogen and progesterone on the
endometrium are integral to the menstrual cycle and the histological changes have
been well documented. Immunohistochemical studies have characterised the
glandular and stromal distribution of sex steroid receptors during the menstrual
cycle. Although the cyclical changes in endometrial leucocyte populations are
dramatic and have also been well documented, the mechanisms controlling these
changes have not been defined.
Studies of endometrial steroid receptor expression generally make no specific
mention of the leucocytes which comprise a large proportion of the stromal cells,
particularly in the late secretory phase of the cycle. Tabibzadeh and Satyaswaroop
(1989) reported that a small proportion (1-7%) of T lymphocytes in basal
endometrial lymphoid aggregates expressed oestrogen receptors. This contrasts with
results of the present study in which sex steroid receptors were not detected on any
group of endometrial leucocytes, and which showed absence of oestrogen receptors
on T lymphocytes in lymphoid aggregates in the basal layer of the endometrium. The
discrepancies in results between these two studies could be due to differences in the
immunohistochemical techniques used. Tabibzadeh and Satyaswaroop (1989) used
peroxidase-labelled secondary antibodies for both primary antibodies in double
immunohistochemical labelling. In the present study two different enzyme systems
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Figure 4.7. Frozen sections ofPipelle endometrial samples. Double
labelled; CD56 (blue), bcl-2 (red), a) b) LH+13
(x20); c) LH+13 (x40).
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for immunolabelling were used. Furthermore, endogenous peroxidase activity was
revealed by 4-chloro-l-naphthol resulting in a blue reaction product (Tabibzadeh and
Satyaswaroop 1989) and it is not clear how this was differentiated from specific
staining with CN-H2O2 which also produced a blue reaction product. The red and
blue reaction products used for double immuno-staining techniques in the present
study were easier to interpret than blue with the brown/black of diaminobenzidine
(DAB). Differences may also result from use of different monoclonal antibodies and
their specificities. The present study used two anti-oestrogen receptor antibodies
(ER-LH2 and ER-6F11) and two antibodies to detect endometrial granulated
lymphocytes (CD56 and MT-1). Consistent and compatible results were obtained
throughout the study. The use of both paraffin and frozen sections indicate that the
tissue preparation alone is not responsible for the negative findings.
King et al. (1996) reported on endometrial leucocyte steroid receptor expression with
similar results. Fixed tissue was examined and double immuno-staining techniques
similar to those used here were used although the study was confined to labelling for
oestrogen and progesterone receptors and CD45 (leucocyte common antigen)
because of the limitations of anti-CD56 in fixed sections. Furthermore, the authors
failed to demonstrate specific oestrogen receptor labelling in decidual tissue. This
may be due to the relative unsuitability of ER-LH2 for paraffin sections. In the
current study it was found that a more recently developed antibody, ER-6F11, gave
greatly improved labelling in paraffin-embedded endometrial sections and confirmed
oestrogen receptor expression in decidual tissue as has been reported elsewhere (Wu
et al. 1993).
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The above findings with respect to bcl-2 expression are in keeping with other work
done in this laboratory (Jones et al. 1998a) where CD56 positively selected cells
from all stages of the menstrual cycle were examined for expression of the bcl-2
antigen. In the early secretory phase only 5% and in late secretory phase 16% of
positively selected CD56 positive cells were found to express bcl-2 antigens. These
findings confirm that a significant proportion of eGLs may be protected from
apoptosis by bcl-2 antigen. In the same study (Jones et al. 1998a) also showed
significant (-45%) expression of Ki67 in the late secretory phase by CD56 positive
cells isolated from normal endometrium. In addition limited studies for apoptosis
using the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end
labelling (TUNEL) assay (Gold et al. 1994, Jones et al. 1998b) demonstrated
apoptotic cells rarely in normal endometrial sections throughout the menstrual cycle.
Conclusion
Endometrial leucocyte populations do not appear to be directly controlled by cyclical
ovarian steroid hormones oestrogen and progesterone. In addition a proportion of
endometrial granulated lymphocytes have been shown to express bcl-2 antigen
potentially protecting them from apoptotic demise in the secretory phase of the cycle.






ENDOMETRIAL LEUCOCYTE POPULATIONS AND SUB-POPULATIONS
Introduction
The endometrial stromal leucocyte population comprises endometrial granulated
lymphocytes (eGLs), macrophages, T cells and a very few B cells (Bulmer 1991,
Starkey et al. 1991). It is recognised that endometrial macrophage numbers increase
slightly towards menstruation whilst T cell numbers remain relatively stable and
eGLs show a marked increase in numbers in the secretory phase which is further
enhanced in early pregnancy decidual tissue (Bulmer et al. 1991b, Starkey et al.
1991, Klentzeris et al. 1992). The putative roles of endometrial leucocytes have been
discussed (Chapter 1). In view of the speculated roles of eGLs and T cells with
regard to implantation, it is of interest to discover whether or not the leucocyte
populations differ in women with otherwise unexplained subfertility compared with
women with no known fertility problem.
If implantation is dependent on normal endometrial leucocyte function then it could
be postulated that it may be hindered by altered numbers of specific leucocyte
populations or alternatively by their abnormal function. This could be due to an
inherent leucocyte abnormality or as a result of an abnormal stimulus affecting either
their expansion or recruitment or their function, such as the NK like activity of eGLs.
An excess of cytotoxic or suppressor T cells (CD8 positive) compared with T helper
cells (CD4 positive) or their subsets and products or an excessive macrophage
response in the secretory phase might similarly affect implantation. The following
study was designed to assess the numbers and distribution of the different
endometrial leucocyte populations in early and late secretory phase endometrium in
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women with unexplained subfertility in order to compare this with the fertile
population. The early secretory phase was represented in this study by samples of
endometrium taken at 7 days post-ovulation during the implantation window, and the
late secretory phase by sampling at 13 days post-ovulation, immediately pre-
menstruation. One previous study of luteal phase endometrial biopsies from fertile
and subfertile subjects timed from the pre-ovulatory LH surge, (Klentzeris et al.
1994) did not address the issue of previous pregnancy and nulliparous subfertile
women were compared with parous fertile controls. In order to take into account the
possible permanent immunological effect of previous pregnancy, as discussed
previously (See Chapter 1), endometrium from parous subjects, both fertile and
subfertile, was compared with endometrium from nulliparous women, again
subfertile and, in this case, presumed fertile. Populations of eGLs, T cells, B cells
and macrophages were considered.
Not only are the relative numbers of leucocytes in the endometrial stroma of interest,
but functional status is also of importance. As has already been discussed, the
controlling factors for endometrial leucocytes, in particular the unique eGLs, are
poorly understood. The role of steroid hormones in this has been addressed in
previous chapters (Chapters 3 and 4). Whilst a direct link was excluded, cyclical and
population differences in the expression of endometrial steroid hormone receptors
may be indirectly implicated. It is well known that leucocytes co-operate in normal
immune responses. Central to these interactions are cytokines which are soluble
polypeptides which act as local intercellular messengers primarily affecting immune
cells. It is known that, for example, helper T (Th) cells produce cytokines which
have modifying effects on the function of cytotoxic (Tc) cells (Roitt 1994).
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Similarly macrophages are activated by cytokines produced into their surroundings.
Little is known about the factors that activate eGLs, but in vitro, IL-2 has been
shown to activate them into cells capable of killing trophoblast, whereas without IL-2
activation eGLs show NK activity but cannot lyse trophoblast (King and Loke 1990,
Ferry et al. 1991).
The activation status of leucocytes can be assessed in part by the expression of cell
surface antigens. Known leucocyte activation antigens are CD69 (T lymphocytes,
decidual NK cells), CD25 (IL-2R) (T-cells, B-cells, macrophages and some eGLs)
and HLA-DR (a proportion of eGLs and T cells). It is of interest therefore to
ascertain the relative expression of these activation markers in the stroma of fertile
compared with subfertile endometrium. This is especially relevant given the finding
that some early spontaneous miscarriages are associated with increased numbers of
activated leucocytes determined by increased expression of decidual CD69, CD25
and HLA-DR (Vassiliadou et al. 1999).
Endometrial granulated lymphocytes display some natural killer cell activity in vitro
but have a characteristic phenotype which differs from that of peripheral blood
natural killer cells (Deniz et al 1994, Loke and King 1995) [Appendix 1]. It is
possible, however, that this phenotypic difference represents a different stage in NK
cell development. Endometrial NK cells may simply be less mature than NK cells in
blood, although it has been recognised that the "mature" form is rarely seen in the
endometrium or decidua. It is therefore possible that these cells may under certain
circumstances, become more like their peripheral blood relatives which are known to
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have a different cytotoxic response in vitro (Christmas et al. 1990). CD57 is an
antigen expressed by NK cells but endometrial granulated lymphocytes exclusively
are CD57 negative (King et al. 1991). Thus this marker can be used to distinguish
between the two cell types and expression in the endometrium would indicate the
change of eGLs to peripheral blood NK type cell. Any such changes in phenotype of
eGLs converting them from specialised uterine NK cells into "classical" NK cells,
could well have serious implications with regard to implantation and the
establishment of pregnancy therefore. CD 16 (FcyRIII) is present on most circulating
peripheral blood NK cells but is detected on only a very small proportion of eGLs in
endometrial sections and appears to confer a functional difference (Chapter 1).
T cell numbers have previously been shown to remain relatively constant throughout
the menstrual cycle. Although Klentzeris et al. (1992) found a significant increase in
CD8 positive T cells from LH+4 to LH+7, there was no significant change
throughout the remainder of the secretory phase of the menstrual cycle. In addition
they found that CD8 positive T cells outnumbered CD4 positive T cells throughout
the secretory phase in a ratio of 2-3:1. Since T cell subtypes have different functions
the assessment of CD8/CD4 balance in subfertile versus fertile endometrium would
be of interest.
Subtypes of CD4 positive T helper cells are by virtue of their expressed cytokines
capable of exerting different immune responses. They may be defined as ThO, ThI
or Th2 cells as described previously (Introduction). The effects these cytokines may
have on the overall function of the endometrium is unknown, but since TH1 cells are
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considered to be detrimental to pregnancy and TH2 cells favourable by virtue of their
cytokine production, it seems likely that an imbalance may affect fertility.
The distinction between those T cells expressing TCRyb antigens in this situation
may also be of interest. y8 T cells, which are both CD4 and CD8 negative, mediate a
non-HLA restricted cytotoxic function involved in the removal of damaged cells
(Christmas and Johnson 1996). These cells remain relatively constant in number
throughout the menstrual cycle and in early pregnancy decidua (Vassiliadou and
Bulmer 1996). Their role in this situation remains speculative but there is the
possibility of an effect on trophoblast invasion and hence fertility. A change in their
representation within the endometrium in relation to fertility status may therefore
indicate altered function of the tissue.
Klentzeris et al. (1994) introduced the idea that leucocyte populations may differ in
fertile compared with subfertile endometrium, suggesting a reduced CD8
positive/CD4 positive T cell ratio and lower numbers of eGLs in the subfertile.
Thus, in the following study a series of leucocyte markers were examined to assess
specific leucocyte populations; total white cells (CD45, leucocyte common antigen),
T cells (CD3) and T cell subpopulations (CD4, CD8, TCRa|3, TCRyS), B cells
(CD19), macrophages (CD14), eGLs and NK cells (CD56, CD16 and CD57) and
leucocyte activation markers (CD69, CD25, HLA-DR). Four groups of women were
considered in order to take into account any effect of previous pregnancy;
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The subject groups described above (Chapter 2) were used; NF (n=7), NI (n=14), PF
(n=10) and PI (n=10) and frozen sections from timed Pipelle endometrial samples
(LH+7 and LH+13) examined. Not all subjects submitted to two samples.
Monoclonal antibodies
The specificities, dilutions and sources of all antibodies used are given in Table 5.1.
All the antibodies used for the study had been evaluated for optimal use in frozen
sections of endometrium in this laboratory previously. Leucocyte populations in
each sample were identified by a single immunohistochemical staining procedure
using the appropriate primary antibodies.
Immunohistochemical labeling procedures
Single immunohistochemical labeling was performed as described in Chapter 2 using
the Vectastain Elite ABC kit. The enzyme reaction was developed using DAB as
chromagen.
Controls
As previously, frozen sections of tonsil were included as positive controls for
leucocyte markers in each immunostaining run. Normal negative controls where
primary antibody was replaced with normal serum were used for each sample.
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Table 5.1. Monoclonal antibodies.




CD3 T lymphocytes Dako 1:200




CD14 Macrophages Dako 1:40
CD16 NK cell marker,
FcyRIII
Becton Dickinson 1:100
CD19 B lymphocytes Dako 1:100
CD56 Natural killer cells Novocastra 1:200
CD57 NK cell marker Novocastra 1:10
TCRccP T cell sub type T Cell Diagnostics 1:10




CD69 Activation antigen Serotec 1:200
HLA-DR Activation antigen Dako 1:2000
Evaluation
For each slide, labelled and non-labelled stromal cells were counted in 2 high-power
fields (x40), using a 10x10mm graticule and amounting to a total of approximately
1,000 cells per slide counted. Fields were randomly selected in areas of good quality
staining with good morphology and including as much stroma as possible. The small
size of some samples made the choice of areas quite limited. It is unlikely therefore
that these sections would have proved suitable for automated analysis where a
relatively large area of uniform tissue is required to give effective results. Since
Pipelle endometrial samples are by nature relatively superficial and piecemeal it is
difficult to identify clearly the distinction between the stratum functionalis and
stratum basalis. In practice there is probably little stratum basalis represented in
biopsies from premenopausal subjects. This is in keeping with the relative rarity of
111
leucocyte aggregates in the sections. For quantitation purposes aggregates were
avoided since it was not possible to count cells in aggregates accurately. Where
there were very scanty numbers of labelled cells, for example CD19 positive B
lymphocytes, an estimated incidence of 1/500, 1/1000 or 0 were given. Numbers of
labelled cells were expressed as a percentage of the total stromal cells.
Statistical analysis
The methods used for the statistical analysis of these data have been described in
Chapter 2.
Results
Total stromal cell counts
There was no significant difference in the total number of stromal cells per high-
power field counted i) between sections of the same tissue labelled with different
monoclonal antibodies, ii) between different tissues from the four groups of subjects,
and iii) between tissues at LH+7 and LH+13 (data not shown).
General Distribution ofLeucocytes
In general the distribution of endometrial leucocytes was seen to be fairly uniform
throughout the stroma in these endometrial samples. There were however, in
keeping with previous studies and the findings described in Chapter 3, occasional
aggregates of leucocytes. These comprised T cells and CD56 positive eGLs. In
Pipelle samples these aggregates were infrequent presumably as a result of the
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relatively superficial sampling of the endometrium compared with post-hysterectomy
specimens where full thickness blocks of endometrial tissue are taken.
Cyclical changes
In all groups, the previously recognised changes in CD45 and CD56 positive cells in
the endometrial stroma were confirmed (Figs. 5.1 and 5.2) reaching significance in
most cases. There were also increases in the numbers of stromal cells expressing
CD3 and CD14 from LH+7 to LH+13 in all subject groups (Fig.5.3), although these
increases generally did not reach significance. There were small but insignificant
changes in numbers of CD19 labelled cells (Fig 5.3) (Table 5.2).
Although there were quite marked differences in the numbers of endometrial stromal
cells expressing CD45 and CD56 in our series, there appeared to be a wide variation
in the number of stromal cells expressing these antigens between individuals
particularly at LH+13 (Fig. 5.4). This may effectively make differences in the
groups appear less significant.
Although in smaller numbers, paired samples (ie. LH+7 and LH+13 samples from
the same subject) were available and were examined as such in order to take this
variation into account (Table 5.3). These paired samples provided similar results to
the unpaired groups and in particular did not produce unexpected significant results.
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Figure 5.1. Frozen sections ofPipelle endometrial samples,
labelledfor CD45. a) LH+7 (xlO); b) LH+7 (x40); c) LH+13 (x20).
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Figure 5.2. Frozen sections ofPipelle endometrial samples. Labelledfor
CD56. a) LH+7 (x20); b) LH+13 (xlO).
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Figure 5.3. Frozen sections ofPipelle endometrial samples. Single
labelled, a) LH+13, CD3 (x40); b) LH+7, CD14 (x20); c) LH+7,
CD19 (x40).
116
Table 5.2. Cyclical changes in endometrial leucocyte populations.
LH+7 LH+13
% of stromal cells labelled % of stromal cells labelled




CD45 7.63 8.17 3.74-14.47 53.31 43.18 11.36-60.55 0.010
CD56 3.05 4.47 0.70-14.47 36.92 28.62 2.71-52.84 0.073
CD3 3.01 3.42 1.58-5.98 3.42 6.85 1.11-12.97 0.164
CD14 1.57 1.92 0.92-3.99 3.07 3.22 0.85-6.57 0.527




CD45 9.87 12.37 5.42-19.45 35.56 32.24 4.28-68.43 0.107
CD56 6.96 7.22 1.86-16.05 33.25 29.59 1.20-60.27 0.023
CD3 3.21 3.47 1.52-6.69 4.82 5.39 2.46-12.59 0.140
CD 14 2.17 2.44 0.10-5.15 2.58 3.16 0.10-12.94 0.923
CD19 0.10 0.10 0-0.50 0.10 0.11 0-0.20 0.310
Parous n=9 n=9
Fertile
CD45 9.26 9.40 4.76-13.96 34.82 35.95 4.03-56.93 0.006
CD56 4.55 4.39 2.16-6.49 29.76 34.69 6.29-73.13 <0.0005
CD3 3.24 3.38 2.10-4.49 4.99 6.34 1.28-11.47 0.021
CD 14 2.85 2.66 0.10-5.08 3.29 3.39 0.40-20.33 0.481
CD19 0.10 0.08 0-0.20 0.10 0.10 0-0.20 0.574
Parous 3 II O n=5
Infertile
CD45 7.42 8.09 3.32-13.03 35.89 31.11 8.11-46.65 0.013
CD56 6.44 8.46 2.87-17.96 35.88 30.68 3.94-45.84 0.106
CD3 3.31 3.89 1.58-6.93 5.66 5.09 1.41-8.32 0.503
CD14 2.63 3.54 0.47-7.61 6.91 8.27 0.99-15.49 0.199
CD19 0.05 0.06 0-0.20 0.10 0.13 0.10-0.20 0.142
*Mann-Whitney. Reaches significance at P < 0.05.
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Figure 5.4. 95% confidence intervalsfor the numbers ofa) CD45 and b) CD56 positive cells. All
groups.
118
Table 5.3. Endometrial leucocyte populations. Changes from LH+7 to LH+13 in paired samples.
NF NI PF PI
(n=*4;**5) (n=*6;**7;***8) (n=*6;**7;***8) (n=*3;**4;***5)
% of stromal LH+7 LH+13 LH+7 LH+13 LH+7 LH+13 LH+7 LH+13
cells labelled
CD45 mean 8.99 43.18** 12.22 30.40*** 9.02 34.51** 7.84 31 12***
P 0.011 0.085 0.010 0.020
CD56 mean 6.24 28.62* 6.95 30.56** 4.39 35.52*** 11.33 39.59*
P 0.061 0.027 0.004 0.014
CD3 mean 3.24 6.85* 3.79 4 71*** 3.55 6.20** 3.78 5.09**
P 0.100 0.426 0.065 0.540
CD14 mean 2.07 3.22* 2.68 3 20*** 2.80 3.55** 4.02 8.27**
P 0.471 0.750 0.465 0.243
CD19 mean 0.10 0.04** 0.13 0.01* 0.08 0.08* 0.05 0.13**
P 0.208 0.695 1.000 0.058
2-tailed, paired t-test. Significance achieved where P < 0.05.
Nulliparous versus parous
There were no significant differences in the numbers of stromal cells expressing
CD45, CD3, CD14, CD56 or CD19 when parous and nulliparous endometrium was
compared in either fertile or subfertile subjects, at either LH+7 or LH+13.
Infertile versus fertile
There appeared to be no significant differences in the endometrial leucocyte
populations between fertile and subfertile groups when parity was taken into account.
What is of interest, however, was a trend for subfertile endometrium to include
greater numbers of CD56 positive leucocytes at LH+7 than their fertile counterparts
but to mount a smaller increase in CD56 positive leucocyte numbers by LH+13.
This is reflected in similar increments in CD45 positive cells in fertile compared with




















































Nulliparous infertile versus parous fertile
These findings do not confirm the results reported by Klentzeris et al. (1994), where
using a different evaluation technique these authors reported significantly fewer
CD56 positive cells in subfertile endometrium compared with fertile controls. The
subject groups used in that study did not take into account previous parity. Although
no clear difference has been shown as a result of previous pregnancy in this study,
nulliparous subfertile and parous fertile groups were compared in order to provide a
direct comparison with this previous study.
The trends previously described for all subfertile groups were observed when
comparing parous fertile and nulliparous subfertile groups. Greater mean numbers of
labelled cells were observed in the subfertile group at LH+7 and a greater increase in
expression of CD45 and CD56 in the fertile group at LH+13 (Fig.5.7). These trends
did not reach significance. The findings still did not confirm those reported by
Klentzeris et al. (1994). There were no differences in the total numbers of stromal
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Figure 5.7. Endometrial stromal leucocyte populations. Nulliparous infertile versus parous fertile.
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T-cell subpopulations
As described above, irrespective of previous pregnancy there was an increase in the
number of CD3 positive cells in both fertile and subfertile endometrium and this
increase reached significance in the parous fertile group (p=0.021) (Table 5.4). The
number of helper T (TH) cells (CD4 positive) were calculated by subtracting the
number of CD8 positive (cytotoxic T [Tc] cells) from the total number of T cells
(CD3 positive). The reason for this was that CD4 antibodies may also label
macrophages giving a falsely high result and in the frozen tissues studied there was
not a ready distinction between the two types of cells (T cells and macrophages)
based on morphology alone. There were no significant differences in the numbers
of Tc or Th (Fig. 5.8) cells between the stages of the cycle examined in these groups
although the increase in expression of each of these approached significance in the
parous fertile group (Th; p=0.167, Tc; p=0.167) (Fig. 5.9). This is in keeping with
the work of Klentzeris et al. (1992) who showed non-significant increases in T cell
subtypes over this period of the menstrual cycle. It is of interest however, that the
CD8:CD4 ratio was lower at LH+13 compared with LH+7 in all groups (Fig. 5.10).
There were no significant differences in T cell sub-populations between the groups
when fertility status or previous parity was considered at either LFI+7 or LH+13. In
addition when nulliparous subfertile and parous fertile groups were compared there
were again no significant differences established at either LH+7 or LH+13.
The T cell sub-types of TCRa$ or TCRyS did not appear to be cycle dependent
although TCRyb positive T cells were very rare in all groups (Figs. 5.9 and 5.11).
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Table 5.4. Cyclical changes in endometrial Tcell sub-populations.
LH+7 LH+13
% of stromal cells labelled % of stromal cells labelled
median mean range median mean range p*
Nulliparous n=7 n=5
Fertile
CD3 3.01 3.42 1.58-5.98 3.42 5.70 1.11-12.97 0.164
CD4 3.86 3.44 0.29-6.15 4.40 4.82 1.68-10.00 0.537
CD 8 2.19 2.16 1.37-2.88 3.75 3.61 1.04-6.32 0.230
TCRap 2.14 2.13 1.30-2.90 1.90 2.02 1.40-3.08 1.000
TCRyS 0.10 0.10 0-0.20 0.10 0.13 0.10-0.20 0.762
Nulliparous n=12 n=10
Infertile
CD3 3.21 3.47 1.52-6.69 4.82 5.39 2.04-12.59 0.140
CD4 2.29 2.33 0.42-5.61 1.49 2.11 0.48-6.11 0.536
CD8 1.44 2.43 0.68-7.39 1.89 2.77 0.65-7.00 0.808
TCRap 1.41 1.65 0.57-3.36 1.95 2.61 1.36-5.10 0.069
TCRyS 0.10 0.12 0.10-0.20 0.10 0.11 0-0.20 0.882
Parous 3 II VO n=9
Fertile
CD3 3.24 3.38 2.10-4.84 4.99 6.06 1.28-11.47 0.021
CD4 1.10 2.33 0.67-4.96 2.32 4.89 1.07-12.63 0.167
CD8 2.11 2.12 1.09-2.35 2.52 2.97 0.89-7.12 0.167
TCRaP 2.25 2.48 1.27-4.80 1.65 2.71 0.63-7.17 0.730
TCRyS 0.10 0.12 0.05-0.20 0.10 0.12 0.10-0.20 0.955
Parous 3 II O n=5
Infertile
CD3 3.31 3.75 1.58-5.48 5.66 5.30 1.42-6.14 0.503
CD4 2.33 2.59 0.20-6.18 1.91 2.65 0.61-6.67 1.000
CD8 2.48 2.54 0.95-4.62 2.88 3.25 1.55-6.30 0.513
TCRaP 2.11 2.48 0.86-6.43 1.94 2.08 0.57-3.68 0.953
TCRy8 0.10 0.11 0-0.20 0.10 0.10 0.10-0.10 0.839
*Mann-Whitney. Reaches significance at P < 0.05.
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Figure 5.8. Frozen sections ofPipelle endometrial samples. Single labelled.
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Fig. 5.9. Endometrial stromal T cell sub-populations. Stromal labelling at LH+7 and LH+13.





Figure 5.10. Endometrial Tcell sub-types. CD8.CD4 ratio.
Endometrial granulated lymphocytes
CD56 labelling has already been reported (above). Anti CD16 produced
unacceptable background reactivity preventing accurate assessment of its expression.
Only very tiny numbers of CD57 positive cells were present in the sections studied
such that their evaluation was rendered semi-quantitative, 0-1/1000 (or 2 high power
fields) labelled cells being present in each section (Fig.5.12). There were no obvious
differences in CD57 cell numbers between the subject groups.
Activation markers
Although only significant in the parous subfertile group (p=0.011), in each of the 4
groups of subjects the expression of HLA-DR in the stroma was seen to increase
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Figure 5.11. Frozen sections ofPipelle endometrial samples. Single labelled.
a) LH+ 7, TCRafi (x40); b) LH+7, TCRyS(x20).
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Figure 5.12. Frozen sections ofPipelle endometrial samples, single labelled
for CD57. a) LH+7 (x20); b) LH+7 (x40).
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from LH+7 to LH+13 (Figs.5.13 and 5.14). This was however, only a marginal
increase in the nulliparous subfertile group (Fig.5.8). CD69 was relatively constant
throughout secretory phase (Figs. 5.13 and 5.14) (Table 5.5).
In all groups CD25 expression in stroma decreased from LH+7 to LH+13
expression in subfertile compared with fertile endometrium. However,
numbers of labelled cells were present in keeping with previous accounts
and these changes were not significant (Fig. 5.14) (Table 5.5).
Table 5.5. Cyclical changes iti endometrial leucocyte activation markers^
LH+7 LH+13
% of stromal cells labelled % of stromal cells labelled
median Mean range median mean range p*
Nulliparous
Fertile
r-II€ 3 ii Ln
HLA-DR 15.42 14.27 7.78-18.24 28.60 25.88 14.12-35.84 0.073
CD69 0.70 0.88 0.10-2.22 0.10 0.41 0-1.85 0.381




HLA-DR 13.64 13.14 3.82-24.23 15.12 13.69 0-21.42 0.503
CD69 0.13 0.44 0-1.62 0.10 0.44 0-2.67 0.600
CD25 0.20 0.38 0.10-1.11 0.10 0.20 0.10-1.00 0.080
Parous n=9 n=9
Fertile
HLA-DR 11.83 17.20 5.87-28.40 17.98 22.88 14.65-37.36 0.210
CD69 0.69 0.72 0-2.11 0.20 0.83 0-3.30 0.622
CD25 0.37 0.74 0.10-1.87 0.10 0.36 0.10-2.14 0.321
Parous n=10 n=5
Infertile
HLA-DR 11.49 12.11 7.63-20.49 21.58 23.78 14.77-37.22 0.011
CD69 0.24 0.40 0-1.04 0.10 0.38 0-1.41 1.000
CD25 0.10 0.42 0-2.65 0.20 0.33 0.10-0.92 0.513















Figure 5.14. Endometrial expression of leucocyte activation markers.
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Discussion
This study has confirmed by direct counting methods the changes previously
reported in the numbers of endometrial stromal leucocytes in the luteal phase
(Bulmer et al. 1991b, Starkey at al. 1991, Klentzeris et al. 1992). In addition,
however, a possible increase in CD3 positive cells from LH+7 to LH+13 has also
been shown, a finding which has not previously been reported. Klentzeris et al.
(1992) demonstrated an increase in CD3 positive T cells and their CD8 positive, Tc,
sub-type as the secretory phase of the cycle progressed. Their data show significant
increases between LH+4 and LH+7, an interval not examined in the study described
here. They have also reported however, a significantly lower number of CD8
positive Tc cells in subfertile compared with fertile endometrium throughout the
secretory phase of the menstrual cycle (Klentzeris et al. 1994). This finding has not
been confirmed even when the subject selection differences have been taken into
account. The difference in the results of this study and that of Klentzeris et al. (1994)
is likely to lie in the evaluation techniques. In the current study actual numbers of
cells were counted rather than the use of automated techniques which are dependent
on surface area of labelling and thus exposed to the vagaries of staining intensity and
spread of colour beyond the cell membrane, a phenomenon which differs between
antibodies and staining techniques. Furthermore cell sizes may vary between cycle
stages for example as a result of proliferative activity and their relative surface area
may be affected by stromal oedema. In addition in the current study results are
expressed as a percentage of the total stromal cells rather than as absolute numbers of
cells per field.
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Despite the possibility that previous pregnancy permanently alters the immunological
status of the endometrium this was not clearly reflected in leucocyte numbers. There
was however, a different pattern of change in CD45 positive and CD56 positive
leucocyte populations when comparing fertile and subfertile groups. Although not
significant, it appeared that CD56 positive leucocyte cell numbers were more
numerous around the time of implantation (LH+7) in subfertile endometrium
compared with fertile but more importantly that there was a less dramatic rise in
CD56 positive cell numbers as the luteal phase progressed from LH+7 to LH+13.
It is of particular interest that there was substantial variation in cell numbers
expressing CD45 or CD56 between individuals at LH+13. This may be expected in
the tissues studied as they were obtained in non-conception cycles. At LH+13 in
such circumstances menstruation is imminent and the relevance of these cells with
respect to endometrial function may be less. In addition the variation of exact timing
of sampling may have a bigger impact on the observed changes at LH+13 when
endometrial "breakdown" is occurring. In support of this and in contrast is the much
"tighter" agreement in cell numbers at LH+7 when their contribution to endometrial
function would be considered to be of greatest importance. As the actual numbers
were similar in fertile and subfertile tissue the difference in expansion of the
populations is likely to be a result of altered control of leucocyte proliferation. There
is no direct corroborative evidence from studies of stromal Ki67 expression (Chapter
3) since, although there is a significant increase in stromal Ki67 expression from
LH+7 to LH+13, fertility status does not appear to affect this.
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Significant changes in T cell numbers from LH+7 to LH+13 have not been
demonstrated previously and the changes in CD3 positive T cells described above
were not large, numbers increasing from -3% at LH+7 to 5% of the total stromal cell
population at LH+13. These changes were only significant in the parous fertile
group (p = 0.021) although approaching significance in the nulliparous groups (NF,
NI; p = 0.164 and 0.140, respectively). Bulmer et al. (1991b) showed no significant
change in CD3 positive cell numbers through the menstrual cycle although
specimens were not timed from the LH surge but dated by Noyes criteria (Noyes et
al. 1950) from the last menstrual period. Klentzeris et al. (1992) demonstrated an
increase in CD3 positive cells in timed endometrial biopsies in parous fertile controls
but the change, significant between LH+4 and LH+7, did not reach significance from
LH+7 to LH+13. Starkey et al. (1991) showed little change in CD3 positive numbers
through the menstrual cycle in frozen sections of normal endometrium examined
immunohistologically. In relation to this it is of note that Klentzeris et al. (1992)
identified a significant increase in CD8 positive cells though not CD4 positive cells
between LH+4 and LH+7 in the secretory phase of the menstrual cycle. In that study
the numbers of CD8 positive cells exceeded CD4 positive cells at all times, but the
early luteal phase increase in numbers was less evident in endometrium from women
with unexplained infertility (Klentzeris et al. 1994). Changes in T cell types were
also seen in this study in both subfertile and fertile groups. The findings in the
present study differ however, from the work of Klentzeris et al. who demonstrated a
reduced CD8:CD4 cell ratio in subfertile compared with fertile endometrium. In
contrast the Tc:TH ratio demonstrated in the current study was greater at LH+7 in
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subfertile compared with fertile endometrium, a finding that was not maintained at
LH+13.
Most of the endometrial T cells were of a(3 sub type. There are very few y8 T cells
present, comprising around 0.1% of stromal cells. This is in keeping with previous
studies (Chen et al. 1995, Vassiliadou and Bulmer 1996). The activation status of the
T cells does not appear to be altered either by fertility status or previous parity.
The full significance these combined results will not be clear until the full functional
roles of all of the cells involved are known. CD56 positive eGLs have long been
believed to play a role in implantation and it may be that higher numbers of the cells
at LH+7 in subfertile endometrium adversely affect this process. Lower numbers at
LH+13 however, may suggest a difference in activation or function in the subfertile
endometrium compared with the fertile. CD56 positive cells are NK like in activity
and have been shown to proliferate in endometrium during the late luteal phase (Pace
et al. 1989). It has been hypothesised that their activity, in conjunction with other
immune cells and regulators, may control trophoblast invasion (Liu et al. 1994).
Hence the possibility that alteration in the numbers of CD56 positive cells and their
functions may affect implantation and the progressive establishment of early
pregnancy. The data presented show no evidence of a change in status of eGLs to a
more "classical" or mature NK phenotype in relation to fertility.
Although there is no clear link between sex steroids and CD56 positive eGLs
(Chapter 4) there remains the possibility that the difference in population expansion
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of eGLs demonstrated in this study may be indirectly linked to, and the result of an
abnormal intermediate response to those hormones. Alternatively this finding may
be the result of abnormalities in the eGLs themselves and a study of Ki67 expression
on eGLs in each of the subject groups would be of interest in relation to this.
It has been proposed that in mice TH1 and TH 2 helper T cells have contradictory
roles in successful pregnancy (Wegmann et al. 1993). Thus it may not be surprising
that T cell populations and ratios of Th/Tc cells differed in subfertile compared with
fertile populations. T cells produce numerous soluble factors in their role as
mediators of the immune response. There are factors to which eGLs are known to be
sensitive, for example IL-2 (Ritson and Bulmer 1989, King and Loke 1990) albeit
present in only small amounts in the endometrium. There is also evidence for effects
of T cell cytokines on placental cells (Athanassakis et al. 1987). Thus it is possible
that this previously unrecognised T cell response to luteal phase, and the variation
between subfertile and fertile T cell sub-populations may be responsible for altered
eGL function and thus pregnancy failure via the production of a different balance of
cytokines.
Any evidence for an increase in activation status of endometrial leucocytes lies in the
higher HLA-DR expression at LH+13 in fertile endometrium, but this may simply
parallel the increase in leucocyte numbers. No difference was seen in the early
activation markers CD25 or CD69.
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Conclusion
There is tight control of endometrial granulated leucocyte numbers around the time
of implantation. A significant increase in eGL numbers occurs from LH+7 to LH+13
but the degree to which this expansion in the population occurs is less in subfertile
compared with fertile endometrium. There is a previously unrecognised late
secretory rise in T cell numbers, in both fertile and subfertile women and the balance
of CD4/CD8 T cell subtypes alters between LH+7 and LH+13. Leucocyte activation
status may differ with respect to HLA-DR expression at LH+13 in subfertile
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ADHESION MOLECULES IN THE ENDOMETRIUM
Introduction
Some of the potential controls of endometrial function have already been considered
in previous chapters. It is presumed that central control is maintained by the ovarian
cycle with its production of steroid hormones, mainly oestrogen and progesterone.
This would constitute the "macro" control, but fine-tuning may be obtained by local
messengers within the endometrium. Two categories of messenger can be
considered; i) adhesion molecules - cell-cell or cell-matrix adhesion molecules
involved in inter-cellular communication, and ii) cytokines - soluble inter-cellular
transmitters of messages. Both of these could be influenced by local hormones.
Previous authors have examined the distribution of a variety of adhesion molecules
with regard to their potential role in the menstrual cycle and fertility. The overall
findings appear to suggest a cycle dependent distribution of the integrins otiPi (VLA-
1, CD49a), avp3 (CD51/CD61) and 0C4P1 (VLA-4, CD49d). Lessey et al. (1994) used
these observations to define the "implantation window" and suggested that aberrant
expression of these adhesion molecules occurred in some cases of infertility. Closer
examination of regional expression of these integrins within the endometrium has
revealed that surface epithelium is the major site for cyclical changes (Lessey et al.
1996a). This is of particular significance when considering the earliest of
embryo/endometrial interactions. Klentzeris et al. (1993) have suggested that there is
an absence of OC4P1 expression in subfertile compared with fertile endometrium. More
recently Murray et al. (1999) have shown that C(6p4 remains constant throughout the
menstrual cycle and thus probably has no role in endometrial receptivity.
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The importance of such adhesion molecules within the endometrium and their
cyclical changes may be in their contribution to normal immune cell function as
discussed above and thus their potential effects on endometrial receptivity. eGLs
express a wide array of adhesion molecules (Appendix 1). Furthermore there is a
potential role for adhesion molecules in the embryo/endometrial interaction either
directly - embryo derived fibronectin may act as a ligand for endometrial or even
eGL OC4P1; or indirectly - ligand binding resulting in altered endometrial cell
function.
Although Grosskinsky et al. (1996) have shown that the in vitro endometrial stromal
expression of some key adhesion molecule subunits (ai, CC3, as, and avPs) is
unaffected by the direct application of steroid hormones, it is likely that their cyclical
expression is linked to the hormone cycle at least indirectly. Indeed Grosskinsky
also noted the induction of endometrial stromal expression of aiPi by some cytokines
in vitro, namely epidermal growth factor (EGF) transforming growth factors-a and -
Pi (TGF-a and TGF-Pi) and of avP3 by IL-la, IL-ip and TNF-a whilst in other in
vitro studies (Simon et al. 1998) have demonstrated an IL-1 mediated up-regulation
of P3 integrin in cultured endometrial epithelial cells.
Integrins have been the most studied of the adhesion molecules with regard to
endometrial function, but if the roles of the different groups of adhesion molecules
are considered it can be seen that there is scope for their involvement in the process
of endometrial cyclicity if not directly in embryo adhesion and implantation.
Cadherins have been considered for their potential role in embryo/endometrial
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attachment and are implicated, by their role in intercellular binding, in the permissive
changes in endometrial epithelium for blastocyst penetration. ICAM, VCAM and the
selectins are implicated by virtue of their roles in immunoregulation (see below).
Thus in this study, in addition to the integrins discussed above, a selection of
adhesion molecules have been studied, which are involved primarily in the immune
response, in particular leucocyte trafficking. These may be of relevance to the
behaviour of the endometrial immune system, which via local effectors may have a
role to play in the expression of integrins throughout the menstrual cycle.
Fibronectin is a ligand for several integrins (including CX4P1) and has been strongly
implicated in the process of trophoblast invasion (Damsky et al. 1994). Its
deficiency in mice and that of its receptor leads to early embryonic loss (Hynes
1996). Aplin et al. (1988) described the distribution of fibronectin in endometrial
stroma throughout the menstrual cycle. They noted its constant presence throughout
the stroma in proliferative, early and late secretory phases. It was detected in blood
vessels but not endometrial glands. Bilalis et al. (1996) found that this protein was
absent in the endometrium of subfertile women throughout the secretory phase of the
endometrium. Once again the studies of subfertile women compared a parous fertile
group with a group of subfertile women of unspecified parity.
The study described in this chapter was designed to consider the distribution of
adhesion molecules in the endometrium and to compare the distribution between
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fertile and subfertile subjects. The effect of previous parity, as in other chapters, was
also taken into account - a factor not considered in previous reports.
Experimental Design
Endometrial samples
Frozen sections from samples obtained from women in the four subject groups
described in Chapter 2 were used.
Monoclonal antibodies
The antibodies, their specificities, source and concentrations used are described in
Table 6.1. The specific adhesion molecules examined are detailed below.
Table 6.1. Monoclonal antibodies.
Antibody Specificity Source Concentration
CD49a ociPi, VLA-1 Immunotec 1/100
CD49d CGpi, VLA-4 Serotec, Oxford, 1/400
UK
CD61 (0Cv)p3 Novocastra 1/100
ICAM-1 CD54 Novocastra 1/60
VCAM CD106 Novocastra 1/100




The integrins are initially classified according to their P subunit (Hynes 1987). Those
possessing the Pi subunit are the very late activation (VLA) family which comprises
the largest group. The VLA family of molecules is expressed by lymphocytes
several days after activation in vitro (Hynes 1987).
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-CD49a (ai(3i, VLA-1). This molecule binds laminin. It is a marker of T cell
activation (Tabibzadeh 1990, 1991).
-CD49d (CC4P1, VLA-4). This integrin is a fibronectin receptor which also binds the
vascular cell adhesion molecule-1 (VCAM-1, discussed below) at a different site.
This integrin is involved in lymphocyte-endothelial cell adhesion but may also be
responsible for lymphocyte aggregation (Bednarczyk and Mclntyre 1990).
-CD61 (P3). CD61 is the P subunit of the vitronectin receptor avP3 (CD61/CD51)
which is also capable of binding fibrinogen, von Willebrand's factor and
thrombospondin. It is present on most mesenchymal cells and in particular on large
vessel endothelium.
B. IMMUNOGLOBULIN SUPERFAMILY;
-CD54 (ICAM-1). Intercellular adhesion molecule-1 is widely expressed on
endothelial and epithelial cells. Its expression is induced by inflammation and it
promotes leucocyte adhesion by binding lymphocyte function-related antigen-1
(LFA-1, 0ClP2 integrin).
-CD 106 (VCAM). This molecule is expressed on endothelial cells which have been
activated by the cytokines interleukin-1 (IL-1) or tumour necrosis factor a (TNFa).
It promotes leucocyte adhesion, binding VLA-4 (above). Deficiency of this adhesion




-CD62e (E-selectin, ELAM-1). These molecules are involved in the inflammatory
response: E-selectin is produced by activated endothelial cells and promotes
leucocyte attachment.
-CD62 (P-selectin, GMP-140, PADGEM). P-selectin is expressed by endothelial
cells, platelets, monocytes and neutrophils in response to activation. It again
promotes leucocyte-endothelial adhesion but also platelet, neutrophil and monocyte
interactions.
Method
Single labelling immunohistochemistry was performed as described in Chapter 2.
DAB was used as the substrate for the peroxidase labelling technique giving a brown
reaction product. Sections were lightly counterstained with Mayer's haematoxylin,
dehydrated, cleared and mounted in DPX with coverslips.
Evaluation
All the sections were examined semi-quantitatively. Expression of antigen in
glandular and surface epithelium, stroma and vascular tissue was scored from 0 to 5
(Chapter 2). The distribution of staining was assessed separately for each tissue area
- stroma, glandular epithelium and surface epithelium. The staining of vessels
within the stroma was noted separately.
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Statistical analysis
The methods employed for the statistical analysis of data obtained in this study are
discussed in Chapter 2 (Materials and Methods).
Results
CD49a(VLA-l,cc,p1)
Clear cyclical changes in the expression of CD49a were demonstrated. For both
fertile and subfertile endometrium there was a trend to increased stromal VLA-1
expression and reduced glandular epithelial expression from LH+7 to LH+13 (Table
6.2) (Figs. 6.1 and 6.2). It is of interest that these changes only reached significance
in the subfertile groups (Table 6.3). There was strong (mean staining score 3.63-
4.00) labelling of vessels for CD49a at both LH+7 and LH+13.
When comparing fertile and subfertile endometrium there was a trend to lower
expression of CD49a throughout the tissue in subfertile endometrium at LH+7 (not
significant) but there was no difference in expression between groups at LH+13
(Table 6.2). The most striking feature in these data is that, although scanty at most,
there was no surface epithelial expression of CD49a at LH+13 (Figs. 6.1 and 6.2).
Parity did not appear to affect the expression of this antigen in endometrium (Table
6.2).
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NF N 4 4 4 2 2 2
Mean 1.88 3.88 0.25 2.75 2.25 0
Median 1.75 4.00 0.25 2.75 2.25 0
Range 1-3 3.5-4 0-0.5 2.5-3 1.5-3 0-0
NI N 8 8 8 8 8 8
Mean 1.38 3.06 0.38 2.31 2.69 0
Median 1.00 3.50 0 2.75 2.75 0
Range 1-2 0-4 0-1.5 1-3 0.5-4 0-0
PF N 6 6 6 6 6 6
Mean 1.67 3.42 1.17 2.25 2.67 0
Median 1.50 4.00 1.00 2.50 2.50 0
Range 1-3 2-4 0-3 1-3.5 1.5-4 0-0
PI N 8 8 8 3 3 3
Mean 1.38 3.50 0.13 3.33 2.67 0
Median 1.50 3.75 0 3.00 3.00 0
Range 0-2 2-4 0-1 3-4 2-3 0-0
Table 6.3. CD49a expression in endometrium. LH+7 versus LH+13.
Stroma Glandular Surface Epithelium
Epithelium
Nulliparous fertile
P 0.267 0.133 0.533
Nulliparous
infertile
P 0.038 0.574 0.234
Parous fertile
P 0.394 0.240 0.180
Parous infertile
P 0.012 0.085 0.776
Mann-Whitney. Results reach significance when P < 0.05.
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Figure 6.1. Frozen sections ofPipelle endometrial samples. Single
labelledfor CD49a (VLA-1, (Zjfij) a) Infertile, LH+7 (x20); b)



























Figure 6.2. Endometrial CD49a expression at LH+7 and LH+13. a) stroma, b) glandular epithelium
and c) surface epithelium.
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CD49d (VLA-4, a4p,)
VLA-4 expression again showed a cyclical pattern (Table 6.4) (Figs. 6.3 and 6.4).
There was a trend to increased stromal and reduced epithelial expression at LH+13
compared with LH+7. The differences were not significant in most cases (Table
6.5), however, and there were also no significant differences between the four groups
of subjects. There was again relatively strong labelling of vessels for this antigen
(mean staining score 3.00-4.00) at both LH+7 and LH+13.










NF N 4 4 3 4 4 4
Mean 2.25 2.50 0.83 2.00 1.38 0.50
Median 2.00 3.00 1.00 2.00 1.00 0.50
Range 2-3 0-4 0-1.5 1.5-2.5 0.5-3 0-1
NI N 10 10 9 6 6 5
Mean 1.80 3.00 0.78 2.17 1.25 0
Median 2.00 2.75 0 2.25 1.25 0
Range 1-2 2.5-4 0-2.5 1.5-2.5 0-2 0-0
PF N 6 6 4 8 8 8
Mean 2.17 2.00 0.88 2.38 0.88 0.13
Median 2.00 2.50 0.25 2.50 1.00 0
Range 1.5-3 0-3 0-3 1.5-2.5 0-1.5 0-0
PI N 9 9 7 4 4 3
Mean 2.22 3.78 1.36 2.63 2.00 0.67
Median 2.00 4.00 1.50 2.50 1.50 0
Range 1.5-3 3-4 0-3 2.5-3 1-4 0-2
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Figure 6.3. Frozen sections ofPipelle endometrial samples. Single
























Figure 6.4. Endometrial expression of VLA-4 at LH+7 and LH+13.
epithelium and c) surface epithelium.
a) stroma, b) glandular
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P 0.686 0.486 0.629
Parous fertile
P 0.345 0.108 0.368
Nulliparous
infertile
P 0.118 0.003 0.190
Parous infertile
P 0.148 0.076 0.383
Mann-Whitney. Results reach significance when P < 0.05.
CD61 (fc subunit of ccvfy)
There were significant cyclical changes in the expression of CD61 in endometrium
(Table 6.6) (Figs. 6.5 and 6.6). Although not quite reaching significance in the
parous subfertile group, there were otherwise significant increases in the expression
of CD61 in both glandular and surface epithelium from LH+7 to LH+13 (Table 6.7).










NF N 6 6 6 5 5 5
Mean 1.42 0.25 0.25 1.00 2.20 2.20
Median 1.25 0 0 1.00 3.00 3.00
Range 1-2 0-1.5 0-1.5 1-1 0-3 0-3
NI N 11 11 11 7 7 7
Mean 1.09 0.68 0.41 1.21 2.07 1.86
Median 1.00 0 0 1.00 2.50 2.00
Range 1-2 0-2 0-2 1-2 0.5-3 0-3
PF N 8 8 7 9 9 7
Mean 1.38 0.44 0 1.39 1.67 1.57
Median 1.00 0 0 1.00 1.50 1.00
Range 1-3 0-2.5 0-0 0-2.5 0-3 0-3
PI N 8 8 7 4 4 3
Mean 1.06 0.31 0.21 1.00 1.50 2.00
Median 1.00 0 0 1.00 1.50 3.00
Range 1-1.5 0-2 0-1 1-1 0-3 0-3
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Figure 6.5. Frozen sections ofPipelle endometrial samples. Single labelled




























Figure 6.6. Endometrial expression ofCD61 at LH+7 and LH+13. a) stroma b) glandular epithelium
and c) surface epithelium.
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P 0.177 0.030 0.030
Parous fertile
P 0.815 0.015 0.026
Nulliparous
infertile
P 0.536 0.008 0.011
Parous infertile
P 0.808 0.109 0.183
Mann-Whitney. Results reach significance when P < 0.05.
There were no significant differences between nulliparous and parous endometrium
or between fertile and subfertile endometrium. Vessels were labelled uniformly at
LH+7 and LH+13.
ICAM and VCAM
The greatest ICAM expression in the endometrium was in the vascular endothelium
(mean staining score 3.63-4.00) elsewhere being of a low level (Fig. 6.7). When the
population subgroups were considered there appeared to be no cyclical change in
ICAM expression (Table 6.8) and the only significant change shown was in
nulliparous subfertile endometrial stroma between LH+7 and LH+13 (p=0.043).
VCAM expression also appeared to have no particular cyclical pattern again being of
a relatively low level but including in vascular tissue (Fig. 6.7, Table 6.9) and neither
parity nor fertility appeared to exert an effect on this.
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Figure 6.7. Frozen sections ofPipelle endometrial samples. Single labelled.
a) LH+13, ICAM(x40); b) LH+7, VCAM(x20).
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NF N 6 6 5 5 5 4
Mean 1.58 0.17 0.10 1.60 0.40 0.13
Median 1.75 0 0 2.00 0 0
Range 1-2 0-1 0-0.5 1-2 0-1 0.0.5
NI N 10 10 10 7 7 6
Mean 1.90 0.15 0 1.14 0.50 0.17
Median 2.00 0 0 1.00 0 0
Range 1-3 0-1.5 0-0 1-2 0-1.5 0-1
PF N 7 7 7 9 9 7
Mean 1.86 0 0 1.61 0.28 0
Median 1.50 0 0 1.50 0 0
Range 1-4 0-0 0-0 1-3 0-1.5 0-0
PI N 7 7 7 3 3 3
Mean 1.93 0.29 0 1.67 0 0
Median 2.00 0 0 2.00 0 0
Range 1-3 0-2 0-0 1-2 0-0 0-0










NF N 6 6 5 5 3 3
Mean 1.08 0.25 0.20 1.10 0.83 0.33
Median 1.00 0 0 1.00 0 0
Range 1-1.5 0-1.5 0-1 1-1.5 0-2.5 0-1
NI N 11 8 7 7 6 6
Mean 1.09 0.63 0.57 1.00 1.00 0.42
Median 1.00 0 0 1.00 1.25 0.25
Range 1-2 0-2 0-2 1-1 0-2 0-1
PF N 8 7 7 9 7 7
Mean 1.06 0.14 0 1.11 0.93 0.14
Median 1.00 0 0 1.00 1.00 0
Range 0.5-1.5 0-0.5 0-0 1-1.5 0-2 0-1
PI N 9 8 6 4 2 2
Mean 1.11 0.19 0 1.13 0 0
Median 1.00 0 0 1.00 0 0
Range 1-2 0-1.5 0-0 1-1.5 0-0 0-0
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P-selectin and E-selectin
Both P- and E-selectins were expressed at low levels throughout the endometrial
stroma and epithelium. Vascular labelling of P-selectin was stronger (mean staining
score 3) in all groups and at both stages of the cycle examined. There were again no
clear changes in expression of these adhesion molecules throughout the luteal phase
(Tables 6.10 and 6.11) or between the different populations studied (Fig. 6.8).










NF n 4 4 4 4 4 2
Mean 0.75 0.88 0.50 0.88 0.88 0.75
Median 1.00 0.75 0.50 1.00 1.00 0.75
range 0-1 0-2 0-1 0.5-1 0-1.5 0.5-1
NI n 10 10 10 6 6 6
Mean 0.65 0.70 0.45 0.75 1.50 1.00
Median 1.00 1.00 0 1.00 1.75 1.00
range 0-1 0-1.5 0-1.5 0-1.5 0-2 0-2
PF n 7 7 5 9 9 7
Mean 0.43 1.14 0.60 0.67 0.83 0.71
Median 0 1.50 0 1.00 1.00 1.00
range 0-1 0-2 0-2 0-1 0-2 0-2
PI n 9 9 9 4 4 2
Mean 1.11 0.94 0.67 1.00 0.50 0.50
Median 1.00 1.00 1.00 1.00 0.50 0.50
range 1-2 0-2 0-2 1-1 0-1.5 0-1
158
Figure 6.8. Frozen sections ofPipelle endometrial sections. Single
labelled, a) LH+7, p-selectin (x40); b) LH+7, e-selectin (x40); c)
fibronectin (x20).
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NF n 4 4 4 4 4 3
Mean 1.00 1.13 1.00 0.88 0.88 1.00
Median 1.00 1.00 1.00 1.00 1.00 1.00
range 1-1 1-1.5 1-1 0.5-1 0-1.5 0.5-1.5
NI n 9 9 7 5 6 6
Mean 0.89 1.00 0.71 1.00 1.75 1.42
Median 1.00 1.00 0.50 1.00 2.00 1.50
range 0-1 0-2 0-2 1-1 1-2 0.5-2
PF n 7 7 6 8 8 8
Mean 1.00 1.43 0.67 0.94 1.38 1.36
Median 1.00 1.50 1.00 1.00 1.00 1.00
range 1-1 1-2 0-1 0-1.5 1-2 1-2
PI n 9 9 9 4 4 4
Mean 0.89 1.33 0.89 1.00 1.25 0.63
Median 1.00 1.00 1.00 1.00 1.00 0.63
range 0-1 0-2.5 0-2 1-1 1-2 0-1
Fibronectin
Fibronectin expression was strong (score 4) throughout the endometrial stroma
including the endothelium (Fig. 6.8). There was no glandular or surface epithelial
expression of fibronectin and expression was the same in all four groups and between
LH+7 and LH+13.
Discussion
Several groups have considered the role of integrins and other adhesion molecules in
endometrial function. Most widely published is the work of Lessey et al., most
importantly in relation to ai, avp3 and a*. antigens. They have described the
distribution of these antigens in defining the "window of implantation" (Lessey et al.
1994) and have suggested that in some subfertile women there is a failure to express
these endometrial integrins in a normal pattern (Lessey 1995). This was related in
particular to so-called "out of phase" endometrium and associated failure of
epithelial progesterone receptor down regulation (Lessey et al. 1996a).
In endometrial stroma, Lessey (1994) described expression of the ai antigen
throughout the menstrual cycle, maximal during the proliferative phase and from the
mid-secretory phase onwards with only low levels in the first part of the secretory
phase. VLA-1 was present in epithelial cells only in the secretory phase. This
distribution of cci expression is confirmed by current data. Similarly the present
study has confirmed the distribution of avP3 in human endometrium which was
reported by Lessey et al. (1994) with a general increase in expression in the late
secretory phase. There was also a general decrease in 04 expression at this stage of
the menstrual cycle. Although both Lessey (1992) and Tabibzadeh (1992) suggested
that 0C4 was present only in epithelial cells, the present study has clearly shown VLA-
4 expression throughout the stroma also, more in keeping with the report from
Lessey et al. (1994). Klentzeris et al. (1993) did not find a significant cyclical
change in VLA-4 either but did report a difference between fertile and subfertile
endometrium, the subfertile tissue expressing little or no glandular epithelial VLA-4
and only low levels of expression elsewhere in contrast to fertile tissue where
expression was detected throughout the endometrium and at all stages of the luteal
phase of the menstrual cycle.
Lessey (1996) reported aberrant 0^3 expression in out of phase endometrium with
failure to produce the day 19 rise demonstrating an absence of P3 in endometrium.
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These findings were not reflected in the current study where neither fertility nor
previous parity appeared to exert an effect on expression of this integrin.
Tabibzadeh and Poubouridis (1990) examined ICAM-1 expression in human
endometrium. ICAM-1 was expressed uniformly throughout the endometrium and
throughout the menstrual cycle, although more strongly in endothelial cells than
either stromal or epithelial cells. This current study showed little or no expression in
epithelium compared with stroma but confirmed the high endothelial expression.
Tawia et al. (1992) suggested that there was no glandular or secretory epithelial
expression of ICAM-1 which is more in keeping with the results described here.
Contrary to the report of Bilalis et al. (1996), fibronectin was clearly detected in the
stroma and vessels of both fertile and subfertile endometrium thus challenging their
interpretation that altered integrin expression may have a secondary effect on the
secretion of extra-cellular matrix (ECM) proteins and thus affect implantation. They
found a similar lack of collagen IV and laminin in subfertile tissue. These ECM
proteins have not been re-examined in this current study.
Some differences in results reported by different groups may be related to the use of
different monoclonal antibodies and also the possibility of cross labelling because of
the shared subunit structure of some adhesion molecules. In addition methods of
assessing the degree of expression of antigens in endometrium and its constituents
varies between studies and different techniques may confer different sensitivities.
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Conclusion
There are clear cyclical changes from LH+7 to LH+13 for some adhesion molecules,
namely CD49a, CD61 and VLA-4. There appears to be little difference between the
fertile and subfertile populations studied.
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CHAPTER 7




THE EFFECTS OF EMBRYO DERIVED FACTORS ON ENDOMETRIAL LEUCOCYTE
FUNCTION.
Introduction
From the preceding chapters and work by previous authors a complex picture of the
potential roles of endometrial compartments and their products is emerging. It is
likely that different areas of the endometrium such as epithelium and stroma are
functionally discrete e.g. epithelium and stroma, although capable of interaction.
There is clearly an overall control by ovarian steroid hormones but this is not
necessarily by direct action on their effectors (Chapter 4).
Although cyclicity in several areas of the endometrium has been demonstrated there
is less agreement on the putative deficiencies in subfertile women. In this study the
fundamental difference in oestrogen and progesterone receptor status has been
demonstrated in the endometrium of subfertile women (Chapter 3). It has not been
possible however, to show a significant difference in potential downstream factors in
these groups, neither leucocytes nor adhesion molecules differing significantly
(Chapters 5 and 6).
It is possible that the endometrium is less dynamic in a non-pregnancy cycle than in
the cycle where implantation is to occur. Its role after all is to provide a source of
nourishment and protection for a successfully implanting embryo. The findings of
the preceding chapters may have been coloured by the influence of late secretory
changes, which in the absence of an embryo may be of less relevance to the functions
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associated with implantation. These changes may represent instead the deterioration
of unsupported tissue heading for menstruation.
In a conception cycle the endometrium is exposed not only to circulating hormones
and endogenous soluble factors but also to a wide range of potential external
effectors. Although much of the semen accompanying sperm does not enter the
uterus, there are a large number of very potent effectors in its composition (Jequier
1995) and it is likely that some of these reach the endometrial cavity. Perhaps there
are factors that influence endometrial function amongst them. It would seem
reasonable that the fine tuning of endometrium is not required in a cycle where
intercourse has not occurred. There is a suggestion that in mice seminal TGF(3l is
responsible for a transient inflammatory response in the endometrium following
mating which may affect the maternal immune response to the pre-implantation
embryo (Robertson et al. 1997). It is of note however, that successful embryo
transfer after IVF is in general not preceded by insemination.
Of greater importance when considering the influence of "external" factors on
endometrial behaviour is the embryo / endometrial interaction. Potential embryo
derived products have been examined to establish a connection with endometrial
receptivity and Nieder et al. (1987) demonstrated the secretion by mouse blastocysts
of an array of 23 proteins in vitro. Lea et al. (1991) identified the polyamines
spermine and spermidine in the pooled supernatants of human transfer grade
embryos. They suggested that the presence of these molecules, conferring
immunosuppressive activity to the supernatant, was required for successful
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implantation. Sheth et al. (1991) measured IL-1 and IL-2 levels in embryo
supernatants using commercially available ELISA kits and reported lower EL-1 levels
in supernatants derived from women who subsequently achieved a pregnancy. The
usefulness of this study was limited by the fact that embryos were cultured in groups
and the supernatants from sibling embryos pooled prior to analysis. Thus no
distinction could be made between individually successful or unsuccessful embryos
and no account could be taken of the potential effect of one embryo on another.
Seifer et al. (1993), in an attempt to overcome these limitations, performed ELISAs
on supernatants of individual embryos cultured in 2mls of medium. They failed to
demonstrate the presence of IL-6, IL-1 a, IL-1 (3 or leukaemia inhibitory factor (LIF)
in these culture supernatants, possibly because the concentrations were lower than
the sensitivity of the ELISA kits. In all these studies culture supernatants were
harvested at the time of embryo transfer, 2-3 days from fertilisation. In 1995
Austgulen et al. reported the presence of IL-1, IL-6, TGF(3 and receptors to TNF but
no TNF in the culture supernatants of embryos derived from IVF. There was no
correlation with embryo morphology. Simon et al. in 1997 described the
examination of individual embryo culture supernatants for IL-1 but did not report
their findings.
The direct examination of embryo culture supernatants has not advanced
significantly and the effects of known embryo derived proteins on the endometrium
itself has been highlighted for consideration. Work in mice has drawn attention to
LIF as an important factor in implantation, focussing attention on this cytokine in the
human system. Several groups (Chamock-Jones et al. 1994, Kojima et al. 1994;
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Arid et al. 1995; Cullinan et al. 1996) have shown cycle dependent expression of
LEF in human endometrium, a cytokine which in mice is an absolute requirement for
fertility (Stewart et al. 1992). Expression of the receptor for this factor has been
inferred from the finding of blastocyst messenger ribonucleic acid (mRNA) for the
LIF receptor (LIF-R) at the appropriate stage of development (Charnock-Jones et al.
1994). Roles for this potential embryo/endometrial interaction include effects on
trophoblast differentiation (Bischoff et al. 1995, Nachtigall et al. 1996). In addition,
recent work by Simon et al. (1993, 1994) has greatly increased the understanding of
the "IL-1 system" in humans, investigating the distribution in endometrium and
embryo of the components of that system (IL-loc, IL-ip, IL-1R types I and II and IL-
1R antagonist [IL-IRa]). This group has shown that the secretion of IL-la and IL-
1P by human embryos is fundamental to their ability to adhere to human
endometrium in vitro (Simon et al. 1997). This appears to be the result of up-
regulation of endometrial P3 integrin expression.
Embryo / endometrial interactions in humans have been reviewed extensively
(Simon and Pellicer 1995; Simon et al.1999). However, the lack of animal models in
which to study the processes of human invasive implantation and the regulated and
restricted used of human embryos in research (Human Fertilisation and Embryology
Act 1990), means that additional novel methods for investigating these interactions
are required.
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In the Centre for Reproductive Medicine, Royal Victoria Infirmary during the time of
this study there was no freezing programme for spare embryos produced following
IVF. Consequently there was a significant number of embryos which were either
discarded or used in licensed research programmes. Embryos, which are to be
discarded, may, under the Human Fertilisation and Embryology Act (1990) be
maintained in-vitro for no longer than 14 days following fertilisation. The value of
prolonged culture performed routinely is to assess blastocyst development (Fig. 7.1).
Crude information derived from this process is used in the assessment of couples for
future cycles of treatment as blastocyst development is considered to reflect good
quality embryos. A couple failing to conceive in a particular cycle of IVF treatment,
but producing a significant number of blastocysts in spare embryos, despite the
"best" ones having been replaced, would be considered to be at an advantage over a
couple where blastocyst development was poor. Embryo quality would be less of a
deciding factor in their chances of a successful cycle of treatment in any subsequent
cycle.
In a research setting the advantage of collecting culture supernatants from such
embryos is that although pregnancy outcome for each embryo cannot be assessed, the
potential success of each embryo can be ascertained by its development or otherwise
to blastocyst stage. In contrast in the studies described above, embryo culture
supernatants were harvested at the time of embryo transfer. In addition the success
of an individual embryo cannot be inferred from pooled culture supernatants since
the contribution of a single embryo cannot be determined and the triplet rate - 100%
implantation rate - is only around 5% for a 3 embryo transfer. As individual cultures
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Figure 7.1. a) 8-cell human embryo, b) human blastocyst.
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are performed in relatively low volumes in this laboratory and culture for these
purposes was for 5 days, then it is possible that higher concentrations of any embryo
products would be established by the time of harvest and analysis.
In considering endometrial leucocyte function it is of value to investigate the
potential effect of embryo derived products on these individual populations. The tiny
volume of supernatants available requires development of low volume assays.
It is with the interest in endometrial leucocytes and their functions underlying this
thesis, that methods have been investigated to examine the effect of embryo derived
factors on individual leucocyte populations isolated from endometrium.
1. Evaluation of a Low Volume Leucocyte Proliferation Assay
As has been discussed, in order to evaluate the properties of individual embryo
culture supernatants, any assay must make use of relatively small volumes of
material. In order to examine the effect of such culture supernatants on endometrial
leucocyte populations, also available in limited numbers, small volume leucocyte
functional assays are required. In the following study peripheral blood lymphocytes
have been used in such a low volume assay. The aim was to evaluate the technique.
Standard mitogen-induced peripheral blood leucocyte proliferation assays are
performed in 96-well, flat-bottom microtitre plates (Nunclon, Paisely, UK) (Fig.
7.2a) requiring lxlO5 cells per well in a final volume of 200pl. The smaller volume
60 well Terasaki plates (Nunclon) (Fig. 7.2b) require around 4xl03 cells per well in a
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Figure 7.2a) Standard 96-wellplate. b) Terisake plate. Scale is in
centimetres.
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hanging drop of 20jxl final volume. This part of this chapter outlines the evaluation
of such low volume assays for proliferation of peripheral blood lymphocytes.
Materials and methods
Preparation ofperipheral blood lymphocytes
20mls of blood was obtained at venepuncture and immediately heparinised (20iu/ml)
in a universal container. An equal volume of phosphate buffered saline (PBS, pH
7.4) was added to the blood and mixed. In universal containers, 10ml aliquots of
diluted blood were each layered onto 5mls of Lymphoprep TM (Nycomed Ltd., Oslo,
Norway) producing a sharp interface. These preparations were centrifuged at 800G
for 20 minutes without the brake. The resulting intermediate cloudy layer was
harvested from the four tubes and each added to 25mls of PBS. Further
centrifugation was performed (400G; 15 minutes; 3 brake). Each pellet was
resuspended in 1ml PBS and topped up to 25mls. Centrifugation was performed
again (200G; 10 minutes; 3 brake). Each pellet produced was resuspended in 1ml
RF10 (incomplete RPMI medium supplemented with 10% fetal calf serum
[Appendix 4]) for a cell count to be performed. This suspension was further diluted
to give an appropriate cell concentration.
Proliferation assay
Assays were set up using standard 96 well plates and the smaller 60 well Terasaki
plates. Triplicate or quadruplet wells were used and cells were incubated with
phytohaemagglutinin (PHA, Sigma) at varying concentrations to stimulate
proliferation. In the 96-well plates 100p.l of mitogen was added to lOOpl PBLs in
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RF10 (lxlO5 cells/well) to achieve a final total volume of 200p,l whilst in the
Terasaki plates 10|il of mitogen was added to 10|al of PBLs in RF10 (4xl03
cells/well). The plates were incubated for three days at 37°C in humidified 5% CO2.
Terasaki plates are inverted for all incubations, producing a "hanging drop" culture.
Controls
Control wells, used in each experiment described below, contained either cell
preparations with medium alone substituting for PHA, or medium containing no cells
replacing the cell preparation. In addition there were wells containing neither cells
nor PHA, both having been replaced by medium.
Pulsing
Tritiated ( H) thymidine (Amersham Life Sciences, Little Chalfont, UK) was added
to each well, 0.4pCiAvell to the 96-well plates (10p.l of 40p.Ci/ml stock solution) and
0.16p,Ci/well to the Terasaki plates (lpml of 160pCi/ml stock). Plates were then
incubated for a further six hours before harvesting.
Harvesting
For 96-well plates, the plate was harvested by aspiration onto filters which were
dried overnight prior to counting with a Direct Matrix P Counter without scintillation
fluid.
For Terasaki plate vacuum harvesting onto filters from the inverted plate was
performed using equipment designed specifically for this purpose (Flow Labs). The
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filters were dried overnight and individual discs combined with 20pl liquid
scintillant (Microscint-O™, Packard, Canberra, Australia) on a microplate
scintillation counter (Top Count™, Packard).
Experimental design
Experiment 1 - 96-well plates compared with Terasaki plates
This experiment was performed to compare peripheral blood leucocyte proliferation
assays in the two plate types using different concentrations of PHA. Triplicate wells
were set up in each plate as described above. PHA concentrations of 2pg/l, lpg/1
and 0.5pg/l were used. Controls were set up as described.
Experiment 2 - Optimisation ofPHA concentration
This experiment was designed to assess the optimal concentration of PHA to induce
PBL proliferation in Terasaki plate assays. PHA concentrations of 4pg/l, 2pg/l and
lp.g/1 were assessed in triplicate wells as described above.
Experiment 3 - Optimisation ofcell concentration
This experiment confirmed the ideal PHA concentration to be used by examining
doubling dilutions from 8pg/l to 0.125|Xg/l. This was combined with an assessment
of the most useful cell concentration to use in the Terasaki plates. A higher cell
concentration was proposed because of relatively low counts achieved in some of the
preliminary experiments. It would be predicted that a higher cell concentration
would achieve a higher stimulation index (SI) but very high cell concentrations may
outstrip a well's capacity to support the proliferating culture and therefore result in a
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lower SI. The experiment was performed with cell concentrations giving 4x10
cells/well and lxlO4 cells/well.
Experiment 4 - The effect ofconditioned embryo culture medium (EC medium)
This experiment tested the effects of a range of mixtures of RF10 and EC medium
[Appendix 4] media (100/0 to 50/50) and 100% EC medium on the above
proliferation assay. This was done to exclude the possibility that EC medium in the
embryo culture supernatants to be assessed would have direct effects on cell
proliferation. EC medium was "conditioned" prior to use by storage in the embryo
incubator (5% CO2) for 24 hours under the same conditions as the embryo cultures
(see below).
Results
In the results of each of the experiments outlined below initial data are expressed in
mean counts per minute (cpm) of either 3 or 4 replicate wells. These values
however, do not allow direct comparisons to be made between different experiments
performed on different plates or on different occasions. In these experiments
stimulation index (SI) relates to the effect of added mitogen and is defined as the
mean cpm from test wells in the presence of PHA / mean cpm for control wells with
cells and medium alone, added. This allows for better comparison between
experiments.
Thus the following equation was employed:-
SI = cpm test wells [cells + PHA1 .
cpm control wells [cells + no PHA]
176
Experiment 1
The results obtained using Terasaki plates in this assay were equivalent to those
obtained using 96 well plates on a qualitative basis (Table 7.1). Direct comparison
of counts cannot be made because of the different techniques and equipment used.
Stimulation index (SI) was calculated for both plates to compare the two (Table 7.1).
Since there is a possibility of synergism between cells in culture, conditions in the
hanging drops of Terisake plates may differ from those of the larger 96-well plate
with bigger cell numbers. The pattern of stimulation between the two plate types is
similar even though actual stimulation index values appear lower (5.4 - 17.9) when
compared with the 96-well plates (26.3 - 56.6). This indicates that use of hanging
drop Terasaki plates is a useful approach to assessing leucocyte function with the
limited numbers of lymphocytes likely to be obtained, for example, from Pipelle
samples.
Table 7.1. Comparison of96-well versus Terasaki plates.
PHA
concentration
2ftg/l lpg/1 0.5jxg/l 0|Tg/l
96-well
median cpm. 10269 5152 4813 177
range 10065-10269 4570-7197 4462-5181 173-199
SI 56.6 30.8 26.3 0
Terasaki
Median cpm 1113 682.5 333.9 63.2
range 1094.7-1131.3 491.6-932.6 303.4-364.4 49.4-74.5
SI 17.9 11.3 5.4 0
Ill
Experiment 2
In order to optimise the experimental conditions used in the Terasaki plates, the
range of PHA concentration used was widened. In this situation 2pg/l gave a higher
optimal SI (43.7) than either 4^ig/l (SI=21.1) or lp.g/1 (SI=39.7) (Table 7.2).
Table 7.2. Comparison ofPHA concentrations in Terasaki plate
PHA
concentration
Wi 2pg/l ljig/1 ong/i
median cpm 1786.6 3682.4 3354.6 103.2
range 1613.9-1959.3 3229.3-4186.2 3331.4-3377.7 46.2-104.3
SI 21.1 43.7 39.7 0
Experiment 3
Again in order to optimise experimental conditions in the Terasaki plates two PBL
concentrations were assessed over a range of PHA concentrations. Higher
stimulation indices were achieved using a higher concentration of cells as was
predicted (maximum SI 23.6 [PHA 4(ig/l]) compared with the lower concentration
(maximum SI 11.4 [PHA 2|ig/l]). Thus a useful working cell concentration of lxlO4
cells/well for use in subsequent assays was demonstrated (Table 7.3). Since the
primary objective was to establish an assay useful for the assessment of the
immunoregulatory effect of embryo supematants on PHA induced leucocyte
proliferation, the capacity for further stimulation in the hanging drop cultures needs
to be allowed for. The maximum SI achieved by lxlO4 cells was at a PHA
concentration of 4p,g/l, whilst increasing the PHA concentration to 8pg/l, reduced the
SI. This may be the result of saturation of the response, a separate inhibitory or even
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Table 7.3. Comparison ofcell concentrations in Terasaki plate
4xl03 cells/well lxlO4 cells/well
PHA Median Range SI Median range SI
concentration cpm cpm
8 fig/1 570.6 418-675 5.6 1223.9 1064-1167 14.1
4pg/l 682.5 488-877 6.8 2009.3 1832-2195 23.6
2 fig/1 1103.0 1034-1294 11.4 1750.5 563-2120 17.4
Wl 1030.7 833-1194 10.2 1370.2 1228-1628 16.5
0.5pg/l 465.4 356-664 4.9 1020.6 428-1186 10.3
0.25pg/l 313.85 230-365 3.1 332.9 146-520 3.9
0.125pg/l 190.7 126-371 2.2 112.3 83-177 1.4
0pg/l 97.3 32-170 0 82.3 57-119 0
toxic effect of higher concentrations of mitogen, or the ability of the culture to
outgrow the nutritional resource of the well such that further expansion cannot be
supported. Thus in order to allow scope for additional stimulation of proliferation in
the presence of embryo supernatants, 2pg/l PHA was considered a suitable
concentration for use in future assays.
Experiment 4
The aim of these experiments was to evaluate the small volume leucocyte
proliferation assay for use with endometrial leucocytes available in restricted cell
numbers and embryo culture supernatants available in restricted volumes. Embryos
are cultured in a specialised medium. This experiment was designed to test the effect
of conditioned embryo medium on PHA induced PBL proliferation. A range of
ratios of conditioned embryo culture medium with RF10 was assessed (0/100 to
50/50 volume/volume). No titratable effect was seen (mean cpm 2874.6 - 3900.2)
confirming that the presence of conditioned embryo culture medium had no
consistent effect on PHA induced peripheral blood cell proliferation (Table 7.4).
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Table 7.4. Effect ofEC medium on cell proliferation.









With reference to the optimisation of experimental conditions, it can be seen that the
use of 60 well Terasaki plates is appropriate for the examination of leucocyte
proliferation using low cell numbers. An optimal working cell concentration of
lxlO4 cells per well and a PHA concentration of 2pg/ml were used. In addition it has
been shown that the presence of conditioned embryo culture medium alone has no
effect on the PHA induced peripheral blood lymphocyte proliferation.
2. Assessment Of The Effect Of Individual Embryo Culture Supernatants
On PHA Induced Peripheral Blood Leucocyte Proliferation.
The second section of this study addresses the potential to assess the effects of single
embryo culture supernatants in small volume leucocyte assays. Following the
evaluation of the use of Terasaki plates in PHA induced peripheral blood leucocyte
proliferation assays it can be seen that such assays could be used with limited
volumes of test culture supernatants. These supematants potentially contain embryo
derived factors involved in successful embryo-endometrial interactions.
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Oocytes retrieved for the process of IVF are mixed with the sperm preparation soon
after collection. 16-20 hours later they are checked for fertilisation. In the presence
of normal eggs and sperm a fertilisation rate of approximately 70-80% is expected.
Embryo replacement is usually performed two days following collection. At the time
of this study, in this unit spare embryos are cultured in lOOpl embryo medium in
droplets containing three or more. These were routinely grown on to blastocyst stage
then discarded. For the experiments to assess the effect of individual embryo culture
supernatants, the technique was modified to culture single spare embryos in 100pi
droplets. The culture supernatants of these individual embryos were harvested at the
time of blastocyst disposal when the low volume of each supernatant was likely to
contain early gene products secreted during the normal growth of the embryo.
Materials and methods
Embryo and blastocyst supernatants
In this unit it was normal practice to set up multiple embryo culture of spare embryos
for growth to blastocyst stage as discussed above. For the purposes of this study,
single embryo cultures were set up when, after embryo transfer, there were
approximately 10 spare embryos available and where it was expected from a couple's
previous history that a "good" blastocyst response would be achieved in those
embryos. Embryos were maintained in lOOpl droplets in EC medium [Appendix 4]
at 37°C and in 5% CO2. For each set of sibling embryos, supernatants from both
blastocysts and less well developed embryos were harvested when the embryos
themselves were discarded (at around day 12). The culture supernatants were
immediately frozen and stored at -70°C.
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Peripheral blood leucocyte preparation
This was performed as described above. The PBL cell concentration was adjusted to
2xl06 cells/ml.
Proliferation assays
60 well Terasaki plates were used and to each well was added 5p,l of PBLs (lxlO4
cells/well), 5pl PHA (to give final concentration of 2p,g/ml) and 10pl of embryo
culture supernatant. Quadruplet wells were set up. Incubation, pulsing and
harvesting were performed as described above.
Controls
Multiple control wells included those where either no cells or no PHA was added in
the presence of the other components with extra medium (RF10) making up the
volume. As a control for the effect of culture supernatant, wells contained
conditioned embryo culture medium.
Evaluation
Plates were analysed as described above giving a value of counts per minute (cpm)
for each well. The stimulation index relating to the effect of embryo culture
supernatants on PHA induced PBL proliferation was calculated using the following
equation:-
SI = cpm test wells fcells + PHA + embryo culture supernatant!.
cpm control wells [cells + PHA + conditioned embryo medium]
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This SI therefore represents only the effect of the presence of the embryo culture
supernatant on PHA induced PBL proliferation. Thus a figure for SI less than 1
denotes suppression whilst a figure greater than 1 denotes stimulation.
In addition the stimulation index for the effect of embryo culture supernatant on PBL
proliferation in the absence of mitogen was calculated thus:-
SI = cpm test wells fcells + embryo culture supernatant!.
cpm control wells [cells + conditioned embryo medium]
In each case the percentage inhibition was calculated using the following:-
% inhibition = (1 - SI) x 100
Statistical analysis
Comparisons of embryo types (blastocysts versus less well developed embryos) and
the effects of their culture supernatants on PHA induced PBL proliferation, were
assessed using the Mann-Whitney test of significance.
Results
The effects of embryo culture supernatants on PHA induced proliferation of
peripheral blood lymphocytes was heterogeneous but generally indicated a reduction
in the level of proliferation.
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The percentage inhibition with supernatants from blastocysts ranged from -48.8 (ie.
no inhibitory effect) to +83.4 (ie. inhibitory effect) with PHA (Table 7.5) and -76.8
to +72.9 without PHA (Table 7.6). In the case of non-blastocyst culture supernatants
the ranges were -119.9 to +58.9 with PHA (Table 7.5) and -142.3 to +61.3 without
PHA (Table 7.6). These wide ranges of effects are reflected in the heterogeneity, not
only between embryos of different subjects but also between sibling embryos.
Figure 7.3 shows the broad scatter of values of percentage inhibition for each group
of embryos tested.
Table 7.5. The effects of individual embryo culture supernatants on PHA induced peripheral blood
lymphocyte proliferation.




BK 1 0.4 58.9 1 1.0 3.3
2 0.7 26.4 2 0.6 44.3
3 1.1 -6.9
JH 1 0.5 50.0 1 0.8 23.2
2 1.2 -21.5 2 0.7 27.7
3 0.7 30.9 3 0.2 81.8
4 1.0 3.8 4 1.5 -48.8
LC 1 0.9 6.9 1 1.0 -1.1
2 1.0 -2.3 2 0.8 22.7
JC 1 2.2 -119.9 1 0.5 52.3




KS 1 1.1 -12.0 1 1.2 -14.7
2 1.1 -7.4 2 1.1 -14.3
JHB 1 0.7 31.9 1 0.7 30.8
2 1.3 -30.2 2 0.8 21.9
3 0.9 11.1 3 0.5 46.4
AB 1 0.9 7.7 1 0.6 35.3
GH 1 1.2 -18.4 1 0.2 83.4
2 1.5 -50.4 2 0.7 28.6
Figures in italics denote stimulation.
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Table 7.6. The effects of individual embryo culture supernatants on peripheral blood lymphocyte
proliferation without PHA.




BK 1 0.8 19.4 1 0.4 62.8
2 0.4 61.3 2 1.3 -28.9
3 0.3 66.9
JH 1 0.8 24.7 1 0.6 42.1
2 0.6 44.4 2 1.8 -76.8
3 0.9 9.2 3 0.9 10.4
4 0.5 45.9 4 0.4 56.1
LC 1 0.7 30.8 1 0.3 68.2
2 0.5 50.4 2 0.3 73.0
JC 1 0.4 57.5 1 1.2 -19.7




KS 1 0.9 5.3 1 0.5 47.5
2 2.4 -142.3 2 0.4 58.3
JHB 1 0.9 13.6 1 1.3 -26.8
2 0.6 44.0 2 0.4 61.3
3 0.6 43.9 3 0.4 60.6
AB 1 1.1 -7.0 1 1.1 -6.7
GH 1 0.9 11.3 1 0.3 70.1
2 0.7 30.1 2 0.3 72.9
Figures in italics denote stimulation.
The data described above were collected in three separate experiments. The PHA
stimulation indices for these experiments, that is, the effect of PHA on PBL
proliferation in the absence of embryo culture supernatant ranged from 5.2 to 39.4.
This illustrates the need for conversion of counts per minute to stimulation index in
order to make useful comparisons between assays performed on different occasions.
Blastocyst versus non-blastocyst
Although both groups, blastocyst and non-blastocyst culture supernatants had an
inhibitory effect on peripheral blood lymphocyte proliferation, there were no
significant differences shown between the blastocyst and non-blastocyst experiments
either with (p=0.446) or without PHA (p=0.550) (Table 7.7).
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Figure 7.3. Scatter ofinhibition (andstimulation - negative plots) ofperipheral
blood lymphocyteproliferation withoutPHA; a) blastocyst and b) non-blastocyst
supernatants andwith PHA; c) blastocyst and d) non-blastocyst supernatants.
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Table 7.7. Percentage inhibition ofperipheral blood lymphocyte proliferation by embryos.
Without PHA Median % inhibition range Significance
Blastocyst 57.2 -76.8 to +73.0 0.446
Non-blastocyst 27.4 -142.3 to +61.3
With PHA
Blastocyst 22.9 -48.8 to +83.4 0.550
Non-blastocyst 0.7 -119.9 to +58.9
Mann-Whitney test. Significant if p<0.05.
The effect ofPHA
Despite the lack of a significant difference between blastocyst and non-blastocyst
supernatants on PBL proliferation, it can be seen that in both groups the inhibition of
proliferation was less when PHA was present. This was significant in the blastocyst
group (p=0.047) (Table 7.8).
Table 7.8. Percentage inhibition ofperipheral blood lymphocyte proliferation by embryos. The effect
ofPHA.
Blastocysts Median % inhibition Range Significance
Without PHA 57.2 -76.8 to +73.0 0.047
With PHA 22.9 -48.8 to +83.4
Non-blastocysts
Without PHA 27.4 -142.3 to +61.3 0.098
With PHA 0.7 -119.9 to +58.9
Mann-Whitney test. Significant if p<0.05.
Conclusion
The supernatants of cultured embryos appeared to be generally inhibitory although
this was less clear when PHA was present. There appeared to be no difference in the
inhibitory effect of supernatants from blastocysts on PBL proliferation when
compared with supernatants from non-blastocysts but the presence or absence of
PHA stimulation had a significant effect in the case of culture supernatants from
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blastocysts. It can be seen however, that individual embryo supernatants varied
widely in their regulatory effects on PBL proliferation and this did not appear to be
associated with parental origin.
3. IsolationOf CD3 + Lymphocytes From Pipelle Endometrial Samples
The previous experiments in this chapter have established the usefulness of the small
volume PHA induced PBL proliferation assay to assay embryo culture supernatants.
In order to make such assays relevant to endometrial work evaluation using isolated
endometrial leucocyte populations is required. In addition, it is preferable to avoid
the cloning of cells such that normal function is compromised as little as possible.
Isolation from endometrium of purified eGLs (98%) has been achieved in this
laboratory by other workers (Jones et al. 1997c, Vassiliadou and Bulmer 1998).
Their function in relation to time of cycle, miscarriage and endometriosis have
subsequently been investigated in vitro without cloning. In these situations however,
endometrium from a major proportion of the cavity of the hysterectomised uterus or
a sizeable portion of early pregnancy decidua has been available as a source of cells
and as previously noted eGLs comprise the greatest proportion of the endometrial
leucocyte population.
For work relevant to fertility, timed endometrial samples are required. Hysterectomy
specimens are therefore rarely of value since when performed in young women, the
indication either far outweighs any research needs for timing, for example cervical
cancer, or may have an endometrial component which could affect the results, for
example endometriosis. Timed endometrial biopsies are more appropriate in this
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setting as previously discussed but the numbers of leucocytes available are likely to
be correspondingly small.
In the final part of this chapter T cells, comprising the smallest, yet a potentially
important endometrial leucocyte population, have been isolated from a Pipelle
sample of endometrium to confirm that adequate numbers of such cells can be
retrieved by this technique for study in low volume assays. This would allow




A Pipelle endometrial biopsy was taken from a uterus obtained at hysterectomy in
the secretory phase for non-endometrial causes. The technique used to obtain the
sample mimicked that performed in vivo [Appendix 2],
Isolation ofCD3+ lymphocytes.
The endometrial sample was finely minced and digested in 0.1% collagenase type II
(Sigma Chemical Co.) and 0.01% DNAase type IV (Sigma Chemical Co.) in
incomplete medium (Appendix 4) at room temperature for 40 minutes. The digest
was sieved through a 40pm cell strainer and then treated with 0.84% ammonium
chloride for a further 10 minutes to lyse red cells. Cells were then washed in
incomplete medium. Nigrosin staining of a small sample confirmed good viability.
The sample was then resuspended in RF10 for a cell count and adjusted to a
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concentration of approximately lxlO6 cells/ml. Plastic adhesion to remove
macrophages and stromal cells was achieved with overnight culture (5% CO2, 37°C)
in a 75cm3 plastic culture flask, and non-adherent cells retrieved, namely
lymphocytes.
For positive selection of T cells, isolated lymphocytes were resuspended in
incomplete medium and incubated with primary FITC conjugated mouse anti-CD3
antibody (Becton Dickinson), used at 5p.l / lxlO6 cells and diluted at 1:100 with
incomplete medium, for 30 minutes at 4°C. This cell and antibody suspension was
added to 20mls ice cold phosphate buffered saline pH 7.4 (PBS) and centrifuged (10
minutes, 200G). The resultant pellet was then resuspended in a further 20mls PBS.
A final pellet was obtained by centrifugation (10 minutes, 200G). This pellet of cells
was then resuspended in Mini MACS buffer containing 40(0.1 of MACS IgGl and
IgG2 mixed microbeads beads and incubated for 15 minutes at 4°C. Mini MACS
magnetic beads are coated with anti mouse IgG and thus bind the antibody labelled
cells. After this period, the cells were adjusted to 1ml with Mini MACS buffer and
dispersed using a 26G needle. The bead labelled cells were loaded onto a Mini
MACS column in a magnetic field which retains them in the column, and washed
with 500pl of Mini MACS buffer to wash out any remaining CD3 negative cells
(fraction MM1) (Fig. 7.4). This fraction therefore should contain all the unlabelled
cells. Further washes with 2 x 500pl of Mini MACS buffer were performed and the




























MMl MM1 MM2 MM3
Figure 7.4. Diagram ofMini MACSprocess. MMl contains all cells not labelled
with beads. MM2 contains no cells. MM3 contains CD3 positive bead-labelled cells.
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The column was then removed from the magnet, and washed 2 further times with 2 x
500pl of Mini MACS buffer to elute the CD3 positive cells into fraction MM3.
Evaluation
Flow cytometrical analysis (FACS) of MM1 and MM3 was performed to assess
purity and characterise the cell populations represented in each. The samples were
analysed immediately using a flow cytometer (FACScan, Becton Dickinson) and the
"Cell Count" software (Becton Dickinson). Gates were set to known T cell values to
exclude dead cells and debris. Histograms were plotted.
Results
Following digestion of the Pipelle endometrial sample 38xl06 cells were obtained in
total with >95% viability. 15.25xl06 non-adherent cells were obtained after
overnight culture.
Following elution from the Mini MACS column the MM1 contained 13.3xl06 cells
(6.65xl06/ml) whilst MM3 contained 0.625xl06/ml.
FACS analysis of the cell preparation prior to Mini MACS selection showed that
9.41% of the cells were CD3 positive. FACS analysis of the Mini MACS fractions
confirmed the separation of two separate populations of cells. MM3 contained CD3
positive cells with a purity of 99.36% whilst MM1 contained only 3.28% CD3
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Conclusion
CD3 positive T cells could be isolated from digested Pipelle samples using the Mini
MACS process in low numbers (~60xl04 cells) suitable for low volume functional
assays in Terasaki plates and at high purity (99.36%).
Discussion
The aim of this chapter was to consider the feasibility of examining the interactions
of isolated endometrial leucocytes and embryo products. The present study has
established that, whereas in previous studies pooled embryo culture supernatants
were used (Sheth et al. 1991), small volume leucocyte functional assays, such as the
PHA induced PBL proliferation assay, can be used to successfully assess the
immunoregulatory effect of individual embryo culture supernatants. In addition, the
present finding of heterogeneity observed amongst supernatants of blastocysts and
non-blastocysts and between sibling embryos means that useful extrapolation of their
in vitro behaviour to in vivo outcome using pooled or even individual culture
supematants is doubtful.
Although cloned isolated CD56 positive eGLs have previously been examined for
function, it is only recently that their in vitro response to possible effectors has begun
to be examined using isolated non-cloned cell populations. The smaller endometrial
leucocyte populations have not previously been isolated and examined in this way. It
has been shown in the present study that there are suitable techniques for their
examination in small numbers; and moreover, these leucocytes may be isolated with
high levels of purity from small endometrial biopsies in sufficient numbers for use in
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these small volume assays. These findings, have not been elaborated further in this
thesis but pave the way for further interesting research into the interactions between






The aim of this thesis was to try to elucidate endometrial features that may have a
bearing on the problem of unexplained sub fertility. Around 1 in 7 couples
attempting to achieve pregnancy will experience difficulties and of those
approximately 25% will have entirely normal investigations. Sadly despite the great
technological advances of recent years in the field of assisted reproductive treatment,
there have been few inroads made in narrowing the diagnosis for this particular
group of couples. It remains therefore that the best option for successful
management of unexplained subfertility is IVF or GIFT. For couples whose chance
of spontaneous conception remains at 1 to 3% per menstrual cycle (Hull et al. 1985),
IVF and GIFT are not only hugely over-sophisticated treatments but they will only
achieve 15-40% pregnancy rate per treatment cycle (Hull 1992). Since numerous
factors may be implicated there is little precision in the use of ART in this situation.
It would be of great benefit to these couples if an identifiable abnormality could be
discovered to explain their problems not only in order to improve treatment options
but also emotionally - a diagnosis is often easier to accept than a statistic. Ideally
such an abnormality could be readily tested for, clearly identified by the appropriate
test and correctable by simple means.
It is likely however, that the condition of unexplained subfertility is heterogeneous.
Potential problems include oocyte abnormalities, dysfunction of the egg release
mechanism or its follicular support, abnormalities of gamete transfer in the Fallopian
tube, the chemical milieu of the tube itself, sperm abnormalities, abnormalities of the
fertilisation process, abnormalities of the uterine environment, abnormalities of
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embryo/endometrial interactions and finally abnormalities of the endometrium itself.
In addition there will be other physical, psychological and social factors that may
play a role in relative subfertility. Some of these problems may become apparent
during the course of treatment; for example, normal appearing sperm may fail to
fertilise normal appearing oocytes in vitro. This difficulty may be by-passed by the
process of intra-cytoplasmic sperm injection (ICSI) and potentially improved by the
various innovative treatments to the zona pellucida such as drilling (Fishel and
Timson 1992). Sperm abnormalities may also be identified at IVF and corrected by
ICSI. Tubal and endometrial environmental abnormalities could potentially be
sampled via local cannulation but may be relatively labile and affected by the
sampling process. Examination of the egg release mechanisms and
embryo/endometrial interactions potentially disrupt a conception cycle.
Endometrium is readily sampled in cycles where conception is avoided. There has
been as yet, little clear evidence of morphological or functional abnormalities
identifiable in the endometrium in relation to infertility however. The intimacy
between the ovarian endocrine and endometrial cycles means that closer examination
may yield cycle or hormone dependent abnormalities which may then be correctable.
Noyes et al. (1950) described the first useful examination of the cyclical changes
occurring in endometrium. Subsequent workers have attempted to improve on this,
recognising that more critical timing of biopsies, such as from ovulation rather than
last or next menstrual period, as well as more precise examination, gave more
reproducible results (Koninckx et al. 1977, Tredway et al. 1979, Johannisson et al.
1982, 1987, Shoupe et al. 1989, Li et al. 1987, 1988, 1989). The diagnosis of luteal
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phase deficiency, still made by some empirically, has remained controversial during
this debate (Li and Cooke 1991). It is difficult to consider so-called out of phase
endometrium if there is no accurate anchor from which to date a specimen. In
keeping with this lack of support for the diagnosis, which was considered in many
cases to be the result of progesterone deficiency, there is no clear evidence of
improved fertility following treatment with progestagens (Li and Cooke 1991). With
the use of better dating techniques it is now considered likely that there is a cohort of
women where the endometrium does not match the stage of cycle, not only at the
histological level but also functionally, and in whom fertility may be abnormal
(Lessey et al. 1992). If it is a cycle dependent abnormality it is to be hoped that
correction may be possible by means of cycle manipulation, perhaps hormonally.
There may also, however, be more static abnormalities which may again be detected,
though perhaps less readily treated.
In this thesis various factors influential to the endometrium and in particular to its
immunology have been considered and their study extended into the subfertile
endometrium. The uterus has always been considered to be a privileged
immunological site where embryos, composed of genetic material derived from both
maternal and paternal DNA can thrive. Although in the early stages of development
gene products are exclusively oocyte derived, around the time of implantation
embryonic genes begin to be expressed (Watson 1992) such that there is the potential
for maternal rejection of antigenically foreign material. Endometrial leucocyte
populations have previously been well characterised and it is of note that whereas
classical IgA-based mucosal immune systems have been detected in both cervix and
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Fallopian tube, no such system occurs in the endometrium (Johnson et al. 1999). In
fact the presence of plasma cells in the endometrium is indicative of endometritis
(Loke and King 1995). The tolerance, which develops in the uterus to allow not only
the survival of such foreign material but also its growth, is unique to this site and
must be the most fundamental function of the endometrium.
It was considered valuable therefore, to consider the immunology of the
endometrium in the first instance. Leucocyte populations of normal endometrium
have been defined throughout the menstrual cycle (Bulmer et al. 1991, Starkey et al.
1991). The CD56 positive endometrial granulated lymphocytes, because of their
dynamic population, have given rise to most interest. They are known to express
some antigens characteristic of NK cells (Bulmer 1991, King and Loke 1991) and
some NK cell activity and other functions have been identified in vitro (King and
Loke 1990, Ferry et al. 1991). Their numbers increase in the late secretory phase of
the menstrual cycle and this is at least in part, due to local proliferation (Pace et al.
1989, Tabibzadeh 1990).
The mechanisms that control the proliferation of eGLs have not been established. As
it is cycle dependent it seems likely that steroid sex hormones may play a role either
directly or indirectly. In this study the possibility of a direct influence of oestrogen
and progesterone on any of the endometrial leucocyte populations has been excluded
(Chapter 4). There was no evidence of expression of oestrogen or progesterone
receptors by any of the relevant populations of cells. This does not in itself exclude
the possibility of an indirect steroid influence, but makes a direct effect unlikely.
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A second aspect of the control of eGL numbers is the question of apoptosis in the
secretory phase. eGLs have an unusual morphology at this stage in the cycle which
has given rise to the hypothesis that they are undergoing apoptosis as part of the
termination of the secretory phase and onset of menses. High expression of bcl-2
antigen has in fact been reported in secretory phase endometrium which by virtue of
its protective properties against apoptosis could negate this argument for
programmed cell death. It is demonstrated in this study however, that only a small
proportion of CD56 positive eGLs express bcl-2 such that the majority of the high
level of bcl-2 expression in the late luteal phase exists in non-leucocyte stromal cells.
The possibility of apoptosis has not been completely excluded by this study but
additional evidence comes from Jones et al. (1998) where utilisation of TUNEL
method of detection failed to confirm significant amounts of apoptosis in late luteal
phase endometrium. This is also in keeping with work by Jones et al. (1997)
showing that eGLs purified from pre-menstrual endometrium are functional.
Steroid hormones clearly have a fundamental role to play in the cyclicity of the
endometrium but as they do not exert a direct influence on endometrial leucocytes it
was of importance to discover whether an indirect steroid hormone effect may have a
bearing on fertility. Oestrogen and progesterone receptor distribution in normal
endometrium has been fully described previously. In this study the distribution in
subfertile endometrium was also examined. Previous parity was also taken into
account. It was of particular interest to find that there was lower endometrial surface
epithelial progesterone receptor expression at LH+7, the time of implantation, in
subfertile endometrium, a finding which was significant in the parous individuals. In
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addition in the parous fertile subjects there was a significant reduction in endometrial
surface epithelial progesterone receptor expression from LH+7 to LH+13 which was
not seen in other groups. Thus for the first time a potential difference in endometrial
control resulting from previous parity has been identified.
Only the study by Klentzeris et al. (1994) has suggested a difference in endometrial
stromal leucocyte populations between fertile and subfertile endometrium. Following
on from the steroid receptor studies quantification of endometrial leucocyte
populations taking both parity and fertility status into account, was done. Although
there were no significant differences numerically in the endometrial leucocyte
populations in relation to parity or fertility, the population expansion of leucocytes
did appear to differ in subfertile tissue. The increase in leucocyte numbers from
LH+7 to LH+13 of which eGLs are primarily responsible is greater in fertile
compared with subfertile endometrium. Although the function of eGLs has not been
fully elucidated, it is likely that although they may not have direct impact on
trophoblast invasion, by virtue of secreted cytokines and co-operation in endometrial
messenger and immunological functioning, such differences may have a bearing on
fertility itself.
This study has not confirmed the findings of Klentzeris et al. (1994) with regard to
endometrial T cell sub-populations. Furthermore, examination of leucocyte
activation molecules, although confirming previous reports, did not show altered
status in subfertile tissue.
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The work of Lessey et al. (1992, 1994, 1995) on adhesion molecules is well
established and the idea of the window of implantation in relation to oci(3i, avP3 and
OC4P1 is generally accepted. They have reported disordered expression of some
adhesion molecules in the endometrium of the subfertile population resulting in the
failure to produce the appropriate window for implantation. Reported here (Chapter
6) is the expression of a battery of relevant adhesion molecules in the endometrium
of the four groups of subjects previously described. The general distribution and
stage specific changes of these adhesion molecules were confirmed but no significant
differences resulting from previous parity or fertility status were distinguished.
Although there have been no clear-cut abnormalities with regard to either
endometrial leucocyte populations or their distant (steroid hormones) and local
(adhesion molecules) controls there is a suggestion that endometrium of women with
unexplained subfertility may differ to some extent from that of fertile controls.
Further important work in this field would include an examination of the function of
the lymphocytes themselves and the response of the endometrium, including the
leucocyte populations to the embryo. Although eGLs have previously been
examined for function, endometrial T cells in particular, have not. In the same way
as eGLs differ from their peripheral blood counterparts it is unreasonable to assume
that endometrial T cells are functionally equivalent to circulating T cells of which
there are many sub-types. Consequently if the function of these cells is to be studied
in vitro they need to be first isolated from endometrium. To this end a pilot study
has been performed confirming that small populations of cells can be extracted from
Pipelle biopsies of endometrium in sufficient numbers to perform relevant functional
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assays. This has been performed successfully for the first time using the Mini
MACS system and opens the way to closer examination of these cells form different
groups of women and at different specified times of the cycle.
The examination of the embryo/endometrial interactions which are unique to the
human species is not straightforward. Investigation of this function in humans is
limited by legal and ethical considerations. The areas of human embryology and
implantation in vivo are covered from a legal point of view by the 1967 Abortion Act
and the 1990 Human Fertilisation and Embryology Act. There is some scope for
licensed work on human embryos in vitro under the auspices of the Human
Fertilisation and Embryology Authority (HFEA) but this is further limited by the
availability of suitable material.
A second pilot study was performed to examine the possibility of testing the effect of
embryo gene products on leucocyte functional assays. By using the small volumes
afforded by the hanging drop technique of the Terasaki plates the use of individual
embryo supernatants has been demonstrated. It is clear from the results that,
certainly at blastocyst stage and in embryos of an equivalent age, there is a
heterogeneity of effects of the supernatants on the standard mixed lymphocyte
proliferation response and this brings into doubt the value of examining pooled
supernatants which has only been reported before. Although Seifer et al. (1993)
failed to demonstrate key cytokines, IL-loc, IL-1(3, IL-6 and LIF using commercially
available ELISA kits, individual supernatants could potentially be examined at a
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variety of embryo stages, including those of transfer grade embryos at the time of
embryo replacement thus allowing some information regarding their outcome to be
obtained.
Although a definitive diagnostic test has not been elaborated from the work
described in this thesis, it has been possible to confirm important features of the
cyclical changes occurring in the endometrium at an immunohistochemical level and
in particular to consider differences in the endometrium as a result of parity.
Previously reported findings with regard to the endometrium in unexplained
subfertility have been challenged and some confirmed. In addition useful pilot
studies have been developed to allow more ready examination of other features of
endometrial immunology and its control. Future work would aim to look more
closely at the findings discussed in this thesis, in particular a closer examination of
the steroid responsiveness of the endometrial superficial epithelium which is the
initial site of contact with the embryo would be of interest in relation to previous
parity. Perhaps the altered receptor status seen here has a role in receptivity for the
establishment of subsequent pregnancies - it is generally accepted that parous
subfertile women are easier to treat than nulliparous. A detailed study of isolated
endometrial leucocytes would be of interest since their functions have not been fully
established. In particular T cell populations which have now been shown to be
amenable to isolation without cloning require further characterisation in the face of
fertility issues. It would be of value to explore further the use of embryo culture
supernatants in the investigation of endometrial/embryo interactions since the
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♦Increased expression in some early spontaneous miscarriages (Vassiliadou et al. 1999).
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APPENDIX 2
Endometrial sampling using Pipelle sampling device
1. Cuscoes speculum inserted.
2a). Cervix visualised.
Pipelle inserted.
3. Pipelle rotated with in-out action
to fill evacuated channel.
2b). Vulsellum applied ifnecessary to
anterior hp ofcervix.




Lymphocyte Populations In Human Endometrium And Their Relation To
Fertility.
This study is intended to look at the types of white cells present in the lining of the
womb. By looking at the nature and properties of these cells it is hoped that insight
into previously unexplained infertility may be gained.
In order to do this samples of endometrium (from the lining of the womb) are
required.
These samples are obtained by a small test taken in a similar way to a cervical smear.
A small tube is passed through the cervix allowing a scraping of tissue to be
obtained. Some crampy pain like a period pain may be experienced during this
procedure but should settle immediately afterwards.
In order to be able to compare the samples from different women they need to be
timed from mid-cycle, a urine test kit will be provided with instructions. Two
samples are required per subject over two cycles. A blood test will also be required at
the time of each sample to confirm your hormone concentration.
I have read and understood the above, and consent to take part in this study involving











Sodium bicarbonate 25 mM
Sodium pyruvate 0.5 mM
Human serum albumin 50 mg/ml
Earle's balanced salt solution (EBSS) 284±2 mOsm
For 200ml stock culture medium
EBSS 20 ml
Sodium bicarbonate 20 ml
Water Approx. 160 ml to give osmolality 284-286
mOsm




Final pH 7.4 in 5% CO2.
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